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Summary 
 
This thesis is divided into three parts with the main goal allocating novel antimicrobial 
compounds that could be used as future antibiotics. 
 
The first part aimed to evaluate the potential of plant suspension cultures for the production 
of antimicrobial proteins. The extracellular, intracellular and cell wall bound fractions of seven 
heterotrophic and photomixotrophic plant cell suspension cultures treated with nine different 
elicitors were tested for the elicitor dependent production of antimicrobial proteins. 
Bioactivities were tested against a selected panel of human isolates including Gram-positive 
and Gram-negative bacteria as well as fungi using the disc diffusion assay. The intracellular 
fractions of elicited cell cultures were more active than extracellular fractions while the cell 
wall bound fractions showed lowest activities. Among the 21 fractions tested, the intracellular 
fraction of Lavendula angustifolia elicited with DC3000 was most active against Candida 
maltosa. The second most active fraction was the intracellular fraction of Arabidopsis 
thaliana elicited with salicylic acid which was moreover active against all test strains. The 
antimicrobial activity of elicited Arabidopsis thaliana cell cultures was tested by 
bioautography to locate the antimicrobial proteins in the crude extract. The intracellular 
fraction of photomixotrophic Arabidopsis thaliana cells elicited with salicylic acid was selected 
for further gel filtration chromatography on S-200 column leading to the purification of one 19 
kDa antimicrobially active protein, designated, AtAMP. Our findings suggest that elicited 
plant cell cultures may present a new promising alternative source of antimicrobial proteins. 
 
The second part comprises the isolation of actinomycetes associated with marine sponges 
and testing the bioactivities of new species for further investigations. Actinobacterial 
communities of eleven taxonomically different sponges that had been collected from offshore 
Ras Mohamed (Egypt) and from Rovinj (Croatia) were investigated by a culture-based 
approach using different standard media for isolation of actinomycetes and media enriched 
with aqueous sponge extract to target rare and new actinomycete species. Phylogenetic 
characterization of 52 representative isolates out of 90 based on almost complete sequences 
of genes encoding 16S rRNA supported their assignment to 18 different actinomycete 
genera. Altogether 14 putatively new species were identified based on sequence similarity 
values below 98.2% to other strains in the NCBI database. The use of M1 agar amended 
with aqueous sponge extract yielded a putative new genus related to Rubrobacter which 
highlighting the need for innovative cultivation protocols. Biological activity testing showed 
that five isolates were active against Gram-positives only, one isolate was active against 
Candida albicans only and one isolate showed activity against both groups of pathogens. 
11 
 
Moreover, the antiparasistic activity was documented for four isolates. These results showed 
a high diversity of actinomycetes associated with marine sponges as well as highlighted their 
potential to produce anti-infective agents. 
 
The third part of the thesis focused on the isolation and structure elucidation of new bioactive 
compounds. Streptomyces strain RV15 recovered from sponge Dysidea tupha, was selected 
for further chemical analysis by virtue of the fact that it exhibited the greatest antimicrobial 
potential against Staphylococcus aureus as well as Candida albicans among the all tested 
strains. Moreover, members of the genus Streptomyces are well known as prolific producers 
of interesting pharmacologically active metabolites. Chemical analysis of the methanolic 
crude extract using different chromatographic tools yielded four new compounds. The 
structures of the new compounds were spectroscopically elucidated to be four new cyclic 
peptides, namely, cyclodysidins A-D. Their bioactivity was tested against different proteases, 
bacteria and Candida as well as tumor cell lines. The compounds did not show any 
significant activities at this point. 
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Zusammenfassung 
 
Die hier vorliegende Dissertation ist in drei Kapitel gegliedert und hatte die Bereitstellung 
neuer antimikrobieller Substanzen, die zukünftig als Antibiotika genutzt werden könnten, zum 
Hauptziel. 
 
Das erste Kapitel befasst sich mit dem Potenzial von Pflanzen zur Produktion von Proteinen 
mit antimikrobieller Wirkung. Pflanzenzellkulturen wurden mit neun verschiedenen 
Induktoren stimuliert und anschließend auf die Produktion von Proteinen mit antimikrobieller 
Wirkung hin untersucht. Dafür wurden die extra-, intrazellulären sowie die 
membrangebundenen Proteinfraktionen von sieben heterotrophen und photomixotrophen 
Pflanzenzellkulturen extrahiert. Mittels Diffusionstests wurden die Wirkung der Proteine 
gegen eine Sammlung menschlicher Pathogene inklusive Gram-positiver und Gram-
negativer Bakterien, sowie Pilze getestet. Die intrazellulären Fraktionen zeigten dabei höhere 
Aktivitäten als die extrazellulären, wohingegen die membrangebundenen Proteine die 
geringsten Aktivitäten aufwiesen. Von den insgesamt 21 getesteten Proteinfraktionen wies 
die mit DC3000 induzierte intrazelluläre Fraktion von Lavendula angustifolia die größte 
Wirkung gegen Candida maltosa auf. Die mit Salicylsäure induzierte intrazelluläre 
Proteinfraktion von Arabidopsis thaliana zeigte eine Hemmung aller getesteten pathogenen 
Stämme. Die antimikrobielle Aktivität der induzierten Arabidopsis thaliana-Zellkultur wurde 
mittels Bioautography weiter untersucht, um das wirksame Protein im Gesamt-(Roh-) extrakt 
einzugrenzen. Die intrazelluläre Fraktion der photomixotrophen Arabidopsis thaliana-
Zellkultur wurde ausgewählt, um ein 19 kDa Protein mit antimikrobieller Wirkung, genannt 
AtAMP, mittels Gelfitrationschromatography über eine S-200 Säule aufzureinigen. Unsere 
Ergebnisse weisen darauf hin, dass induzierte Pflanzenzellkulturen zukünftig als 
aussichtsreiche alternative Quelle für antimikrobiell wirksame Proteine herangezogen 
werden können.  
 
Der zweite Teil dieser Dissertation beinhaltet die Isolation von mit marinen Schwämmen 
assoziierten Actinomyceten und deren Testung auf Bioaktivität. Aus 11 taxonomisch 
verschiedenen, an den Küsten von Ras Mohamed (Ägypten) und Rovinj (Kroatien) 
gesammelten Schwammspezies, wurden Actinobakterien auf verschiedenen 
Standardmedien kultiviert. Um seltene, neue Stämme zu isolieren, wurden diese Medien mit 
wässrigen Schwammextrakten angereichert. Die auf der 16S rRNA-Gensequenz 
basierenden phylogenetischen Charakterisierung von 52 der insgesamt 90 Isolate, zeigte die 
Zugehörigkeit zu 18 verschiedenen Actinomyceten-Gattungen. Die 16S rRNA-Gene von 14 
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Isolaten zeigten Homologien von weniger als 98,2% zu denen anderer in Datenbanken 
abgelegten Bakterien und stellen somit vermutlich neue Arten dar. Die Verwendung von mit 
Schwammextrakt angereichertem M1-Agar resultierte in der Kultivierung einer mutmaßlich 
neuen, mit Rubrobacter verwandten Gattung und bestätigt die Notwendigkeit der 
Entwicklung neuer innovativer Kultivierungsprotokolle. Aktivitätstests von fünf Isolaten 
zeigten deren hemmende Wirkung nur gegen Gram-positive Bakterien, ein Isolat zeigte 
Aktivität nur gegen Candida albicans und ein Isolat war wirksam gegen beide genannten 
Pathogengruppen. Desweiteren konnten antiparasitäre Wirkungen von vier Isolaten 
dokumentiert werden. Die hier beschriebenen Ergebnisse zeigen die große Diversität von mit 
Schwämmen assoziierten Actinomyceten und deren Potential Antiinfektiva zu produzieren.  
 
Der dritte Teil dieser Arbeit fokussierte sich auf die Isolation und Strukturaufklärung neuer 
bioaktiver Substanzen. Streptomyceten sind bekannt für die Produktion von interessanten, 
pharmakologisch aktiven Metaboliten. Der aus dem Schwamm Dysidea tupha isolierte 
Stamm Streptomyces RV 15 zeigte eine hohe Aktivität gegen Staphylococcus aureus und C. 
albicans und wurde deshalb für nähere Untersuchungen ausgewählt. Die chemische Analyse 
des Methanol-Rohextrakts unter der Verwendung verschiedener Chromatographie-Verfahren 
resultierte in der Isolation von vier Substanzen. Die spektroskopische Analyse zeigte, dass 
diese neuen Substanzen zyklische Peptidstrukturen aufweisen und wurden daraufhin als 
Cyclodysidin A-D benannt. Die Bioaktivitäten dieser Substanzen wurden gegen verschiedene 
Proteasen, Bakterien und Candida sowie gegen verschiedene Tumorzelllinien getestet. Bis 
zum jetzigen Zeitpunkt zeigte keine der getesteten Peptide eine aussagekräftige Wirkung.  
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Chapter 1 
General introduction 
 
 
1.1 Infectious diseases  
 
Infectious disease is a clinically evident illness resulting from the presence of pathogenic 
viruses, bacteria, fungi, protozoa and parasites. Infectious diseases caused by viruses 
(human immunodeficiency virus, hepatitis C), parasites (malaria, trypanosomiasis and 
leishmaniasis) and bacteria (tuberculosis and cholera) are the world's biggest killers of 
children and young adults (Tibayrenc 2007). Perhaps it is not surprising to expect this crisis 
in developed countries but what may be remarkable is that mortality rates from infectious 
disease are actually growing in developing countries (Woolhouse 2008). The continuous 
misuse of antibiotics has resulted in multi-resistant bacterial strains all over the world such as 
methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci 
(VRE) which are the most commonly encountered as multiple drug resistant organisms in 
patients residing in non-hospital healthcare facilities. At the time when few classes of 
antimycotic drugs are available for treatment of fungal infections, there is an increase in 
fungal infections (known and emerging) particularly in immunocompromised patients as in 
patients with AIDS, cancer chemotherapy or organ transplantation. The increased use of 
antifungal drugs has resulted in the development of resistance to these few available drugs. 
In addition to the bacterial and fungal resistance, parasitic infections resulted in severe 
complications and high mortality rates worldwide. Malaria is considered to be the most 
dangerous parasitic disease causing nearly one million deaths annually, mostly among 
African children (Zacarias and Andersson 2010). African trypanosomiasis (sleeping 
sickness), leishmaniasis and Chagas disease are also caused by parasitic protozoa. It is 
estimated that these three diseases are responsible for more than 110,000 deaths every 
year (Brun et al. 2010; Clayton 2010). The lack of long-term protection by vaccination makes 
the treatment difficult and frequently accompanied by severe side effects (D'Alessandro 
2009). Generally, two major groups of antimicrobial agents were used in the treatment of 
infectious diseases. The first group include antibiotics which are natural compounds 
produced by certain groups of microorganisms and the second are the chemotherapeutic 
agents which are chemically synthesized. A hybrid substance is a semisynthetic antibiotic, 
wherein a compound produced by the microbe is then chemically modified to obtain desired 
properties or to avoid toxic effects of the parent drug. The first trial of antimicrobial 
chemotherapy began with the discovery of penicillin by Fleming (1929) and injection into 
experimental animals, where it was found not only active against infections but also to 
possess low toxicity for the host. Few years later, Domagk (1935) discovered the synthetic 
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antimicrobial agents, sulfonamides, with a broad antimicrobial activity spectrum. This 
discovery directed researchers towards searching for new antimicrobial agents of low toxicity 
to animals that might be useful in the treatment of infectious disease. The discovery of 
chloramphenicol, streptomycin, gentamicin, tetracycline and other antibiotics spurred the 
industry to develop large research and development programs around natural product 
discovery. The increase in the current problems of growing resistance of numerous 
pathogens together with the new emerging infectious diseases as well as the toxic effects of 
some of the currently used drugs necessitates the searching for new anti-infective drugs.  
 
1.2 Drug discovery from nature 
 
Historically, nature was the source for the majority of the drugs in use. Natural products have 
been successfully used for the treatment of various diseases through many centuries. 
Natural products are secondary metabolites of organisms such as animals, plants and 
microbes. Secondary metabolites are not directly involved in the normal growth, development 
or reproduction of organisms and their absence does not result in immediate death but rather 
in long-term impairment of the organism's survivability or perhaps in no significant effects at 
all. They might also be interpreted to be signal molecules or defense mechanisms against 
competitors, herbivores or pathogens. These characteristics make them lead compounds for 
development as drugs for oncology and infectious diseases wherein death or injury to 
populations of cells is desired. Although different exciting methodologies such as genomics, 
proteomics, combinatorial chemistry, DNA shuffling, combinatorial biosynthesis and 
bioinformatics have been discovered, screening of natural products is still one of the 
successful ways to allocate new drugs. Traditionally, dried herbs have been utilized for 
millennia either by decoction in water to make a tea or by infusion to treat systemic bacterial 
and fungal infections as well as directly on the skin to treat local infections. Garlic (Allium 
sativum) is a natural antibiotic herb that has been used since the days of the Egyptians and 
Babylonians to alleviate many infectious diseases. Crushed garlic extract is considered to be 
the most potent antibacterial agent listed by the British Journal of Biomedical Science 
(Gonzalez-Fandos et al. 1994). Golden Seal (Hydrastis canadensis) is a natural antibiotic 
herb traditionally used by Native Americans either internally or externally to cure mucous 
membrane, bladder as well as fungal infections. Golden Seal is available as a tincture, 
nutritional supplement and cream. Pharmaceutical companies developed different 
pharmaceutical formulations using plant extracts but with the advancement of drug research 
in the mid-twentieth century, semi-pure forms of compounds have been more in use. Natural 
products or their semi-synthetic derivatives have been developed for clinical use to treat 
human diseases in almost all therapeutic areas (Newman and Cragg 2007). Large number of 
terrestrial and marine natural products was used for treatment of bacterial and fungal 
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infections as well as various parasitic infections (Table 1.1). At least half of the antibiotics 
and antitumor agents approved by the Food and Drug Administration (FDA) have been 
natural products, derivatives of natural products or synthetic compounds inspired by natural 
product chemistry (Zhang 2005). 
 
Table 1.1 Selected natural products with promising antibiotic activities. 
 
Compound name Source Class Activity Reference 
Allicin Allium sativum 
 
Alkaloid Antibacterial (Uchida et al. 1975) 
Aspoquinolones A-D  Aspergillus nidulans Alkaloid Anticancer (Scherlach and 
Hertweck 2006) 
Parthenolide Tanacetum
 
parthenium 
Sesquiterpene 
lactone 
Antileishmanial (Tiuman et al. 2005) 
Berberine Jatrorrhizine Tinospora cordifolia Alkaloid Antibacterial (Chintalwar et al. 2003) 
Biflorin Eremophila 
neglecta 
Naphthoquinone Antibacterial (Ndi et al. 2007) 
Belamide A  Symploca sp. Tetrapeptide Anticancer (SimmonSa et al. 2006) 
Camalexin 
 
Arabidopsis thaliana Indole Antifungal (Sellam et al. 2007) 
Cyanosporasides A & B  Salinispora pacifica Sordarins Anticancer (Oh et al. 2006) 
GE81112 Streptomyces sp.  Tetrapeptide Antibacterial (Brandi et al. 2006) 
Lariatins A & B  Rhodococcus sp. Cyclic peptide Antibacterial (Iwatsuki et al. 2007) 
Manzamine A 
 
Haliclona sp. Alkaloid Antimalarial (Ang et al. 2001) 
Marinomycins A-D  Marinispora sp. Macrolide Antibacterial 
Anticancer 
(Kwon et al. 2006) 
Moriniafungin  Morinia 
pestalozzioides 
Sordarins Antifungal (Basilio et al. 2006) 
Morin Pisidium guajava Flavonoid Antibacterial (Arima and Danno 2002) 
Platensimycin  Streptomyces 
platensis 
Ketolide Antibacterial (Wang et al. 2006) 
Plectasin  Pseudoplectania 
nigrella 
Linear peptide Antibacterial (Mygind et al. 2005) 
Phomallenic acids A-C  Phoma sp. Acetylenic allene Antibacterial (Ondeyka et al. 2006) 
Rosmarinic acid Ocimum basilicum Polyphenolic Antifungal (Bais et al. 2002) 
Bruceine A  Brucea javanica  Quassinoid Antitrypanosomal (Bawm et al. 2008) 
Scopoletin 
  
Nicotiana tabacum Coumarin Antifungal 
Antibacterial 
(Goy et al. 1993) 
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Sorbicillactones A & B  Penicillium 
chrysogenum 
Sorbicillinoid Anticancer (Bringmann et al. 2005) 
Stellettazole B Stelletta sp. Alkaloid Antibacterial (Matsunaga et al. 1999) 
Spongistatin Hyrtios erecta Macrocyclic 
lactone 
Antifungal (Ovechkina et al. 1999) 
α-tomatine 
 
Lycopersicon 
esculentum 
Saponin Antifungal (Ito et al. 2007) 
Topsentiasterol sulfates Topsentia sp. Sterol Antibacterial 
Antifungal 
(Fusetani et al. 1994) 
Taxol, baccatin III Taxus baccata Terpenoid Anticancer (Cusido et al. 1999) 
Withaferin A Withania somnifera Hydroquinone Antibacterial (Ciddi 2010) 
 
 
1.2.1 Drug discovery from terrestrial plants 
 
Several options are available for the production of pharmaceutically active natural products 
including natural harvesting, total chemical synthesis, semisynthesis from natural precursors 
and expression of biosynthesis pathways in microbial systems (Bourgaud et al. 2001). The 
first source for natural products are the terrestrial organisms. Plants have always been the 
main source of medicinal ingredients, providing a wide range of valuable biologically active 
substances. Among the 250,000 flowering plants in the world (Thorne 2000), more than 
50,000 have been used for medicinal purposes (Schippmann et al. 2002). Plant cell cultures 
have been used as alternative biotechnological source for production of numerous 
commercially important compounds such as medicinal compounds, flavors, fragrances and 
colorants (Kolewe et al. 2008). This technology provided continuous and reliable source of 
plant pharmaceuticals and could be used for the large-scale culture of plant cells from which 
these metabolites can be easily extracted and purified (Mulabagal and Tsay 2004; Georgiev 
et al. 2009). In some cases due to the complexity of the chemical nature of molecule and/or 
the lack of knowledge about its complete biosynthetic pathway, plant cell culture technology 
has been successful alternative to complex molecules such as taxol (Paclitaxel). Paclitaxel is 
an anticancer drug against various types of cancer including breast, ovarian and lung cancer. 
Initially, it was obtained by extraction from the bark of Taxus sp. and currently derived mainly 
by biotechnological production through Phyton Biotech (USA) to supply Bristol-Myers Squibb 
paclitaxel for its taxol formulation (Zhong 2002; Tabata 2006; Frense 2007). The 
protoberberine alkaloids, berberine and jatrorrhizine isolated from Tinospora species are of 
considerable value due to their antimicrobial, anti-inflammatory, antileukemic as well as 
antimalarial activities (Kuo et al. 2004; Yu et al. 2005). They are currently produced by 
means of cell cultures though Mitsui Petrochemical Industries (Japan).  
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1.2.2 Drug discovery from marine animals 
 
The second important source for natural products discovery is the marine environment. 
Whereas the terrestrial environment has been screened for sources of new drugs for 
thousands of years, until recently, the marine environment was to a large extent not 
accessible for such investigations. Ocean covers two-thirds of the earth and have remained 
an unexplored valuable source of novel natural pharmaceutical compounds (Molinski et al. 
2009). Marine natural products are often very different in their chemical nature from their 
terrestrial counterparts. Therefore, marine-derived pharmaceuticals in many cases provide 
completely novel pharmacological modes of actions. Marine natural products played a crucial 
role in biomedical research and drug development, either directly as drugs or as lead 
structures for chemical drug synthesis. Dozens of marine-derived natural products are in 
clinical or pre-clinical trials for treating various diseases. Ziconotide is a synthetic form of ω-
conotoxin MVIIA which has been isolated from the venom of marine snail Conus magus. It 
became the first marine-derived drug approved by the FDA under the trade name Prialt for 
the management of severe and chronic pain caused by various diseases (Bowersox and 
Luther 1998; Terlau and Olivera 2004). The anticancer cyclic tridecapeptide, Kahalalide F 
has been isolated from Sacoglossan mollusk Elysia rufescens as well as the green alga 
Bryopsis sp. and is currently in Phase II clinical trials against solid tumors including 
melanoma and hepatocellular carcinoma (Hamann and Scheuer 1993; Goetz et al. 1999). 
(+)‑Discodermolide has been isolated from the deep-water sponge Discodermia dissoluta 
and showed immunosuppressant activity and in vivo activity against HCT-116 colorectal 
cancer and is in Phase I clinical trials (Hung et al. 1994; Honore et al. 2004). Bryostatin is a 
macrocylic lactone that has been purified from the bryozoan Bugula neritina (Berkow et al. 
1993; Mutter and Wills 2000). It demonstrated potent in vitro activity against the P388 
lymphocytic leukaemia cell line with an ED50 of 0.89 μg/ml and is currently in phase II. 
Although few representatives from sponges are approved as drugs, hundreds of new 
compounds with interesting pharmacological activities are discovered from sponges every 
year. Several sponge-derived compounds are already in clinical trials as agents against 
cancer, microbial infections, inflammation and other diseases. However, in many cases drug 
development is severely hampered by the limited supply of the respective compounds, as 
they are often present only in minute amounts in the sponge tissue. 
 
1.2.3 Drug discovery from marine microorganisms  
 
Microorganisms are the source of various medicaments for bacterial and fungal infections 
(e.g., penicillin, erythromycin, streptomycin, tetracycline, vancomycin, amphotericin B), 
cancer (e.g., daunorubicin, doxorubicin, mitomycin, bleomycin), transplant rejection (e.g., 
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cyclosporin, FK-506, rapamycin) and high cholesterol (e.g., lovastatin and mevastatin). 
Marine bacteria have recently taken the limelight as potential sources of novel chemical 
structures with promising pharmacological activities that could be used as drug leads. Among 
marine bacteria, actinomycetes are prolific producers of clinically interesting compounds with 
various biological activities (Fenical and Jensen 2006; Solanki et al. 2008; Olano et al. 2009; 
Asolkar et al. 2010; Kekuda et al. 2010; Orhan et al. 2010). Examples of the recently 
discovered drugs from actinomycetes are the marinomycins A–D which are a novel class of 
polyketides that have been discovered from the marine actinomycete Marinispora with 
significant anti-bacterial activities against Gram-positive strains including the drug-resistant 
bacterial pathogens MRSA and VRE. They also exhibited potent and highly selective activity 
in the National Cancer Institute’s (NCI) 60 tumor cell line panel with six of the eight 
melanoma cell lines, especially SK-MEL-5, being very sensitive to marinomycin A (Kwon et 
al. 2006). Salinosporamide A is another example that has been isolated from the new genus 
Salinispora (Feling et al. 2003). Salinosporamide A has completed Phase I clinical trials for 
multiple myeloma under the sponsorship of Nereus Pharmaceuticals in La Jolla, California 
(Fenical et al. 2009).  
 
1.3 Problems in natural products research 
  
Despite the medical and commercial success of natural products as drugs, the investment in 
the discovery and the commercialization of new natural products has significantly decreased 
since it reached its peak in the mid to late twentieth century. They are some problems behind 
this decline such as the decrease in the discovery of new classes of natural compounds with 
interesting new activities and the reisolation of known natural products. New strategies are 
required for natural products-based drug discovery that might increase chemical diversity 
and reduce redundancy. The output can be increased by spending more time to select the 
appropriate strains and extracts. In order to focus on the extracts of most interest as quickly 
as possible and to avoid repeatedly isolating known compounds, efficient dereplication 
process is required. Dereplication strategies can be done at early stages using analytical 
techniques and database searching either at the level of the microorganism or the chemical 
extracts. Each culture collection is likely to have a high number of duplicate strains. Thus, it 
is important to dereplicate the culture collection at the beginning taking in consideration that 
strains of the same subspecies may produce different compounds. By the aid of molecular 
methods such as restriction fragment length polymorphism (RFLP), morphogenic groups can 
be separated further to differentiate strains up to the subspecies level (Vermis et al. 2002).  
The most effective selection method from the metabolic aspect is the chemical profile 
analysis using high throughput tools such as high-performance liquid chromatography 
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coupled with detectors such as photodiode array detection (HPLC-DAD) or evaporative light 
scattering detection (HPLC-ELSD) or by the aid of classical methods such as thin-layer 
chromatography (TLC) as well. Identical HPLC retention time or TLC Rf values are not 
enough to decide if two compounds are exactly the same or not but different values definitely 
indicate that they are different. If the extract contains a reported compound which is 
commercially available, the sample and the authentic material should be co-
chromatographed for TLC and HPLC. If a reference standard is not available, MS data is 
enough to decide if the compounds are the same or not. A powerful and very sensitive 
method in identification of new natural products in the crude extracts is to couple the mass 
spectrometry (MS) to liquid chromatography (LC). Comparison of the extract chromatography 
to databases such as Antibase database or the Dictionary of Natural Compounds as well as 
published literature will provide valuable information to determine whether an extract and/or 
activity is novel or not. The coupling of high performance liquid chromatography with nuclear 
magnetic resonance spectroscopy (LC-NMR) is one of the recent and powerful methods for 
the separation and identification of known and unknown compounds in crude extracts 
(Bobzin et al. 2000; Provera et al. 2010). Although LC-NMR has lower sensitivity than LC-
MS, it is very useful in the chemical screening and dereplication of crude extracts especially 
if the data from LC-MS are incomplete or do not allow confident identification of the active 
component of an extract.  
The second reason behind the decline is the difficulty to have reliable sources to get 
significant quantities of relatively pure compounds for chemical and biological studies as well 
as for commercial production after finishing the clinical phases. Since the last two decades 
there have been considerable efforts made in the use of plant cell cultures in bioproduction, 
biotransformation and biosynthetic studies. Different classes of natural products such as 
alkaloids, flavonoids, terpenes, steroids, glycosides and proteins have been produced using 
plant-cell-culture technology (Smetanska 2008). The production of secondary products from 
the plant cell culture is less expensive than extraction of the whole plant grown under natural 
conditions and also less expensive than the chemical synthesis of the product of interest. 
Plant cell cultures have the potential for commercial production of pharmaceuticals if 
appropriate cell lines with suitable genetic, biochemical, and physiological characteristics 
have been selected. Plants and plant cells in vitro are capable to show physiological and 
morphological responses to microbial, physical and chemical factors which are known as 
elicitors. Thus, the use of various biotic and abiotic elicitors could be useful strategy to 
stimulate secondary metabolites production in plant cell cultures. An example of a high-value 
drug that is commercially produced by plant cell cultures is the paclitaxel which is an anti-
cancer drug originally extracted from the bark of 50-year-old Pacific yew trees, Taxus 
brevifolia (Tabata 2006). The other reliable source for production of natural products at 
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commercial level is the microbes. Although not a new technology, microbial fermentation 
continues to evolve and is now the preferred production method for large number of 
therapeutics especially the antibiotics, offering an optimal economic route which allows 
pharmaceutical companies to shorten production processes and time to market.  
The third reason behind the decrease in development of natural products is the time and 
expense for the production of compounds for clinical and commercial use. For example, 
paclitaxel, took over 20 years from structural determination and reporting until FDA approval. 
These reasons have moved the pharmaceutical drug discovery programs away from natural 
products in favor of synthetic approaches. However, the abundance of synthetic compounds 
with similar chemical functional groups and, therefore, limited chemical diversity has renewed 
interest in nature as a good resource for finding new fascinating leads to be applied to design 
the next generation of drugs. 
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1.4 Aims 
 
The increase in the current problems of resistance of numerous pathogens together with the 
new emerging infectious diseases as well as the adverse effects of some of the currently 
used drugs necessitate the searching for new anti-infective drugs. Natural products have 
provided considerable value to drug market over the past half century. In particular, the 
therapeutic areas of infectious diseases and oncology have benefited from various drug 
classes derived from natural product sources. The main goal of this Ph.D. study is to allocate 
novel anti-infective compounds from terrestrial sources represented by plant cell cultures and 
marine sources represented by sponge-associated actinomycetes. 
 
The first aim of the study (Chapter 2) was to evaluate the potential of heterotrophic and 
photomixotrophic plant suspension cultures for the production of antimicrobial proteins and/or 
peptides against a selected panel which includes human Gram-positive and Gram-negative 
bacterial pathogens as well as human Candida. This was followed by purification and 
characterization of an antimicrobial protein from an active fraction. 
 
The second aim of the study (Chapter 3) was to isolate the bioactive novel actinomycete 
species associated with marine sponges collected from Egypt and Croatia by cultivation. 
Strains were identified based on 16S rRNA gene sequence analysis and their bioactivity was 
tested against a panel of clinically relevant, Gram-positive and Gram-negative bacterial 
pathogens. Moreover, human fungal pathogen as well as human parasites was also tested. 
 
The third aim of the study (Chapter 4) was the isolation, identification, and structural 
elucidation of new and preferably biologically active secondary metabolites from marine 
sponge-associated actinomycetes. Bioactive and taxonomically novel strains were fermented 
at optimized conditions and the crude extracts were subjected to various chromatographic 
methods in order to obtain pure compounds. The compounds were then identified using 
different spectroscopic tools and the biological activity was evaluated for the pure 
compounds. 
 
General introduction about the infectious diseases and natural product research was 
presented in Chapter 1. 
 
Finally, a general discussion of new antimicrobials from plant cell cultures and marine 
sponge-associated actinomycetes as well as future perspectives was provided in Chapter 5. 
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Chapter 2 
Synthesis of distinctly different sets of antimicrobial activities by 
elicited plant cell suspension cultures 
 
 
2.1 Introduction 
 
2.1.1 Plant cell culture  
 
Plant cell cultures have emerged as an important alternative source to whole plants in many 
fields of research (Karuppusamy 2009; Ratner 2010). Unlike field-grown plants, plant cell 
lines are cultivated independently from climate, soil, season, day length and weather 
conditions. Furthermore, there is no risk of contamination with mycotoxins, herbicides or 
pesticides. Perhaps the most striking advantage of secondary metabolite production via plant 
cell lines versus whole plants is the simpler procedure for isolation and purification of 
compounds, especially when the metabolites are secreted into the culture medium (Caretto 
et al. 2010). Among various approaches for in vitro cultivation of plant cells, research efforts 
have been focused on suspension cell cultures as they are the most amenable to GMP 
procedures and as they can be easily cultivated in large scale for industrial and/or 
pharmaceutical purposes (Hellwig et al. 2004; Shinde et al. 2010). It has already been shown 
that plant cell cultures possess antimicrobial activities against a wide spectrum of bacteria 
and fungi (Sokmen et al. 1999). Furthermore, many pharmacologically active and 
commercially interesting secondary metabolites such as berberine, codeine, diosgenin, 
ginsenosides, morphine, scopolamine, taxol, vinblastine and vincristine have been produced 
by plant cell cultures (Vanisree et al. 2004; Bøezinová et al. 2007; Hernandez-Vazquez et al. 
2010). Moreover, in vitro cell cultures yielded multimeric proteins as well as glycoproteins 
(Marden et al. 1997) and this further underscores their significance. 
Elicitors are compounds which are capable of stimulating any type of plant defense such as 
the induction of phytoalexin biosynthesis (Zhao et al. 2010). The treatment with elicitors has 
gained special interest in many biotechnological fields to enhance the production of 
secondary metabolites. So far, elicitors have been categorized according to their nature into 
two distinct groups: abiotic elicitors (light intensity, temperature and chemicals) (Chong et al. 
2005; van Hulten et al. 2006) and biotic elicitors (bacteria, fungi and insects or their 
derivatives) (Solano et al. 2008; Ramos-Solano et al. 2010). The use of biotic elicitors as 
compared to abiotic elicitors for the enhanced production of metabolites from plant cell 
cultures (Zhao et al. 2010) is promising and could have important outcome for industry. Upon 
elicitation of plant cells, one or more signal transduction pathways are invoked by ligand 
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receptor interactions that lead to the activation of a set of defense-related genes (Nurnberger 
1999; Abramovitch et al. 2006; Boller and He 2009). In cell culture systems, low elicitor 
concentrations and short incubation times are sufficient to provoke cellular reactions because 
there are no cuticles or thick walls which could hinder elicitor perception (Roitsch and Sinha 
2002; Basu and Goyal 2009). Treatment of plant cells with elicitors such as chitosan, 
methyljasmonate and salicylic acid induces substantial modulations directed at establishing 
plant defense reactions and in many cases, resulted in enhanced production of secondary 
metabolites (Namdeo 2007; Baldi et al. 2009; Ciddi 2010). The diversity of biochemical 
pathways responding to elicitor treatment may reflect a switch from primary metabolism to 
primed secondary metabolism leading to the production of defense proteins and compounds 
(Chivasa et al. 2006; Allwood et al. 2010). 
 
2.1.2 Antimicrobial proteins from plants 
 
Plants have developed specific and nonspecific mechanisms of defense that can provide 
long-term protection against a wide array of pathogens. There are at least two main 
mechanisms of pathogen resistance in plants, the first being represented by the compounds 
synthesized during the plant normal development (constitutive resistance) and the second 
mechanism being activated only after contact with the pathogen (induced resistance) (Dangl 
and Jones 2001; Ahuja et al. 2010). The induced resistance can occur in a localized or 
systemic way. The localized resistance can only be detected immediately at host-pathogen 
interface, followed by a fast collapse and cell death, a reaction named hypersensitivity 
response (Lam et al. 2001). Systemic acquired resistance (SAR) is induced by prior 
challenge with a pathogen or the application of an elicitor (Jones and Dangl 2006; Gilbert 
and Parker 2010). Once activated, the SAR pathway can confer resistance to a number of 
pathogens. SAR has been studied extensively in tobacco (Nicotiana tabacum) and 
Arabidopsis thaliana (Kurusu et al. 2010). It involves the fast production of reactive oxygen 
species (ROS) which have a direct antimicrobial effect (Yoshioka et al. 2009), alterations in 
the cell wall constitution leading to reinforcement of cell walls (Lake and Wade 2009), 
increase of endogenously synthesized salicylic acid and the enhanced production of 
pathogenesis-related (PR) proteins (Alvarez 2000; Jha et al. 2009), activation and synthesis 
of defense peptides and proteins (Castro and Fontes 2005; Gomi 2009) and the induced 
accumulation of antimicrobial low molecular weight secondary metabolites known as 
phytoalexins (Gilbert and Parker 2010). Plants produce over 100,000 small-molecules (Dixon 
2001; Lewis and Ausubel 2006), peptides or proteins with potentially inhibitory effects on the 
growth and development of other organisms (Fritig et al. 1998; Park et al. 2010).  
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The widespread resistance of microbes to commonly used antibiotics has increased interest 
in alternatives such as bacterial interference therapy (probiotics), bacteriophage therapy and 
in particular, antimicrobial peptides (Bolton et al. 2008; Coutinho et al. 2008; Labrie et al. 
2010). Antimicrobial peptides offer the advantages of selective inhibition and low risk of 
resistance development (Pereira 2006). In recent years, many constitutive and inducible 
antimicrobial peptides have been characterized in animals, insects and plants and these 
have been recognized as important components of the innate defense system (Reddy et al. 
2004; Kido et al. 2010). Several antibacterial and antifungal proteins have been isolated from 
plants (Table 2.1) and most of them were derived from seeds (Flores et al. 2002; Wang and 
Ng 2007; Hammami et al. 2009b; Pelegrini et al. 2009; Park et al. 2010). Among them are 
enzymes such as glucanases (Leelasuphakul et al. 2006) and chitinases (Ye and Ng 2005), 
thaumatin-like proteins (Liu et al. 2010) as well as several kinds of basic cysteine-rich 
peptides and other less-known low molecular weight proteins.  
 
Table 2.1 Antimicrobial proteins from plants. 
 
Antimicrobial 
protein Source Class Activity Reference 
An 1 Atriplex nummularia seeds Thionin Antibacterial (Last and Llewellyn 1997) 
AP1 Solanum tuberosum leaves Defensins Antifungal (Feng et al. 2003) 
DmAMP1 Dahlia merckii seeds Defensins Antifungal (Thevissen et al. 2003) 
FaAMP1            
Fa AMP2 
Fagopyrum esculentum 
Moench seeds Defensins 
Antibacterial 
Antifungal (Fujimura et al. 2003) 
TuAMP 1      
TuAMP 2 Tulipa gesneriana bulbs Thionin- like 
Antibacterial 
Antifungal (Fujimura et al. 2004) 
WJAMP1 Wasabia japonica leaves Havein-like protein 
Antibacterial 
Antifungal (Kiba et al. 2003) 
LJAMP1 Leonurus japonicas seeds Napin-like storage protein Antifungal (Yang et al. 2007) 
Pr 1 pumpkin rind Thaumatin-like protein Antifungal (Park et al. 2010) 
HaAP 10 helianthus annus seeds lipid-transfer proteins Antifungal 
(Regente and de la Canal 
2000) 
PaAMP1 Phytolacca americana seeds Cystein-rich 
Antibacterial 
Antifungal (Liu et al. 2000) 
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The main groups of antimicrobial peptides that found in plants are thionins, defensins and 
lipid transfer proteins (Broekaert et al. 1995; Carvalho et al. 2006; Franco et al. 2006; Jha 
and Chattoo 2010). A database named PhytAMP (http://phytamp.pfba-lab-tun.org) has been 
established for the different classes of antimicrobial peptides from plants (Hammami et al. 
2009a). These peptides differentially inhibit a wide variety of phytopathogenic bacteria and 
fungi. Various plant antimicrobial peptides such a DmAMP1 from Dahlia merckii seeds, 
HsAFP1 from Heuchera sanguinea seeds and RsAFP2 from Raphanus sativus seeds 
showed potent activity against the human pathogen Candida albicans at micromolar 
concentrations (Portieles et al. 2006). This highlights the potential of plant antimicrobial 
peptides as new candidates for drug development.  
 
Thionins represent a family of low molecular weight (5 kDa) basic peptides (pI >8) which are 
rich in basic and sulfur-containing residues such as arginine, lysine and cysteine. Their 
diverse members have high sequential and structural similarities besides presenting potent 
inhibitory effects against wide range of bacteria and fungi. They were isolated from members 
of the Viscaceae family such as phoratoxins C-F from Phoradendron tomentosum which 
exhibited highly selective cytotoxicity to human breast cancer cells (Johansson et al. 2003). 
Another toxic protein was isolated from Pyrularia pubera seeds (Vernon et al. 1985). The 
Pyrularia thionin represents four disulfide bridges like cereal thionins and shares eight 
consecutive amino acid residues identical to purothionins. Susceptibility against thionins was 
demonstrated in phytopathogenic bacteria such as Pseudomonas, Xanthomonas, Erwinia 
and Corynebacterium as well as in phytopathogenic fungi such as Thielaviopsis paradoxa 
and Drechslera teres. Cytotoxic effects on numerous cell lines such as mouse fibroblasts 
L929, HeLa cells and monkey cells CV10 have been reported (Castro and Fontes 2005). It 
was also observed that viscotoxins exert strong immunomodulatory effects (Tabiasco et al. 
2002). Thionins inhibit protein synthesis through direct interaction with mRNA or at initial 
translation level (Brummer et al. 1994). Different thionins were found in seeds such as 
viscotoxins, purothonins and hordothionins which could also work as storage proteins, 
especially as sources of sulphur (Schrader-Fischer and Apel 1993). Some members of 
thionins such as α-hordothionin were already used to confer resistance to transgenic plants 
against phytopathogenic fungi. The expression of α-hordothionin gene under control of 
CaMV35S promoter led to increase the resistance against Pseudomonas syringae (Carmona 
et al. 1993). Another example is viscotoxin expression in Arabidopsis thaliana conferring 
resistance to Plamodiophora brassicae (Holtorf et al. 1998). 
 
Defensins are cystein-rich peptides with a characteristic antiparallel β sheet folded 
infrastructure. α and β defensins share similar 3D structures but differ in the pairing of 
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cysteines in the disulfide bonds (Zasloff 2002). Plant defensins are quite diverse in their 
amino acid composition with only eight structure stabilizing cysteines appear to be conserved 
among all plant defensins (Allen et al. 2008). They are small (45–54 amino acids), highly 
basic cysteine-rich peptides that are apparently ubiquitous throughout the plant kingdom. 
They have been isolated from different plant species such as wheat, barley, sorghum, 
radishes and other species of Brassicaceae (Montesinos 2007). Sequences of more than 80 
different plant defensin genes from different plant species are available and at least 13 
putative plant defensin genes are only derived from Arabidopsis thaliana (Thomma et al. 
2002). Many plant defensins showed a potent fungicidal action and occasional antibacterial 
activity (Segura et al. 1998). Interestingly, they are nontoxic to either mammalian or plant 
cells, indicating their role in the defense process (Thevissen et al. 1999). The exact mode of 
action of plant defensins is yet unclear, and most molecular components and targets involved 
in signaling remain unknown. There are different theories describing the mode of 
antimicrobial activity of plant defensins. One postulates the formation of multimeric pores 
within microbial membranes. After initial electrostatic binding of these positively charged 
peptides to negatively charged phospholipids on the target cell surface of the microbe, they 
enter into the excited cell membrane and most likely form ion-permeable channels in a 
voltage-dependent way (Wimley et al. 1994; Maget-Dana and Ptak 1997). The plant 
defensins DmAMP1 and RsAFP2 are examples of potent antifungal proteins exhibiting their 
action against Fusarium culmorum via induction of an array of relatively rapid responses in 
fungal cells accompanied with increased K+ efflux and Ca2+ uptake leading to changes in 
membrane potential and membrane-permeabilization (Thevissen et al. 1999). Defensins 
were heterologously expressed in diverse hosts such as bacteria, yeasts, fungi and plants 
(Padovan et al. 2010). The constitutive expression of a novel alfalfa defensin gene in potato 
provides high levels of field resistance against Dahliae, the causal agent of the “early dying 
disease” of potato (Gao et al. 2000). Interestingly, some members within the plant defensin 
family do not exhibit antimicrobial activity but display other biological activities such as 
proteinase (Wijaya et al. 2000) and α-amylase (Zhang et al. 1997) inhibitory activities, which 
may also contribute to their role in plant defense. 
 
Lipid transfer proteins (LTPs) facilitate movement of lipid from its biosynthesis site, especially 
the endoplasmic reticulum to other organelles like chloroplasts and mitochondria in 
membranes formation (Kader 1996). Several LTPs were purified from various plant species 
(Castro et al. 2003; del Carmen Ramirez-Medeles et al. 2003). The plant LTPs are divided 
into two subfamilies with relative molecular masses of 9 KDa (LTP1s) and 7 KDa (LTP2s). 
The plant LTPs consist mainly of α-helix segments (40% of secondary structures total) 
connected by disulfide bridges (Samuel et al. 2002). Various functions have been attributed 
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to this family of proteins such as its participation in cuticle formation and embryogenesis 
(Sterk et al. 1991), establishing symbiotic relationships (Krause et al. 1994), plant adaptation 
to various environmental conditions, like temperature, humidity and salinity (Torres-
Schumann et al. 1992) and finally in the defense against pathogens (Castro and Fontes 
2005). According to Garcia-Olmedo (1995), plant LTPs should be considered as important 
peptides involved in plant defense against pathogens, as they present adequate inhibitory 
activities, suitable distribution and concentration in plant tissues and a rapid increase in their 
gene expression levels soon after infection. Molina (1997) has shown that Barley LTP2 
expression in tobacco and Arabidopsis transgenic plants promoted a steep reduction of 
necrotic effects resulted from Pseudomonas infection, confirming the involvement of LTPS in 
plant defense mechanisms against microbial pathogens. Ge and collaborators (2003) studied 
the antifungal and antibacterial properties of LTP110, a lipid transfer protein isolated from 
rice. After cloning and expression, the protein was purified and tested in vitro against rice 
pathogens, Pyricularia oryzae and Xanthomonas oryzae. LTP110 was able to inhibit the 
germination of P. oryzae spores with slight effect on the growth of X. oryzae. 
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2.1.3 Aim of the work 
The aim of this chapter was to evaluate the potential of heterotrophic and photomixotrophic 
plant suspension cultures for the production of antimicrobial proteins and/or peptides against 
a selected panel which includes human Gram-positive and Gram-negative bacterial 
pathogens as well as human Candida. This was followed by purification and characterization 
of an antimicrobial protein from an active fraction. 
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2.2 Materials and Methods  
 
2.2.1 Maintenance of plant cell cultures 
 
Seven plant cell cultures were used in the study, six of them heterotrophic (Agrostis tenuis, 
Baphicanthus cusi, Daucus carota, Lavendula angustifolia, Nicotiana tabacum petit havanna 
and Rauvolfia verticillata) and one being a photomixotrophic (Arabidopsis thaliana). Cell 
suspension cultures were maintained in 300 ml Erlenmeyer flasks on a rotary shaker (130 
rpm) in the light at 26 ºC (heterotrophic) or 22 ºC (photomixotrophic). Photomixotrophic 
cultures were grown on B5 medium (Gamborg et al. 1968) supplemented with 20 g sucrose 
and 10 µM 2,4-dichlorophenoxyacetic acid (2,4-D) while the heterotrophic ones were grown 
on LS medium (Linsmaier and Skoog 1964) supplemented with 30 g sucrose and 10 µM 2,4-
D naphthalene acetic acid (NAA). The pH of the media was adjusted to 5.8 before 
autoclaving. Cells were sub-cultured every 7 d (heterotrophic and photomixotrophic) using a 
1:3 dilution of inoculum to fresh medium. 
 
2.2.2 Treatment with elicitors 
 
Cell cultures were elicited after 2 days incubation and elicitors were prepared as previously 
described (de Sa et al. 1992; Bourgaud et al. 1999; Frankfater et al. 2009; Roat and 
Ramawat 2009). Fungal elicitors were prepared by boiling a suspension of Alternaria 
brassiciola conidia (for Alt) with spore concentration of 5 x 105 spores/ml or 0.1% (w/v) 
mycelia of the fungus Fusarium oxysporium lycopersici (for Fol) for 10 min at 100 oC and 
stored at -20 oC. Bacterial elicitors were prepared by boiling a suspension of the virulent 
strain of Pseudomonas syringae (for DC3000) or avirulent strain of Pseudomonas syringae 
(for RPM1), each of OD600 = 0.2 for 10 min at 100 oC and stored at -20 oC. Acetylsalicylic acid 
(ASA) and salicylic acid (SA) were prepared by dissolving in H2Od and pH was adjusted to 
7.2 with 5 M NaOH then microfiltration. Chitosan was prepared by dissolving chitosan in 1% 
acetic acid containing 0.1% sodium nitrite, neutralization with 1 M NaOH and dialyzing for 18 
h against H2Od. Methyljasmonate (MeJ) was prepared by dissolving in 50% methanol. 
Polygalacturonic acid (PGA) was prepared by dissolving polygalacturonic acid in 10 mM 
sterile NaOH and dialyzed for 18 h at 4 oC against H2Od. The final concentrations of elicitors 
were listed in Table 2.2. For control treatments, only solvent was added to the cultures. All 
cultures were collected after a 2 days incubation period in the presence of elicitor.  
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Table 2.2 Final concentrations of elicitors in cell cultures.  
 
Elicitor Nature Final Conc. 
Alt Fungal preparation (A. brassicicola) 100 μg/ml 
Acetylsalicylic acid  Analogue to salicylic acid 1 mM 
Chitosan Microbial cell wall preparation 0.01% 
DC3000 Bacterial preparation (virulent strain of P. syringae) 100 μg/ml 
Fol Fungal preparation (F. oxysporium lycopersici) 100 μg/ml 
Methyljasmonate Plant hormone 50 μM 
Polygalacturonic acid Plant cell wall preparation 0.01% 
RPM1 Bacterial preparation (avirulent strain of P. syringae) 100 μg/ml 
Salicylic acid Plant hormone 1 mM 
 
 
2.2.3 Preparation of fractions for bioactivity testing 
 
The elicited plant cell cultures were collected by filtration through two layers of cheesecloth 
and the supernatant was collected as fraction A. Cells were immediately frozen in liquid 
nitrogen. Five grams of cells were ground under liquid nitrogen and powder was suspended 
in 15 ml of extraction buffer A (15 mM Na2HPO4, 15 mM NaH2PO4, 2 mM PMSF and 1 mM 
benzamidine hydrochloride, pH = 7) and stirred for 3 h at 4 oC. After centrifugation at 5000 
rpm for 10 min, the supernatant was collected as fraction B. The pellet was resuspended in 
15 ml extraction buffer B (15 mM Na2HPO4, 15 mM NaH2PO4, 1 M NaCl, 15 mM EDTA, 2 
mM PMSF and 1 mM benzamidine hydrochloride, pH = 7) and stirred overnight at 4 oC. After 
centrifugation at 5000 rpm for 10 min, the pellet was discarded and the supernatant was 
collected as fraction C. The fractions were centrifuged at 16.000 rpm for 20 min and the 
pellets were dissolved in 500 µl buffer A to be used as extracellular (fraction A), intracellular 
(fraction B) and cell wall bound fractions (fraction C), respectively. The fractions were 
dialyzed using dialysis tube of cut off = 14 KDa, overnight against distilled water with 3x 
change of water during dialysis. The dialyzed fractions were stored at 4 oC for bioactivity 
testing.  
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2.2.4 Antimicrobial activity screening of extracellular, intracellular and cell wall bound   
         fractions 
 
The in vitro antimicrobial activity testing was performed using the standard disc diffusion 
assay (Inderlied and Salfinger 1995) against panel of human isolates included bacteria 
(Bacillus subtilis ATCC 6059, Escherichia coli ATCC 11229, Pseudomonas aeruginosa 
ATCC 27853, Staphylococcus aureus ATCC 6538) and yeast (Candida maltosa SBUG 700). 
100 µl of the overnight cultures (bacteria in LB medium and yeast in YPD medium) with an 
optical density of OD600 = 0.2 was spread on 100 mm plates containing solid LB or YPD agar 
medium. Sterile filter paper discs with a diameter of 6 mm were impregnated with testing 
solution (20 µl/disc), dried (3 times impregnation and drying) and placed on the agar plates 
inoculated with the target microorganism. The plates were inverted and incubated for 24 h at 
37 oC (for bacteria) or 30 oC (for yeast) and the activity was quantitatively assessed by 
inhibition zone diameter (in mm) measurement. The result is an average of two readings (2 
discs used for each sample) and each experiment was repeated 3 times. Chloramphenicol 
25 µg/ml (as antibacterial) and nystatin 25 µg/ml (as antifungal) were used as positive 
controls and buffer A was used as a negative control.  
 
2.2.5 Purification of antimicrobial proteins from Arabidopsis thaliana cell culture 
 
Thirty grams of collected A. thaliana cells elicited with salicylic acid were ground under liquid 
nitrogen and powder was suspended in 60 ml of extraction buffer A (15 mM Na2HPO4, 15 
mM NaH2PO4, 2 mM PMSF and 1 mM benzamidine hydrochloride, pH = 7) then stirred 
overnight at 4 oC. After centrifugation at 5000 rpm for 10 min, the pellet was discarded, the 
supernatant was centrifuged at 16.000 rpm for 20 min and the pellet (crude protein extract) 
was redissolved in 3 ml of 8 M urea for gel filtration. Crude protein extract was loaded onto a 
HiPrep Sephacryl S-200 HR column (Amersham Biosciences) connected to a peristaltic 
pump (Amersham Pharmacia Biotech) and previously equilibrated with 50 mM phosphate 
buffer for 30 min (2 ml/min). Elution was carried out using a gradient of 0-1 M NaCl in 50 mM 
phosphate buffer and about 100 fractions (each 1.5 ml) were collected at room temperature 
(RT) using a flow rate 1 ml/min. The peak fractions were analyzed for protein content using a 
UV spectrophotometer (Kontron Uvikon 860, Pharmacia) as well as for antimicrobial activity 
using the disc diffusion assay. The active fractions were pooled and concentrated by freeze 
drying. The combined freeze dried fractions were dissolved in 3 ml of 8 M urea and reloaded 
on Sephacryl S-200 column for further purification as previously described. The purity of 
different active fractions was tested using 12% SDS-PAGE and gels were silver stained. All 
purification steps were performed at RT.  
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2.2.6 Protein analysis  
 
Protein concentrations in extracellular, intracellular and cell wall bound fractions were 
estimated according to Bradford (1976) using bovine serum albumin (BSA) as a standard. 
One hundred microliters of sample was mixed with 900 µl of Bradford reagent and incubated 
at RT for 10 min. The OD was measured at 578 nm and standard was made with 0-10 µg of 
BSA. 
 
2.2.7 SDS-PAGE 
 
SDS-PAGE (Sodium dodecyl sulfate polyacrylamide gel electrophoresis) was carried out 
according to Laemmli (1970). The acrylamide gel cast was set up by laying two spacers 
sandwiched between two rectangular glass plates. A separating gel (12%) was pipetted into 
the space. Upon polymerization of the separating gel, a comb was inserted in the sandwich 
plates. The stacking gel (5%) was filled on top of the separating gel and allowed to solidify. 
Protein samples were mixed with sample buffer (10:1) and were boiled at 95 oC for 5 min. 
The sample was loaded into the gel along with the unstained protein molecular weight 
standard (Fermentas). In the presence of electrophoresis running buffer, electrophoresis was 
performed with constant current 35 mA until the blue dye front reached the bottom. 
 
2.2.8 Gel staining 
 
For Coomassie Blue staining, the gels were immersed in 100 ml of Coomassie Blue staining 
solution (Merril 1990) overnight with continuous shaking. After removal of the remaining of 
staining solution, the gels were destained using destaining solution with changing of the 
solution until clearance of protein bands. Silver staining was performed according to Merril 
(1990) by fixation of the gel in 50% methanol supplied with 1% acetic acid for 20 min, 
washing in methanol for 10 min then in water for 10 min. After incubation with 150 ml 0.02% 
sodium thiosulfate for 1 min, the gels were rinsed with water 3 times. The gels were then 
submerged in 150 ml silver nitrate solution (0.1%) containing 0.08% formaldehyde for 20 min 
at 4 oC. After rinsing with water, developing was stopped using 5% acetic acid and final 
rinsing with water for 5 min. The gels were dried at 65 oC under vacuum. 
 
2.2.9 Bioautography  
 
Bioautography was performed according to the modified method by Vigers et al (1991). After 
SDS-PAGE, the gel was incubated with shaking in 100 ml of 1% (v/v) Triton X-100 for 20 min 
at room temperature and washed with water for 10 min then incubated in 100 ml of 20% LB 
broth medium with gentle shaking for 30 min at RT. The gel was placed in a 100 mm-
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diameter Petri dish and 20 ml of slightly warm 20% LB medium containing 1.5% (w/v) agar 
inoculated with a final concentration of 4-6 x 105 per milliliter of bacterial or fungal cells was 
poured over the gel and allowed to solidify. The plate was incubated overnight at 30 oC 
(fungi) or 37 oC (bacteria) and the location of antimicrobial activity on the gel was detected as 
a clear band of growth inhibition against a background of microbial growth. For molecular 
weight determination of the targeted protein(s), an unstained protein molecular weight 
marker was run in one lane of the gel, and in a second lane, 50 µl of sample was run 
simultaneously. After electrophoresis, these two lanes were cut and visualized using silver 
staining. By comparing the stained part of the gel with the incubated gel, the molecular 
weight of the desired protein(s) which was responsible for the antimicrobial activity could be 
estimated. 
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2.3 Results and Discussion 
 
2.3.1 Antimicrobial activities from plant cell cultures 
 
In this Ph.D. study, heterotrophic and photomixotrophic plant cell cultures were investigated 
with respect to the induction of antimicrobial proteins upon challenge by different elicitors. 
Heterotrophic and photomixotrophic cultures showed a higher antimicrobial potential than the 
photoautotrophic cultures (Table 2.3) which have been studied by Ali (2007). Generally, 
intracellular fractions of elicited cell cultures were more active than extracellular fractions 
while the cell wall bound fractions showed low activities (I-III, Annex). Among the 21 
fractions tested, the intracellular fraction of L. angustifolia elicited with DC3000 was most 
active against C. maltosa. The second active fraction was the intracellular fraction of A. 
thaliana elicited with salicylic acid which was active against all test strains with all stimuli with 
the highest activity in response to SA. N. tabacum petit havanna showed broad spectrum 
activity against all test pathogens upon elicitation with different elicitors but the activity was 
not as strong as A. thaliana. R. verticillata exhibited only antifungal activities with all elicitors. 
D. carota was active only against Gram-negative bacteria, while all elicitors except chitosan 
stimulated B. cusi to produce activity against Gram-positive bacteria. A. tenuis showed 
activities against both Gram-negative bacteria and C. maltose in response to all elicitors 
except MeJ which did not produce any detectable activity. The controls of the three fractions 
of the all cultures were performed simultaneously replacing the elicitor with sterile water and 
showed nearly no activity against all tester isolates and also the protein content for all 
fractions was low. 
 
Table 2.3 Antimicrobial activity results of elicited plant cell cultures. 
 
Cell line Gram-positive 
bacteria 
Gram-negative 
bacteria 
Fungi 
Agrostis tenuis - + + 
Arabidopsis thaliana + + + 
Baphicanthus cusi + - - 
Chenopodium rubrum - - - 
Daucus carota - + - 
Eschscholtzia californica (AST) + - - 
Eschscholtzia californica (ECO) + - - 
Gypsophila arabia + + + 
Lavendula angustifolia - - + 
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Lycopersicon esculentum 
(autotrophic) 
- - - 
Lycopersicon esculentum 
(heterotrophic) 
- + + 
Nicotiana tabacum (BY2) + + + 
Nicotiana pulmbaginifolia + + + 
Nicotiana tabacum petit havanna + + + 
Petroselium crispum + -  
Rauvolfia verticillata - - + 
 
+: Active, -: Non active  
 
Nine preparations of elicitors under three different categories and with diverse chemical 
natures were used. The first type of elicitors represents different fungal components and 
includes chitosan (polysaccharide formed by the action of plant enzymes on microbial cell 
walls), fungal spores such as Alt elicitor (fungal spore suspension of boiled spores of 
Alternaria brassicicola) and suspension of the whole fungus such as Fol elicitor (mycelial 
suspension of Fusarium oxysporium lycopersici). The second type of elicitors represents 
different bacterial components which includes DC3000 (boiled bacterial suspension of 
virulent strain of Pseudomonas syringae) and RPM1 (boiled bacterial suspension of avirulent 
strain of Pseudomonas syringae). The last type of elicitors represents different plant 
components including plant response-signaling compounds such as methyljasmonate, 
salicylic acid or their synthetic analogues such as acetylsalicylic acid (analogue to salicylic 
acid) and plant preparations such as polygalacturonic acid. Elicitation by the DC3000 and 
salicylic acid resulted in pronounced increases in the antimicrobial potential of heterotrophic 
and mixotrophic cell cultures. The bacterial (RPM1, DC3000) and fungal (Alt, Fol) elicitors 
were more effective than other elicitors of non microbial origin with respect to antimicrobial 
activity induction. The responses of the cell cultures to MeJ, PGA and chitosan were rather 
weak. Several studies have been done regarding the effect of elicitors on the induction of 
defense secondary metabolism and showed that application of elicitors to plants or cultured 
plant tissues resulted in increase the formation of secondary metabolites in addition to 
defense-related proteins (Zulak et al. 2009). This highlights the use of elicitors to induce plant 
defense reactions and production of antimicrobially active compounds that have not been 
isolated from untreated cells. 
 
The antimicrobial activities of elicited A. thaliana cell cultures were selected for further 
characterization using bioautography by virtue of the fact that this culture exhibited broad 
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spectrum antimicrobial activity and it is the only plant with a sequenced genome in our 
screening analysis. The active fraction was detected as a clear inhibition zone on the gel 
after SDS-PAGE (Figure 2.1). The molecular weight of antimicrobial protein(s) was 
estimated to be around 19 KDa. We thus confirmed that the antimicrobial activity of an 
extract from an elicited A. thaliana cell culture is due to an antimicrobial protein(s). These 
results highlight the efficiency of bioautography as a technique for screening antimicrobial 
agents in complex matrices and mixtures. 
 
                      
Figure 2.1 Bioautography of the intracellular fraction of A. thaliana cell culture elicited with 
salicylic acid against C. maltosa. 
 
 
2.3.2 Optimization of antimicrobial proteins production from Arabidopsis thaliana cell 
culture  
 
The rationale for choosing the Arabidopsis thaliana cell culture and salicylic acid as an 
elicitor were the highly promising results against the tester strains. One of the key limiting 
steps is the elicitor concentration which can control the production of pathogenesis related 
proteins and may affect the biosynthesis of some secondary metabolites. A high dosage of 
elicitor was reported to induce a hypersensitive response leading to cell death, whereas an 
optimum level was required for induction (Namdeo 2007). A. thaliana cell suspension culture 
was treated with five different concentrations of salicylic acid (0.1 mM, 0.25 mM, 0.5 mM, 1.0 
mM and 2.0 mM) to determine the optimum concentration required to produce high 
concentration of antimicrobial proteins and reduce other unwanted proteins. In this regard, 
two day-old cell cultures were used and the plant cell suspension cultures were exposed to 
the elicitor for another two days with the same nutrient composition of the medium. Among 
the five concentrations used (Table 2.4), one millimolar produced the highest titer of 
antimicrobial proteins against the tester isolates. On the other hand, salicylic acid at 
concentration 2.0 mM increased the protein content with decreasing the antimicrobial 
potency of the cell cultures against most of the pathogens which is not preferred and makes 
the purification process more difficult.  
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Table 2.4 Treatment with salicylic acid at different concentrations. 
 
SA Conc.  
(mM)        
            Pathogen 
Inhibition zone diameter (mm) Protein content 
(µg/µl) B. subtilis C. maltosa E. coli P. aeruginosa S. aureus 
0.1 7 7 8 9 9 0.4 
0.25 8 9 9 11 8 0.6 
0.5 12 9 8 10 6 0.7 
1.0 12 11 10 11 9 0.7 
2.0 10 9 8 10 8 0.9 
 
Furthermore, two periods of incubation, two days and four days were investigated. The use 
of two days incubation period increases the antimicrobial activity of the Arabidopsis cell 
culture and also the concentration of antimicrobial proteins (Table 2.5). While, in the case of 
four days incubation period the antimicrobial potency was decreased against most of the 
pathogenic bacteria and fungi with significant increase in the concentration of other non-
microbial proteins.  
Cell cultures of various ages such as two days, five days and seven days. Among them, two-
day old cell culture produced the highest antimicrobial activity while the use of five day and 
seven day-old cell cultures gave low antimicrobial activities (Table 2.5). It therefore, 
concluded that the age of subculture plays an important role in production of bioactive 
compounds by elicitation process. 
 
Table 2.5 Change in incubation period and duration of exposure to salicylic acid. 
 
Incubation 
period        
                 
         Pathogen 
Inhibition zone diameter (mm) 
Protein content 
(µg/µl) B. subtilis C. maltosa E. coli P. aeruginosa S. aureus 
2d,2d 12 13 10 10 11 0.6 
2d,4d 8 7 0 8 9 0.9 
5d,2d 0 9 8 7 8 0.6 
5d,4d 0 7 0 0 7 0.4 
7d,2d 0 9 0 8 7 0.5 
7d,4d 0 7 0 0 0 0.7 
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2.3.3 Purification and characterization of the antimicrobial protein from Arabidopsis 
thaliana cell culture  
 
The bioassay guided purification was performed using gel filtration with Sephacryl HR 
column. This column was selected because it has a cross-linked copolymer of allyl dextran 
and N,N-methylenebisacrylamide which gives the matrix good rigidity and chemical stability 
results in good resolution power for small peptides and proteins. Further purification was 
conducted by re-chromatography on the same column. This antimicrobial protein, designated 
AtAMP (Arabidopsis thaliana antimicrobial protein), was purified to homogeneity as 
determined by SDS-PAGE using silver staining and Coomassie blue staining (Figure 2.2). 
The molecular mass of AtAMP was estimated to be approximately 19 kDa, while calibrated 
with polypeptide markers on SDS-PAGE (Figure 2.2). 
 
                            
Figure 2.2 SDS-PAGE of AtAMP after (A) Silver staining (B) Coomassie blue staining. Lane 
1: protein molecular weight marker, lane 3: purified protein. 
 
The antimicrobial activity of AtAMP was tested in vitro using the disc diffusion assay against 
an array of human bacteria including Gram-positive and Gram-negative as well as one 
human Candida (Table 2.6). The protein showed potent activity against Candida maltosa 
and Gram-negative bacteria, while the activity against Gram-positive bacteria was low.  
 
 
 
 
21 3 2 31
BA
66.2 kDa 
45 kDa 
35 kDa 
25 kDa 
18.4 kDa 
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Table 2.6 Antimicrobial activity profile of AtAMP. 
Pathogen Inhibition zone diameter   (mm) 
B. subtilis 8 
C. maltosa 14 
E. coli 12 
P. aeruginosa 11 
S. aureus 7 
 
The simple procedure of extraction and purification from plant cell cultures rather than intact 
plants makes the production of antimicrobial proteins more easy and efficient. To our 
knowledge this the first report describing antimicrobial proteins from plant cell cultures. This 
highlights the potential of plant antimicrobial peptides as promising molecules for drug 
development.  
 
2.3.4 Conclusion and Outlook 
 
Elicited heterotrophic and photomixotrophic plant cell suspension cultures showed diverse 
inhibitory activities against human pathogenic bacteria and fungi. One putatively 19 kDa 
antimicrobially active protein, named AtAMP, was purified from Arabidopsis thaliana cell 
culture elicited with 1.0 mM salicylic acid using sephacryl S-200 gel filtration 
chromatography. Future work will include further characterization of this protein and 
heterologous expression in transgenic tobacco plants. Our results show that plant cell 
cultures can be promising sources of novel peptide antibiotics. 
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Chapter 3 
Isolation, phylogenetic analysis and anti-infective activity screening 
of marine sponge-associated actinomycetes 
 
 
3.1 Introduction 
 
3.1.1 Sponge microbiology 
 
Sponges (phylum Porifera) are one of the oldest, evolutionarily ancient multicellular animals 
dating back to Precambrian times (Li et al. 1998). The phylum Porifera consists of three 
major classes, namely, the Hexactinellida (glass sponges), Calcarea (calcareous sponges) 
and Demospongiae (demosponges), with the last group representing 85% of all living 
sponges (Wörheide et al. 2005). More than 6,000 species have been described so far and it 
is estimated that this is only half the number of species still to be discovered (Hooper et al. 
2002). Sponges populate tropical reefs in great abundance but also the polar latitudes as 
well as fresh water lakes and rivers (Belarbi el et al. 2003). They are sedentary filter-feeders 
capable of pumping thousands of liters of water per day (Hooper et al. 2002). 
Microorganisms and other food particles removed from the flowing water by phagocytosis, 
are transported into the mesohyl interior and are then digested by amoeboid archaeocytes 
that move freely through the extracellular matrix of the sponge. Sponges feed unselectively 
on particles up to 50 μm in size which is about the maximum size that the pores allow (Pile 
1996; Ribes et al. 1999). Microorganisms that can resist phagocytosis can successfully 
populate sponges (Wilkinson 1987). Sponges have developed intimate contact with diverse 
microorganisms such as viruses, bacteria, archaea, fungi, protozoa and single-celled algae 
and the nature of the sponge-microbe interaction is manifold (Vacelet J 1977; Lafi et al. 
2005; Hentschel et al. 2006). Although the proportion of sponge-associated bacteria can vary 
dramatically from sponge to sponge, bacteria can occupy up to 40-60% of the sponge 
volume, being densely extracellulary in their mesohyl matrix (Figure 3.1). The type of 
sponges classified as “high-microbial abundance sponges” (HMA) harbor uniformly 
distributed cells with bacterial concentrations in the range of 108-1010 cells g-1 sponge, two to 
four orders of magnitude higher than what is typically found in seawater. The other group of 
sponges with a mesohyl essentially free of bacterial cells were classified as “low-microbial 
abundance sponges” (LMA) with 105-106 cells g-1 sponge which is equivalent to that of 
natural seawater (Hentschel et al. 2006).  
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Figure 3.1 Scanning electron micrograph of Aplysina aerophoba showing the 
microorganism-filled mesohyl matrix (Hentschel et al. 2003). 
 
The novel cultivation-independent techniques, including 16S rDNA sequencing, denaturing 
gradient gel electrophoresis (DGGE) and fluorescence in situ hybridization (FISH) provided 
new insights on microbial communities in sponges (Lee et al. 2001; Imhoff and Stöhr 2003; 
Hill 2004; Hentschel et al. 2006; Olson and Kellogg 2010). At least 18 different prokaryotic 
phyla (Taylor et al. 2007) and one new candidate phylum Poribacteria have been so far 
discovered from marine sponges; with the most common phyla frequently recovered, being 
the Acidobacteria, Chloroflexi and Proteobacteria (Figure 3.2) (Fieseler et al. 2004; 
Scheuermayer et al. 2006; Taylor et al. 2007). Phyla such as Bacteroidetes, Cyanobacteria, 
Firmicutes, Nitrospira, Planctomycetes, Proteobacteria, and Verrucomicrobia have been 
isolated from marine sponges (Head et al. 1998; Schmidt et al. 2000; Friedrich et al. 2001; 
Montalvo et al. 2005; Jiang et al. 2007). Several diversity studies on sponge microbial 
communities have shown that actinomycetes are a major component of these communities 
(Webster et al. 2001; Sun et al. 2010). 
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Figure 3.2 16S rRNA gene sequences derived from marine sponges (Hentschel et al. 2002). 
 
Archaeal members (Preston et al. 1996; Margot et al. 2002) as well as fungi belonging to 
genera Acremonium, Aspergillus, Arthrium, Coniothyrium, Fusarium, Mucor, Penicillium and 
Trichoderma have also been reported from different marine sponges (Höller et al. 2000; 
Thakur and Muller 2004; Paz et al. 2010). The bacterial diversity and abundance from 
freshwater sponges was much lower and only Actinobacteria, Chloroflexi, Alpha- and 
Betaproteobacteria have been recovered from 16S rRNA gene library constructed from the 
freshwater sponge Spongilla lacustris (Gernert et al. 2005). Microbial distribution within 
sponge follows a general pattern with the photosynthetically active microorganisms such as 
cyanobacteria and eukaryotic algae, being located in the outer light exposed layers 
(Wilkinson 1992) while, heterotrophic and possibly autotrophic bacteria inhabit the inner core 
(Hentschel et al. 2003). 
 
The interaction between sponges and microbes is highly diverse, ranging from mutualism to 
commensalism to exploitative (parasitism/pathogenesis) interactions (Taylor et al. 2007). 
Many potential benefits have been attributed to the associated microorganisms such as 
nutrient acquisition (Wilkinson 1992; Vacelet et al. 1995), stabilization of the sponge skeleton 
(Rutzler 1985), processing of metabolic waste (Bewley et al. 1996; Beer and Ilan 1998), 
protection from UV light (Shick and Dunlap 2002) and chemical defense (Proksch 1994; 
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Unson et al. 1994; Schmidt et al. 2000). However, until details of the functional relationships 
of sponges and their microbial associates can be estimated, it is difficult to anticipate the true 
nature of the association. Recent studies with the aid of molecular approaches have shown 
that bacterial communities are consistently associated with a particular species (Webster et 
al. 2004). Substantial variability exists in microbial communities from different sponge 
species, and therefore, some bacteria are thought to be host-specific (Taylor et al. 2004). 
Sponge-specific actinobacterial clusters have been recovered from sponges Aplysina 
aerophoba and Theonella swinhoei (Hentschel et al. 2002; Montalvo et al. 2005). Theonella 
swinhoei showed a specific association species of δ-proteobacteria (Schmidt et al. 2000). A 
species of α-proteobacteria is dominant in sponge Rhopaloeides odorabile over various 
habitats and it has not been detected from seawater, which strongly suggests that the 
symbionts are species specific (Webster et al. 2001). The new group of bacteria 
“Poribacteria,” has been identified in several sponges and proved to be sponge-specific 
using molecular approaches (Fieseler et al. 2004).  
 
3.1.2 Sponge-derived compounds of likely microbial origin  
 
Because sponges cannot move and lack physical defences, they are highly susceptible to 
marine predators such as fish, turtles, and invertebrates. Thus, it is not surprising that 
sponges have developed a wide suite of defensive chemicals to deter predators (Thomas et 
al. 2010). They also use their defensive chemicals to keep the offspring of small plants and 
animals (fouling organisms) from settling onto their outer surfaces (Mol et al. 2009; Hertiani 
et al. 2010). These sessile animals are a prolific source of a huge diversity of secondary 
metabolites that has been discovered over the past 50 years (Faulkner 2002; Blunt et al. 
2005; Laport et al. 2009; Hertiani et al. 2010; Proksch et al. 2010). The bioactive compounds 
are very diverse in both structure and bioactivity. It is often unclear whether the compounds 
of interest are produced by the sponges or their microbial associates (Osinga et al. 2001). 
Many bioactive natural products from marine invertebrates have striking similarities to 
metabolites of their associated microorganisms especially bacteria (Table 3.1) (Unson et al. 
1994; Flowers et al. 1998; Proksch et al. 2002; Thiel and Imhoff 2003; Piel 2004).  
 
Table 3.1 Structurally-related microbial metabolites with sponge metabolites (Piel 2004).  
 
Sponge 
metabolite Source 
Bacterial 
metabolite Source 
Andrimid Hyatella sp. Andrimid Vibrio sp. 
Arenastatin A Dysidea arenaria Cryptophycin 1 Nostoc sp. 
Diketopiperazines Tedania ignis Diketopiperazines Micrococcus sp. 
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Jaspamide  Jaspis sp. Chondramide  Chondromyces crocatus 
Mimosamycin  Petrosia sp. Mimosamycin Streptomyces lavendulae 
Manzamine Acanthostrongylophora sp. Manzamine Micromonospora sp. 
Okadaic acid Halichondria okadai Okadaic acid Prorocentrum lima 
Salicylihalamide Haliclona sp. Apicularen A Chondromyces sp. 
Swinholide A T. swinhoei Tolytoxin Tolypothrix sp. 
 
In most cases development and production of sponge-derived drugs is hindered by 
environmental concerns and technical problems associated with harvesting large amounts of 
sponges. The presence of possibly producing microbial symbionts is therefore especially 
intriguing, as a sustainable source of sponge-derived drug candidates could be generated by 
establishing a symbiont culture or by transferring its biosynthetic genes into culturable 
bacteria. For example, the sponge Tedania ignis produces diketopiperazines which are also 
produced by an associated bacterium Micrococcus sp. (Stierle et al. 1988). Another 
bacterium Vibrio sp. produces brominated biphenyl ethers formerly ascribed to the host 
sponge Dysidea sp. (Elyakov et al. 1991). A dinoflagellate Prorocentrum lima produces 
okadaic acid, first isolated from the host sponge Halichondria okadai (Kobayashi and 
Ishibashi 1993). A Vibrio sp. produces peptide, andrimid that was purified from the sponge 
Hyatella sp. extract (Oclarit et al. 1994). Manzamine alkaloids, the promising leads for 
extended preclinical assessment against malaria, tuberculosis and HIV, have been 
previously isolated from sponge Acanthostrongylophora sp. and have also been isolated 
from the associated microorganism Micromonospora sp. (Hill et al. 2005). Thus, the microbial 
association that occurs on or in sponges could be of great interest to look for potential uses 
as new sources of bioactive compounds, in particular as a solution of the supply problem of 
most of pharmaceutical compounds produced by reef’s invertebrates. 
 
 
                                                                        
                   
                                                              
                                                             Diketopiperazines                      
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3.1.3 Actinomycetes 
 
The phylum Actinobacteria represents one of the largest taxonomic units among the 18 
major lineages currently recognized within the domain bacteria (Ventura et al. 2007). The 
best known of these is the subclass Actinobacteridae, which includes the order 
Actinomycetales whose members are commonly referred to as actinomycetes. Thirty nine 
families have been recognized with the most common ones being Actinomycetaceae, 
Actinoplanaceae, Dermatophilaceae, Frankiaceae, Mycobacteriaceae, 
Micromonosporaceae, Nocardiaceae, and Streptomycetaceae comprising altogether 147 
genera (Garrity et al. 2004). Based on the 16S rRNA gene classification system, these 
genera have been grouped in ten suborders: Actinomycineae, Corynebacterineae, 
Frankineae, Glycomycineae, Micrococineae, Micromonosporineae, Propionibacterineae, 
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Pseudonocardineae, Streptomycineae, Streptosporangineae and a large number of 
actinomycetes are still remains to be grouped (Nisbet and Fox 1991). Actinomycetes are a 
diverse group of aerobic Gram-positive microorganisms with high G+C content in their DNA. 
They are characterized by their diverse shapes and colors, formation of a network of aerial 
and substrate hyphae as well as production of melanoid pigments of various colors (i.e., 
greenish brown, brownish black or distinct brown) on the medium. The composition of cell 
wall in actinomycetes varies greatly among different groups and is of considerable taxonomic 
significance based on the composition and structure of peptidoglycan. Actinomycetes are 
metabolically and morphologically more complex than other bacteria. Metabolically, they are 
prolific producers of a vast array of secondary metabolites. Complex morphological 
development between their genera is apparently phenotypically related to secondary 
metabolism (Conn et al. 2008). Although most of actinobacteria are of medical or economical 
significance, serious human diseases could be caused by some members of actinobacteria 
such as Mycobacterium, Corynebacterium and Nocardia (Hall 2008).  
 
Actinomycete diversity  
 
Actinobacteria are widespread in nature and have been recovered from wide variety of 
sources, where they can be as saprophytes, symbionts, parasites or even pathogens 
(Shirokikh and Merzaeva 2005; Ward and Bora 2006). Actinomycetes populations have been 
identified as one of the major groups of the soil microbial community (Loqman et al. 2009; 
Jayabarath et al. 2010; Lin et al. 2010), where they play a crucial role in the recycling of 
refractory biomaterials by decomposing complex mixtures of polymers in dead plant, animal 
and fungal materials producing several volatile sesquiterpene substances namely, geosmins, 
responsible for the characteristic “wet earthy odor”. In a study carried out by Moncheva et al 
(2002), 47 actinomycete strains belonged to the genera Actinomadura, Kitasatospora, and 
Streptomyces, have been isolated from soil. Actinobacteria have also developed intimate 
associations with plants and colonize their inner tissues. The actinomycete bacteria that 
reside in the tissue of living plants and do not visibly harm the plants are known as 
endophytic actinobacteria. Endophytic actinobacteria have attracted attention, with 
increasing reports of isolates from a range of plant types, including crop plants, cereals, such 
as wheat, rice, potato, carrots, tomato and citrus (Chen et al. 2009; Qin et al. 2009) as well 
as from medicinal plants (Zin et al. 2007; Qin et al. 2008). The culturable endophytic 
actinobacteria from various plants have been found to fall within a narrow species 
distribution, with Streptomyces as the most predominant genus and the rest belonging to 
genera Actinosynnema, Actinomadura, Microbispora, Micromonospora, Streptosporangium, 
Nocardia and Nocardioides (Coombs and Franco 2003; Hasegawa et al. 2006). From the 
healthy shoots and roots of Aquilaria crassna Pierre, 10 endophytic actinomycete strains 
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have been recovered (Nimnoi et al. 2010). Phylogenetic analysis based on 16S rDNA 
sequencing of those isolates showed that they belong to genera: Actinomadura, Nocardia, 
Nonomuraea, Pseudonocardia and Streptomyces. Actinomycetes have also been isolated 
from niche habitats such as caves, pristine forests, high salt environments and endophytic 
niches (Seong et al. 2001; Groth et al. 2002; Ningthoujam et al. 2009). Wang et al. (1999) 
investigated the actinomycete diversity in the rainforests of Singapore. Thirty six 
actinomycete genera were recovered, among them Streptomyces, Micromonospora, 
Actinoplanes, Actinomadura, Nonomuria, Nocardia and Streptosporangium were the most 
abundant. They have been also found in sewage sludge compost (Vaz-Moreira et al. 2008). 
Actinomycetes belong to genera Actinomyces, Amycolatopsis, Corynebacterium, 
Streptomyces, Nocardia and mycobacterium have been isolated from various clinical human 
specimens (Sarkonen et al. 2001; Huang et al. 2004; Wauters et al. 2005). 
 
It has long been known that actinomycetes can be cultured from marine samples (Grein and 
Meyers 1958), yet it was not clear if these common soil bacteria should be considered 
terrestrial “contaminants” or a true component of the marine microbial community 
(Goodfellow and Haynes 1984). Early evidence for the existence of indigenous marine 
actinomycete populations came from the recovery of strains from deep-sea sediments 
(Weyland 1969), the description of the first marine species, Rhodococcus marinonascene 
(Helmke and Weyland 1984), the metabolic activity of some strains in marine sediments 
(Moran et al. 1995) and the isolation of obligate marine strains (Jensen et al. 1991; Moran et 
al. 1995). The first marine actinomycete taxon, Salinispora, was described in 2005 
(Maldonado et al. 2005a). Actinomycetes have been cultivated from seawater (Agogue et al. 
2005), marine snow (Alldredge and Silver 1988) and marine sediments (Jensen et al. 2005; 
Xiao et al. 2010), including deep-sea sediments (Stach et al. 2003). Actinomycetes are 
ubiquitous in marine sediments, but at lower abundances than in soil (Fiedler et al. 2005; 
Fenical and Jensen 2006; Bredholdt et al. 2007a; Maldonado et al. 2009). Members from 
families Micromonosporaceae, Nocardiaceae, Pseudonocardiaceae, Streptomycetaceae and 
Thermomonosporaceae have been recovered by Gontang et al (2007) from marine 
sediments collected in the Republic of Palau. Actinomycetes have been found in symbiosis 
with different marine invertebrates such as sponges, corals, tunicates and jellyfish (Han et al. 
2003; Inagaki et al. 2003; Charan et al. 2004; Lampert et al. 2008), with the majority have 
been isolated from sponges (Hentschel et al. 2002; Kim and Fuerst 2006; Wang 2006; Zhang 
et al. 2008; Selvin et al. 2010). At least 28 actinobacterial genera have been reported from 
sponges (Taylor et al. 2007). Montalvo et al. (2005) showed that actinobacteria are major 
component of the microbial communities of Xestospongia muta and X. testudinaria.  
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Both molecular studies and culture-based methods revealed the existence of extensive, 
uncharacterized marine actinobacterial diversity in comparison to terrestrial ones (Sun et al. 
2010). The difference observed in almost all cases between cultured and culture-
independent marine actinobacterial diversity could be discussed in a number of ways. It is 
known that the majority of the recovered actinomycetes belong to the suborders 
Micromonosporineae and Streptomycineae, thus, it is possible that these bacteria could 
occur in the marine environment as spores which are not easily detected due to relatively 
poor DNA extraction procedures when culture-independent approaches are used. It is also 
could be that these actinomycetes occur at low abundances which could not be detected by 
most of culture-independent approaches (Mincer et al. 2005). Nevertheless, all of these 
studies revealed considerable actinobacterial diversity in marine samples, evidence that 
actinomycetes are capable of growing in the marine environment.  
 
Members of actinobacteria have been cultivated from diverse marine samples when selective 
isolation protocols are applied with recent efforts leading to the description of new genera. 
Taxonomically novel isolates have been discovered from ocean sediments from four different 
locations, displayed an obligate requirement of seawater for growth. Phylogenetic 
characterization of representative isolates based on almost complete sequences of genes 
encoding 16S rRNA yielded a monophyletic clade within the family Micromonosporaceae and 
suggested novelty at the genus level with the name proposed name, Salinispora gen. nov. 
Different species have been recognized from the new genus such as Salinispora arenicola, 
Salinispora tropica and Salinispora pacifica which have been recovered from ocean 
sediments (Maldonado et al. 2005a) as well as from a sponge (Kim et al. 2005). A new 
actinomycete strain containing L-ornithine as the diagnostic amino acid has been isolated 
from a sea water sample from the East Sea, Korea. A phylogenetic analysis based on 16S 
rRNA gene sequences showed that this strain represents a phyletic line within the suborder 
Micrococcineae, adjacent to the genus Ornithinimicrobium with a sequence similarity of 94.1-
94.3% to other published strains within this genus. Physiological, biochemical and 
chemotaxonomical evidences clearly separated the marine isolate from other members of 
the suborder Micrococcineae and proposed the affiliation to a novel genus and species, for 
which the name Serinicoccus marinus gen. nov., sp. nov. has been proposed (Yi et al. 2004). 
Another example of newly described taxa is Salinibacterium amurskyense gen. nov., sp. 
nov., the new actinomycete strain that has been isolated from sea-water samples and 
represented a distinctive taxon in the family Microbacteriaceae (Han et al. 2003). The marine 
environment still unexplored source of new species and sometimes new genera of 
actinomycetes that could be exploited in the biotechnological, medicinal, and agricultural 
industries. In addition to the new genera that have been discovered from marine 
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environment, several obligate marine species have also been isolated from such as 
Streptomyces axinellae sp. nov. (Pimentel-Elardo et al. 2009) and Saccharopolyspora 
cebuensis sp. nov. (Pimentel-Elardo et al. 2008b). 
 
Marine actinomycetes as a source of new bioactivities  
 
Marine environments consist of taxonomically diverse microbial groups which exhibit unique 
physiological and structural characteristics enabling them to survive in the extremes of 
pressure, salinity and temperature, with the potential production of interesting 
pharmacological activities not observed in terrestrial microorganisms. Actinomycetes account 
for approximately half of the bioactive secondary metabolites that have been discovered 
among associated bacteria yet (Figure 3.3) (Lam 2006; Thomas et al. 2010). These 
metabolites exhibited diverse activities such as antibacterial, antifungal, pesticidal, herbicidal, 
immunomodulatory, anti-inflammatory and anticancer activities (Newman and Cragg 2007; 
Olano et al. 2009; Engelhardt et al. 2010; Pimentel-Elardo et al. 2010). The activities 
represented by diverse classes of natural products such as polyketides, alkaloids, fatty acids, 
peptides and terpenes (Boonlarppradab et al. 2008; Oh et al. 2008; Asolkar et al. 2010). 
 
 
 
 
 
Figure 3.3 Percentage distribution of compounds produced by associated bacteria (Thomas 
et al. 2010). 
 
Resistance of pathogenic bacteria and fungi toward antibiotics is certainly increasing; 
meanwhile the rate of discovery and development of new and effective antibiotic compounds 
is declining. Thus, the discovery of novel anti-infective agents has become a pressing need. 
Among the clinically used antibiotics, over two thirds have been discovered from microbial 
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sources or are the semi-synthetic derivatives of microbial products (Newman 2008; Rahman 
et al. 2010) and about three quarters have been derived only from actinomycetes. 
Abyssomicin C, is a novel polycyclic polyketide antibiotic produced by a marine 
Verrucosispora strain (Riedlinger et al. 2004). It is a potent inhibitor of para-aminobenzoic 
acid biosynthesis therefore, inhibits the folic acid biosynthesis at an earlier stage than the 
well-known synthetic sulfa drugs (Rath et al. 2005). Abyssomicin C exhibited potent activity 
against Gram-positive bacteria, including clinical isolates of multiple-resistant and 
vancomycin-resistant Staphylococcus aureus. Abyssomicin C has the potential to be 
developed as antibacterial agent against drug-resistant pathogens and is now in clinical 
trials. Three novel phenoxazin-derived antibiotics, chandrananimycins A, B and C have been 
isolated from the culture broth of a marine Actinomadura sp. isolate M045, exhibited high 
antibacterial and antifungal activities (Maskey et al. 2003). The new macrotetrolide antibiotic, 
bonactin has been purified from the liquid culture of a marine Streptomyces sp. BD21-2. 
Bonactin displayed antibacterial activity against both Gram-positive and Gram-negative 
bacteria as well as antifungal activity (Schumacher et al. 2003).  
 
               
 
           
        Abyssomicin C                   Chandrananimycin                              Bonactin 
                          
                                                                                                                                   
The antiparasitic activity from marine environment has been reported especially from 
sponges with few representatives have been characterized from actinomycetes (Gademann 
and Kobylinska 2009; Orhan et al. 2010). Salinosporamide A has been isolated from the 
marine Salinispora tropica and is known to be potent inhibitor of human multiple myeloma, 
has been found to be highly potent inhibitor of the human malaria parasite both in vitro (IC50 
= 11.4 nM, Plasmodium falciparum) and in vivo (ca. 90 % reduction in parasitemia at 130 
μg/kg in mice, P. yoelii) (Chauhan et al. 2005; Prudhomme et al. 2008). The lactone-derived 
compound, butenolide has been isolated from Streptomyces sp. cultivated from sponge 
Tethya sp. as well as from marine sediment-derived Streptomyces sp. strain M027750 (Cho 
et al. 2001). Butenolide exhibited antitrypanosomal activity (IC50 0.022 μM) (Pimentel-Elardo 
et al. 2010). The cyclic depsipeptide, valinomycin has been purified from Streptomyces sp. 
recovered from sponge Aplysina aerophoba as well as from previous terrestrial 
actinomycetes (Brockmann and Schmidt-Kastner 1955). Valinomycin exhibited significant 
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inhibitory activities against the parasites Leishmania major (IC50 < 0.11 μM) and 
Trypanosoma brucei (IC50 0.0032 μM) (Pimentel-Elardo et al. 2010). 
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A great number of known antitumor compounds are natural products or their derivatives, 
many of them produced by marine microorganisms (Fiedler et al. 2008). In particular, 
actinomycetes are the producers of a large number of secondary metabolites with antitumor 
properties (Olano et al. 2009). These antitumor compounds belong to several structural 
classes such as anthracyclines, enediynes, indolocarbazoles, isoprenoides, macrolides, non-
ribosomal peptides and others (Fiedler et al. 2008; Salas and Mendez 2009). Marinomycins, 
novel class of polyketides which contain unusual macrodiolides composed of dimeric 2-
hydroxy-6-alkenyl-benzoic acid lactones with conjugated tetraene-pentahydroxy polyketide 
chains, produced by marine Marinispora sp. CNQ-140. These compounds inhibit cancer cell 
proliferation with an average IC50 of 0.2-2.7 μM against the NCI’s 60 cancer cell line panel 
(Kwon et al. 2006). Parimycin, an anthraquinone derivative produced by marine 
Streptomyces sp. isolate B8652 showed activity against human tumor cell lines of stomach 
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cancer (GXF 251L), lung cancer (H460, LXFA 629L, and LXFL 529L), breast cancer (MCF-7 
and MAXF 401NL), melanomas (MEXF 462NL and MEXF 514L) with IC70 values ranging 
from 0.9 to 6.7 μg/ml (Maskey et al. 2002). 
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3.1.4 Aim of the work 
 
Actinomycetes are prolific producers of secondary metabolites and preferential targets in the 
search for new bioactive natural products. The aim of this work was to isolate the bioactive 
novel actinomycete species associated with marine sponges collected from Egypt and 
Croatia by cultivation. Strains were identified based on 16S rRNA gene sequence analysis 
and their bioactivity was tested against a panel of clinically relevant, Gram-positive and 
Gram-negative bacterial pathogens. Moreover, human fungal pathogen as well as human 
parasites was also tested. 
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3.2 Materials and Methods  
 
3.2.1 Sponge collection 
 
The first group of sponges (Aplysina aerophoba, Dysidea avara, D. tupha, Hemimycale 
culumella, Ircinia fasciculata) was collected by SCUBA diving at depths of 3-20 m in the 
Mediterranean Sea (Rovinj, Croatia, (GPS: 27˚47.655 N; 34˚12.904 W) in August 2008. 
Taxonomic identification was performed by W.E.G. Müller and I. Müller (University of Mainz, 
Germany). The second group (Amphimedon sp., Callyspongia sp., C. aff. implexa, Hyrtios 
erecta, Negombata magnifica, Spheciospongia vagabunda) was collected at a depth of 10 m 
in the Red Sea (Ras Mohamed, Sinai, Egypt; (GPS: 27˚47.655 N; 34˚12.904 W) in August 
2006. Amphimedon sp. and Hyrtios erecta were identified by M. Kelly (National Institute of 
Water and Atmospheric Research (NIWA) Auckland, New Zealand) and the remaining 
sponges by R.W.M. van Soest (University of Amsterdam, Netherlands). Sponges were 
transferred to plastic bags containing seawater and transported to the laboratory. Sponge 
specimens were rinsed in sterile seawater, cut into pieces of ca. 1 cm3, and then thoroughly 
homogenized in a sterile mortar with 10 volumes of sterile seawater. The supernatant was 
diluted in ten-fold series (10-1, 10-2, 10-3) and subsequently plated out on agar plates. 
 
3.2.2 Isolation of sponge-associated actinomycetes 
 
Eight different media [M1 (Mincer et al. 2002), ISP medium 2 (Shirling and Gottlieb 1966), 
Oligotrophic medium (OLIGO) (Olson et al. 2000), M1 plus (Webster et al. 2001), Actinomycete 
Isolation Agar (AIA) (Kurup et al. 1975), Marine Agar (MA) (Weiner et al. 1985), Glycerol 
Asparagine Agar (GAA) (Lechevalier and Lechevalier 1975) and R2A Agar (Reasoner and 
Geldreich 1985)] were used for the isolation of actinobacteria. All media were supplemented 
with 0.2 µm pore size filtered cycloheximide (100 µg/ml), nystatin (25 µg/ml) and nalidixic 
acid (25 µg/ml) to facilitate the isolation of slow-growing actinobacteria. Cyclohexamide and 
nystatin inhibit fungal growth, while nalidixic acid inhibits many fast-growing Gram-negative 
bacteria (Webster et al. 2001). All media contained Difco Bacto agar (18 g/L) and were 
prepared in 1 L artificial sea water (Lyman and Fleming 1940). To promote the growth of 
selected sponge-associated actinobacteria, 1% “aqueous sponge extract” was added to the 
autoclaved medium (M1 plus). Aqueous sponge extract was prepared by grinding 20 g of 
sponge biomass in a mortar containing 20 ml of sterile seawater followed by centrifugation 
(5000 rpm, 10 min) and sterilized by filtration through a 0.2 µm pore size filter. The freshly 
prepared supernatant served as aqueous sponge extract. The inoculated plates were 
incubated at 30 °C for 6-8 weeks. Distinct colony morphotypes were picked and re-streaked 
until visually free of contaminants. The strains were selected by the morphological 
differences based on visible examination of the growth characteristics (tough leathery 
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texture, dry or folded appearance, aerial mycelium, substrate mycelium and diffusible 
pigments). Pure isolates were inoculated into liquid media (M1 or the medium on which 
colonies were initially isolated). The isolates were maintained on plates for short-term 
storage and long-term strain collections were set up in medium supplemented with 30% 
glycerol at −80 °C. The isolates from Egypt are abbreviated as “EG” and from Rovinj as “RV”.  
 
3.2.3 Molecular identification and phylogenetic analysis 
 
16S rRNA gene amplification, cloning and sequencing were performed according to 
Hentschel et al. (Hentschel et al. 2001) using the universal primers 27F and 1492R (Lane 
1991). Total genomic DNA was extracted from each strain by scrapping few colonies, 
suspending in sterile water and incubation at 95 oC for 10 min then centrifugation at 3000 
rpm for 30 s or using FastDNA spin kit for soil (Q-Biogene) following manufacturer’s 
instructions. Three milliliters of well grown liquid cultures were centrifuged at 8000 rpm for 5 
min and the supernatant was discarded. Pellet was resuspended in 978 μl sodium phosphate 
buffer and 122 μl MT buffer. The solution was transferred to lysing matrix tubes then 
processed using a FastPrep instrument (Q-Biogene) for 30 s with speed set at 5.5. The 
resulting solution was centrifuged at 13000 rpm for 30 s and supernatant was transferred to a 
clean tube and 250 μl of PPS reagent was added. The solution was mixed by shaking the 
tube ten times with hands, centrifuged at 13000 rpm for 5 min. Supernatant was transferred 
to clean 2-ml microfuge tube. 1 ml of binding matrix suspension was added to the 
supernatant and the solution was mixed for 2 min to allow binding of the DNA to the matrix. 
The tube was allowed to stand for 3 min to allow settling of the silica. Five hundred 
microliters of the supernatant was discarded and 600 μl was transferred to a spin filter, 
centrifuged at 13000 rpm for 1 min and catch tube was emptied. The remaining supernatant 
was added to the spin filter and centrifuged at 13000 rpm for 1 min. 500 μl of SEWS-M was 
added, followed by centrifugation at 13000 rpm for 1 min. The flow-through was discarded 
and the spin filter was centrifuged at 13000 rpm for 2 min. The spin filter was removed, 
placed in a new catch tube and subsequently air-dried for 5 min at room temperature. 50 µl 
of DES (DNAse/pyrogen-free) water was added and the filter matrix was gently stirred using 
a pipette tip to resuspend the silica and for efficient elution of the DNA. After centrifugation at 
13000 rpm for 1 min, eluted DNA was transferred to new catch tube and stored at -20 C.  
 
From the genomic DNA, nearly full-length 16S rRNA genes were amplified by polymerase 
chain reaction (PCR) using primers 27F (GAGTTTGATCCTGGCTCAG) and 1492R 
(GGTTACCTTGTTACGACTT). The PCR mixture consisted of 5 µl of 10 X buffer (Mg2+ free), 
2 µl of 2.5 M MgCl2, 1 µl of dNTPs mixture, 10 µl of Q solution, 1 µl of each primer, 1 µl of 
template DNA and 0.25 µl of 5 U Taq DNA polymerase (Promega, USA) and 28.75 µl of 
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water in a final volume of 50 µl. PCR was performed in a thermal cycler (Biometra, Germany) 
using an initial denaturation at 95 oC for 2 min, followed by 30 cycles of denaturation at 95 oC 
for 1 min, annealing at 56 oC for 1 min followed by primer extension at 72 oC for 90 s and a 
final extension at 72 oC for 10 min. PCR amplification products were visualized by agarose 
gel electrophoresis.  
 
PCR amplification products were purified using QIAquick gel extraction kit (Qiagen, 
Germany). Five volumes of buffer PB was added to one volume of PCR product and mixed 
using a pipette. The mixture was applied to a QIAquick column and centrifuged at 13000 rpm 
for 1 min. The flow-through was discarded and the column was placed back into the same 
tube. Buffer PE (750 μl) was added to the column followed by centrifugation at 13000 rpm for 
1 min. The flow-through was discarded and the column was centrifuged for an additional min 
at 13000 rpm. The column was then placed in a clean 1.5-ml microfuge tube, 30 μl of buffer 
EB was added and allowed to stand for 1 min. A final centrifugation step at 13000 rpm for 1 
min was performed and the resulting purified PCR product was stored at -20 C. 
 
Purified PCR product were subsequently ligated into the pGEM-T Easy vector (Promega, 
USA) by mixing 5 μl (50 ng/μl) 2x T4 DNA ligase buffer, 1 μl (3 U/μl) pGEM-Teasy vector 
(Promega), 1 μl T4 DNA ligase and 4 μl PCR product on ice. The ligation reaction was 
incubated overnight at 4 C. 2-3 μl of the ligation mixture was transformed into DH5α 
Escherichia coli Novablue cells. The positive recombinants were screened on X-Gal (5-
bromo-4-chloro-3-indoly-β-D-galactopyranoside)-IPTG (isopropyl-β-thiogalactopyranoside)-
ampicillin-indicator plates by colour-based recombinant selection. Two clones were selected 
from each library and the plasmid DNA was purified using the QIAquick spin Miniprep kit 
(Qiagen, Germany). Few white colonies were inoculated in 2 ml of LB/amp broth and 
incubated with shaking at 37 C overnight. After incubation, liquid culture was centrifuged at 
13000 rpm for 5 min and the supernatant was discarded. The pellet was then resuspended in 
150 μl of buffer P1. 150 μl of buffer P2 was added and allowed to stand for 5 min at RT and 
subsequently 150 μl of buffer P3 was added on ice for 5 min. The solution was mixed by 
gentle shaking of the tube after each addition of the buffer. Suspension was centrifuged at 
13000 rpm for 10 min; supernatant was transferred to clean 1.5-ml microfuge tube and 
centrifuged 13000 rpm for 10 min. The supernatant was again transferred to clean tube, 
mixed with 0.7 volume of isopropanol with gentle shaking, followed by centrifugation at 
13000 rpm for 15 min. Pellet containing the plasmid DNA was washed with 70% ethanol and 
allowed to air-dry. Pellet was then resuspended in 50 µl sterile water and the plasmid DNA 
was stored in -20 C. The correct inserts were checked by digestion with EcoRI restriction 
endonuclease (Promega, USA). Restriction digestion (New England Biolabs) was carried out 
by mixing 2 μl 10x EcoRI buffer, 12 μl water, 1 μl EcoRI (20,000 U/ml) and 5 μl plasmid DNA. 
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The reaction mix was incubated at 37 C for 3 h and the restriction patterns were analyzed 
by agarose gel electrophoresis.  
  
Sequencing was done using an ABI 377XL automated sequencer (Applied Biosystems) and 
almost complete 16S rRNA gene sequences were determined using sequencing primers 
SP6 (5′ GATTTAGGTGACACTATAG-3′), T7 (5′-TAATACGACTCACTATAGGG-3′) and the 
16S rDNA-specific primers, 341F (5'- CCTACGGGAGGCAGCAG-3') and 907R (5'-
CCGTCAATTCCTTTAAGTTT-3') with the following PCR conditions: 96 °C for 2 min, 25 
cycles of 96 °C for 30 s, 45 °C (SP6 and T7), 59 °C (341F) or 52 °C (907R) for 15 s, 60 °C 
for 4 min, with a final extension step of 60 °C for 10 min. Sequences were manually edited 
using Invitrogen’s Vector NTI Advance 10 (InforMax, Inc) and Contigs of ~1,400-kb length 
were tested against all DNA sequences available in GenBank (www.ncbi.nml.nih.gov) using 
the BLASTn tool to identify the nearest neighbor to the amplified sequence. Chimeric 
sequences were identified by using the Pintail program (Ashelford et al. 2005). The genus-
level affiliation of the sequences was validated using the Ribosomal Database Project 
Classifier (Wang et al. 2007). Sequence alignment and phylogenetic analysis were 
performed using the ARB software package (Ludwig et al. 2004). Tree construction was 
conducted using neighbour-joining algorithm (Jukes-Cantor correction) with bootstrap values 
based on 1000 replications. The 16S rRNA gene sequences of the putatively novel isolates 
were deposited in GenBank under the accession numbers indicated in parentheses: EG4 
(GU318354), EG7 (GU318355), EG33 (GU318356), EG36 (GU318357), EG37 (GU318358), 
EG45 (GU318359), EG47 (GU318360), EG49 (GU318361), EG62 (GU318362), EG69 
(GU318363), RV15 (GU318364), RV113 (GU318365), RV13 (GU318366) and RV89 
(GU318367).  
 
3.2.4 Extract preparation and anti-infective activity screening  
 
Fourteen strains selected based on phylogenetic novelty and six selected based on their 
affiliation to known metabolite-producers were cultured in 100 ml Erlenmeyer flasks 
containing 50 ml of 5 different production media (M1, ISP2, OLIGO, AIA and R2A) for each 
isolate. The liquid cultures were grown for 7-14 days depending on their growth rate at 30 °C 
while shaking at 150 rpm. An equal volume of methanol was added to the liquid cultures for 
cell lysis and shaking was continued (150 rpm, 1 h at RT; Shaker SM 30, E. Bühler). The 
broth was centrifuged in 50 ml falcon tubes (5000 rpm, 15 min at RT; Megafuge 1.0R, 
Heraeus) and the supernatant was stored at 4 °C for bioactivity testing.  
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Antibacterial and antifungal activities 
 
The in vitro antimicrobial activity testing was carried out using the standard disc diffusion assay 
(Inderlied and Salfinger 1995) against pathogenic bacteria (Staphylococcus aureus strain 
8325, Enterococcus faecalis strain JH212, Escherichia coli strain 536, Pseudomonas 
aeruginosa strain Nr. 3) and yeast (Candida albicans strain S314). The overnight broth 
cultures prepared freshly from plates for each assay by overnight growing the bacterial 
isolates in LB and yeast in YPD broth at 37 oC with shaking at 220 rpm (Innova 4300 
incubator shaker). 100 µl of the overnight culture with an optical density of OD600 = 0.2 
adjusted with LB or YPD using spectrophotometer (Ultrospec 3100 Pro) was spread on 100 
mm-dry plates containing solid LB or YPD-agar medium, allowed to absorb in the agar for 10 
min, then the plates dried and inverted at 37 °C for approximately 30 min until the bacterial 
overlay had dried. Sterile Whatman filter paper (Roth, Germany) discs with a diameter of 6 
mm were impregnated with testing solution (20 µl/disc) and let to dry under the fume hood (3 
times impregnating then drying). Loaded discs were placed on the agar plates inoculated 
with the target microorganism and gently taped each disc to ensure contact with the agar 
surface. The plates were inverted incubated for 24 h at 37 oC and the antimicrobial potential 
was quantitatively assessed as diameter of the inhibition zone (n = 2). Different antibiotics 
(chloramphenicol and gentamycin as antibacterial and nystatin as antifungal) were used as 
positive controls in the plates and 50% methanol was also used as a negative control. 
  
Antileishmanial activity 
 
Antileishmanial activity was tested following the method of Ponte-Sucre et al. (Ponte-Sucre 
et al. 2006). Leishmania major promastigotes were seeded at a cell density of 1 x 107 
cells/ml into 96-well plates containing 200 μl Complete Medium without phenol red, in the 
presence or absence of the extracts. These were then incubated for 24 h at 26 °C, 5% CO2, 
and 95% humidity. Following the addition of 20 μl of Alamar Blue, the plates were incubated 
again and the optical densities measured after 24 and 48 h with a Multiskan Ascent enzyme-
linked immunosorbent assay (ELISA) reader (Thermo Electron Corporation, Dreieich, 
Germany) using a test wavelength of 540 nm and a reference wavelength of 630 nm. 
Absorbance in the absence of extracts was set as 100% of growth. Amphotericin B was used 
as a reference compound and positive control. Each extract was assayed in duplicate from 
two independent experiments.  
 
Antitrypanosomal activity 
 
Antitrypanosomal activity was tested following the protocols of Huber and Koella (Huber and 
Koella 1993). Trypomastigote forms of Trypanosoma brucei brucei laboratory strain TC 221 
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were cultured in Complete Baltz medium (Baltz et al. 1985). A defined number of parasites 
(104 trypanosomes per ml) were exposed in test chambers of 96-well plates to various the 
test extracts (previously dissolved in DMSO) to make a final volume of 200 μl in duplicates. 
Positive (trypanosomes in culture medium) and negative controls (test substance without 
trypanosomes) were run simultaneously with each plate. The plates were then incubated at 
37 °C in an atmosphere of 5% CO2 for a total time period of 72 h. After addition of 20 μl of 
Alamar Blue, the activity of extracts was measured by light absorption using MR 700 
Microplate Reader at a wavelength of 550 nm with a reference wave length of 630 nm. First 
reading was done at 48 h and subsequently at 72 h. Each extract was assayed in duplicate 
from two independent experiments. 
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3.3 Results and Discussion 
 
3.3.1 Diversity of sponge-associated actinomycetes  
 
Homogenates from eleven taxonomically different marine sponges collected from Ras 
Mohamed (Egypt) and Rovinj (Croatia) were plated on a range of selective media for 
actinomycetes isolation. On the basis of characteristic colonial morphology, notably the dry 
folded appearance, the ability to form aerial hyphae and substrate mycelia as well as 
pigment production, organisms putatively identified as actinobacteria were selected and 
obtained as pure cultures. Phylogenetic analysis based on nearly complete 16S rRNA gene 
sequences revealed that 52 out of 90 putative actinobacterial cultivated strains were affiliated 
to 18 different genera (Table 3.2) after BLAST against the sequences in the NCBI GenBank 
database (Abdelmohsen et al. 2010b). Taxonomic ordering using Bergey's Manual of 
Systematic Bacteriology (Garrity et al. 2004) showed that these genera represent 14 different 
families and seven suborders under two subclasses (Figure 3.4).  
 
 
 
Figure 3.4 Taxonomic ordering of cultivated actinomycete strains. 
 
The number of Actinobacteria isolated from the eleven sponge species was significantly 
different. Callyspongia aff. implexa yielded the highest number of isolates (22), followed by 
Aplysina aerophoba (16), Spheciospongia vagabunda (11), Hemimycale culumella (9), 
Hyrtios erecta (8), Dysidea tupha (6), Callyspongia sp. (6), Dysidea avara (4), Amphimedon 
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sp. (4), Negombata magnifica (4), while no actinomycete strains were cultivated from Ircinia 
fasciculata (Figure 3.5). It has been shown by different studies that actinomycetes are 
consistent, diverse and sometime major component of sponge-associated microbial 
communities (Hentschel et al. 2002; Sun et al. 2010). Zhang et al. (2006a) isolated 106 
actinomycete strains representing seven genera from the sponge Hymeniacidon perleve. 
Another study described the diversity of actinobacteria isolated from the marine sponge 
Iotrochota sp. collected in the South China Sea, revealed 52 isolates belonged to three 
genera (Jiang et al. 2008).   
 
 
 
 
Figure 3.5 Number of actinomycete isolates per sponge species. 
 
The actinomycetes isolated in this study displayed considerable diversity, which distributed 
under seven suborders with the highest number of isolates were found to be affiliated with 
the genus Mycobacterium (14.4%), followed by Micrococcus (13.3%), Micromonospora 
(12.2%), Microbacterium (12.2%), Brevibacterium (10%), Kocuria (6.6%), Corynebacterium 
(5.5%), Rhodococcus (5.5%), Brachybacterium (3.3%), Rubrobacter (2.2%), Streptomyces 
(2.2%), Dietzia (2.2%), Salinispora (2.2%), Actinokineospora (2.2%), Gordonia (2.2%), 
Arthrobacter (1.1%), Nocardiopsis (1.1%) and Rothia (1.1%) (Figure 3.6). Diverse genera 
have been isolated from marine sponges, specifically, Actinoalloteichus, Brachybacterium, 
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Brevibacterium, Curtobacterium, Gordonia, Kocuria, Micrococcus, Micromonospora, 
Nocardiopsis, Rhodococcus, Salinispora and Streptomyces which may therefore be common 
components thereof (Lee et al. 1998; Montalvo et al. 2005; Radwan et al. 2009). However, 
none of the strains isolated in our study showed sequence similarities with those previously 
reported from sponges, thus rendering the existence of sponge-specific actinomycete clades 
in the sense of Hentschel et al. (2002) unlikely. It has been reported that the genera 
belonging to Micromonospora, Rhodococcus and Streptomyces are the dominant 
actinobacterial genera in marine environments (Zhang et al. 2008). Representatives of all 
three taxa were isolated from the marine sponges studied here although other genera such 
as Mycobacterium, Micrococcus, Microbacterium were also represented by high numbers of 
isolates.  
 
 
 
 
 
Figure 3.6 Number of actinomycete isolates per actinomycete genera. 
 
Among the eight actinomycetes-selective media used in the study, M1 exhibited the highest 
recovery producing 27 isolates and MA recovered only two isolates (Figure 3.7). In terms of 
diversity, M1 also produced isolates belonging to the highest number of genera (13), followed 
by ISP medium 2 (11 genera), R2A (eight genera), AIA (six genera), M1 plus (five genera), 
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OLIGO (four genera), GAA (two genera) and the lowest diversity was observed with MA 
which recovered only one genus. Previous studies showed that only 0.1% of microorganisms 
from marine sponges were amenable to culture using standard cultivation approaches 
(Webster et al. 2001; Zhang et al. 2008). The diversity of recovered actinomycetes among 
the different media likely reflects the effect of media composition on the growth of specific 
strains as many marine bacterial species have unknown growth requirements and have not 
yet been cultured. 
 
 
 
Figure 3.7 Number of actinomycete isolates per cultivation media. 
 
Actinobacterial communities in sponges are diverse and the extent of diversity may vary 
between different sample collection regions, different sponge species and the isolation 
methods. In our study, six Red Sea sponges yielded 67 actinomycete isolates representing 
13 genera. Red Sea sponges represent rich source for diverse bioactive compounds 
however, only few studies have been done to investigate the actinobacterial diversity of Red 
Sea sponges. One study has been recently carried out by Radwan et al (2009) to explore the 
microbial diversity of two Red Sea sponges, Amphimedon sp. and Hyrtios erectus using 
cultivation-dependent and cultivation-independent analyses. Focused cultivation on 
actinobacteria yielded 35 actinomycetes represented by four genera. Comparing our results 
with the previous study, we recovered a high diversity of culturable actinobacteria from 
Egyptian marine sponges. A broad study concerning diversity of actinobacteria associated 
with the marine sponge Hymeniacidon perleve from the South China Sea has been carried 
out by Sun et al (2010) using both culture-independent and culture-dependent methods. 
Eight actinobacterial genera (Amycolatopsis, Arthrobacter, Brevibacterium, Microlunatus, 
Mycobacterium, Nocardioides, Pseudonocardia and Streptomyces) have been uncovered by 
the molecular method while, the cultivation techniques using seven media revealed six 
actinobacterial genera (Gordonia, Mycobacterium, Nocardia, Rhodococcus, Salinispora and 
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Streptomyces). Interestingly, only two genera (Mycobacterium and Streptomyces) have been 
detected by both approaches. Although, culture-based and molecular-based approaches 
provided very different views of actinobacterial diversity, both techniques are complementary 
and important in exploring the diversity of marine sponge-derived actinobacteria.  
 
3.3.2 Phylogenetic analysis  
 
Out of 90 isolates cultivated in this study, fourteen strains representing five suborders and 
belonged to eleven different genera, exhibited only 92.9-98.2% sequence similarities with the 
closest type strains (IV, Annex). The low sequence similarities suggest that these strains 
belong to novel actinomycete taxa which is further supported by phylogenetic analysis 
(Stackebrandt and Ebers 2006). These putatively novel isolates were affiliated to the genera 
Rothia, Kocuria, Micrococcus, Brachybacterium, Brevibacterium and Microbacterium 
(suborder Micrococcineae) (Figure 3.8). Pairwise comparison of the 16S rRNA gene 
sequences from the two Microbacterium isolates (EG4 and EG62 from Callyspongia sp. and 
Amphimedon sp., respectively) showed relatively high similarities (98.0 and 97.4%) to the 
type strains of the genus Microbacterium. However, the phylogenetic analysis indicated that 
they were diversely distributed within this genus and clustered singly in the phylogenetic tree, 
suggesting that isolates EG4 and EG62 might belong to new species. The high sequence 
similarity (99.8%) of the isolates with only three nucleotide differences suggests that they are 
the same strain although they were isolated from different sponge species. The other 
putatively novel isolates were affiliated with the following genera: Mycobacterium and 
Rhodococcus (suborder Corynebacterineae), Actinokineospora (suborder 
Pseudonocardineae), Streptomyces (suborder Streptomycineae) and Rubrobacter (suborder 
Rubrobacterineae) (Figure 3.9). Comparison of the 16S rRNA gene sequences of this isolate 
US49 and the closest neighbours indicated that this strain was closely related to the type 
strain Actinokineospora diospyrosa. New actinomycete species have been cultivated from 
marine sponges in different studies. In a study carried by Tabares et al (2010), seventy nine 
actinomycetes belonging to 20 genera have been recovered from 18 different Caribbean 
sponge species, sediment and seawater; seven of these strains exhibited sequence similarity 
less than 98.1% to the validly described sequences in NCBI GenBank database, suggesting 
that these strains belong to putatively novel species. This highlight sponges potential as 
excellent source of actinobacteria especially the new species. 
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Figure 3.8 Neighbor-joining tree of the strains and representative species of the 
suborder Micrococcineae based on nearly complete 16S rRNA gene sequences. 
Numbers at the nodes indicate the levels of bootstrap support based on 1000 
resampled data sets. Only values greater than 50% are shown. The arrow points to the 
outgroup consisting of five species belonging to Enterobacteriaceae. The scale bar 
indicates 0.01 substitution per nucleotide position. 
80 
 
 
 
 
 
Figure 3.9 Neighbor-joining tree of the strains and representative species of the suborders 
Corynebacterineae, Pseudonocardineae, Streptomycineae and Rubrobacterineae based on 
nearly complete 16S rRNA gene sequences. Numbers at the nodes indicate the levels of 
bootstrap support based on 1000 resampled data sets. Only values greater than 50% are 
shown. The arrow points to the outgroup consisting of five species belonging to 
Enterobacteriaceae. The scale bar indicates 0.01 substitution per nucleotide position. 
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Eight media with different compositions were used for isolating new species and a dilution 
culture technique was used to isolate oligotrophic species which do not grow on nutrient-rich 
media. Given that the majority of microorganisms are not easily cultured using standard 
microbiological techniques (Rappe and Giovannoni 2003), the use of innovative isolation 
approach is critical for improving the recovery of actinobacteria (Webster et al. 2001). The 
use of M1 medium without added sponge extract produced the largest number of different 
colony morphotypes, while the addition of aqueous sponge extract to M1 medium resulted in 
an increase in the number of novel cultivated morphotypes but decrease in the total number 
of morphotypes isolated. This new approach yielded an isolate RV113 from sponge Aplysina 
aerophoba which exhibited 92.9% sequence similarities to type strains of genus Rubrobacter 
as well as to several uncultured clones (Figure 3.9). Phylogenetic analysis revealed that the 
isolate RV113 forms a distinct clade within the family Rubrobacteraceae in the phylogenetic 
tree, most closely related to Rubrobacter radiotolerans and the low sequence similarity 
values further suggest that RV113 possibly represent a novel genus within the family 
Rubrobacteraceae. This is the first report describing the isolation of genus Rubrobacter from 
marine sponges. Members of this genus are radiotolerant and slightly thermophilic with an 
optimum growth temperature of about 45 oC (Carreto et al. 1996). They have been isolated 
from terrestrial sources especially thermal environments and desert soils where they survive 
for long periods of time and grow during sporadic rainy periods (Chen et al. 2004). Recently, 
they have been described from seawater (Jensen and Lauro 2008). Very little research has 
been done on these organisms and little is known other than their taxonomic characterization 
(Suzuki et al. 1988). This may be interesting to go further within this new genus to know 
more about its members especially from the chemical point of view. These results show that 
variation from standard isolation protocols is a worthwhile procedure.  
 
3.3.3 Anti-infective activity screening  
 
A major goal of our study is to establish new sources of antibiotics and other bioactive 
compounds. It has been reported that the novel actinomycete taxa produce new leads with 
new bioactivities, making this targeted approach a more productive way to new discoveries 
(Fiedler et al. 2005; Pimentel-Elardo et al. 2008a). In order to avoid reisolation of already 
known compounds, the 14 putatively novel strains plus six additional ones based on their 
moderate relatedness to known metabolite producers from literature were selected for 
bioactivity against panel including clinically relevant, Gram-positive (Enterococcus faecalis 
and Staphylococcus aureus) and Gram-negative (Escherichia coli and Pseudomonas 
aeruginosa) bacterial pathogens, the human fungal pathogen Candida albicans as well as 
parasites (Leishmania major, Trypanosoma brucei). The antimicrobial activity was assessed 
by the disc diffusion assay as the diameter of inhibition zone while the antiparasitic activity 
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was measured in multi-well plates and is represented as the percentage of growth inhibition 
in comparison to a reference compound. Of the twenty strains tested, ten produced 
antimicrobially active metabolites inhibiting at least one tested pathogenic microorganism. 
Five isolates were capable of inhibiting the growth of Gram-positives only, one isolate was 
active against C. albicans only and one isolate showed activity against both groups of 
pathogens (Table 3.2). The inhibition was greatest with the Streptomyces sp. RV15 against 
S. aureus. Gram-negative bacteria were not susceptible to our isolates.  
 
                Table 3.2 Antimicrobial activities of sponge-derived actinomycetes. 
 
Inhibition zone diameter (mm)  
Sponge isolate 
C. albicans 
S314 
E. faecalis 
JH212 
S. aureus 
8325 
12 0 0 Actinokineospora sp. EG49* 
0 0 13 Dietzia sp. EG67  
0 9 10 Microbacterium sp. EG69* 
0 10 12 Micromonospora sp. RV115  
0 8 12 Rhodococcus sp. EG33* 
0 0 9 Rubrobacter sp. RV113** 
13 11 17 Streptomyces sp. RV15* 
                 
               *: putatively new species; **: putatively new genus. 
 
In terms of the antiparasitic activity, four isolates exhibited activity against T. brucei and two 
isolates showed activity against L. major (Table 3.3). The putatively novel Actinokineospora 
sp. EG49 showed highest antitrypanosomal potential at 48% growth inhibition. The inhibitory 
activity of these strains against a variety of pathogens suggested that these actinobacterial 
strains may be potential candidates for the production of bioactive compounds. Antiparasitic 
activities from marine-derived actinomycetes are reported only sporadically (Loiseau et al. 
2002). The cyclic depsipeptide, valinomycin that has been purified from sponge-derived 
Streptomyces sp. strains 22, exhibited significant inhibitory activities against the parasites L. 
major (IC50 < 0.11 μM) and T. brucei (IC50 3.2 nM) (Pimentel-Elardo et al. 2010). 
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                Table 3.3 Antiparasitic activities of sponge-derived actinomycetes. 
 
Sponge isolate 
% Growth inhibition 
L. major T. brucei TC 221 
Actinokineospora sp. EG49* 24 48 
Brevibacterium sp. EG10 0 30 
Gordonia sp. EG50 36 28 
Kocuria sp. RV89* 0 19 
                
               *: putatively new species. 
 
Five putatively novel actinomycetes exhibited antibacterial and antifungal activities while two 
strains showed antiparasitic activity and one strain related to genus Actinokineospora, 
showed both antifungal and antiparasitic potential. Because crude extracts were tested for 
bioactivities, the chemical nature of the bioactive compound is currently unknown. 
Nevertheless, some genera, to which the novel isolates belong to, are well known and prolific 
metabolite producers. For example, the genus Streptomyces accounts for about 80% of all 
natural products recovered from actinomycetes to date (Bull and Stach 2007) and produced 
the of majority of the antibiotics available in the market (Watve et al. 2001). As one example, 
Streptomyces sannanensis produces new aminoglycoside antibiotics sannamycins A, B and 
C with potent activities against Gram-positive bacteria (Deushi et al. 1980). Rhodococcus 
species, of which one putatively novel and bioactive strain was isolated in this study, 
produced a number of commercially interesting and potentially useful products including 
various types of steroids and peptides (Bell et al. 1998). For example, two antimycobacterial 
cyclic peptides, lariatins A and B, were isolated from the culture broth of Rhodococcus sp. 
K01-B0171 (Iwatsuki et al. 2007). The genus Microbacterium, of which two putatively new 
species were isolated in this study, produced different glycolipids. For example, five anti-
tumor glycoglycerolipids were obtained from Microbacterium sp. which was isolated from the 
sponge Halichondria panicea (Wicke et al. 2000). Antimicrobial activities have to our 
knowledge not been reported for the genera Actinokineospora, Kocuria and Rubrobacter, 
making them good candidates for further chemical analysis to identify the bioactive 
candidates. 
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3.3.4 Conclusion and Outlook 
 
Considerable actinobacterial diversity was recovered from eleven marine sponges from two 
different geographical locations. Altogether 90 actinomycete isolates were affiliated with 18 
different genera including 14 putatively novel species. One possibly new genus related to 
Rubrobacter was isolated on M1 agar amended with sponge extract. Antibacterial, antifungal, 
antitrypanosomal and antileishmanial activities were reported for 10 of the isolates including 
six putatively novel species. Marine sponges represent therefore a still largely untapped 
resource for novel actinomycete diversity as well as for new bioactivities. 
 
Our future plans will include physiological, biochemical and chemotaxonomical 
characterization to validate the taxonomic position of the putatively novel actinomycete 
isolates cultivated in this study. The bioactive new strains will be chemically investigated 
using different chromatographic and spectroscopic techniques to identify and characterize 
the anti-infective metabolites. 
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Chapter 4 
New cyclodysidins from the new Streptomyces strain RV15 
 
 
4.1 Introduction 
 
4.1.1 Cyclic peptides from the marine environment 
 
The marine environment continues to yield a diverse array of biologically active molecules, a 
remarkable number of which are peptides (Fenical 1993). Cyclic peptides are polypeptide 
chains whose amino and carboxyl termini are themselves linked together with a peptide bond 
that forms a circular chain. A number of cyclic peptides have been discovered in nature and 
they can range from just a few amino acids to hundreds in length. The increased discovery of 
cyclic peptides has enriched our understanding of their chemical behavior and the associated 
pharmacological activities. One property of cyclic peptides is that they tend to be extremely 
resistant to the process of digestion, enabling them to survive intact in the human digestive 
tract. This makes them very interesting candidates for drug development especially when 
oral delivery is required. Cyclic peptides have been isolated from different marine 
invertebrates especially sponges which produced large number of cyclic peptides and 
cyclodepsipeptides with unique structures and diverse biological activities (Vera et al. 2009; 
Andavan and Lemmens-Gruber 2010; Fusetani 2010). The cyclic heptapeptide, 
stylissamides A has been isolated from the Caribbean sponge Stylissa caribica (Schmidt et 
al. 2007). Another example is the callyaerin G which has been isolated from the Indonesian 
sponge Callyspongia aerizusa and was found to be cytotoxic towards the mouse lymphoma 
cell line (L5178Y) and HeLa cells with ED50(s) of 0.53 and 5.4 µg/ml, respectively (Ibrahim et 
al. 2008). Four new cytotoxic cyclodepsipeptides, geodiamolides, have been isolated from 
the sponge Pseudaxinyssa sp. with in vitro cytotoxicity against different cell lines (de Silvaa 
et al. 1990). 
                  
                           Stylissamide A                                                      Geodiamolide A 
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Cyclic peptides have been also reported from various marine fungi (Cueto et al. 2000; Tan et 
al. 2003; Meyer et al. 2010) such as the petrosifungins which have been purified from 
Penicillium brevicompactum, isolated from the Mediterranean sponge Petrosia ficiformis 
(Bringmann et al. 2004). The cyclic peptides, clonostachysins A and B have been purified 
from a marine sponge-derived fungus Clonostachys rogersoniana and exhibited a selectively 
inhibitory effect against the dinoflagellate Prorocentrum micans at a concentration of 30 mM 
(Adachi et al. 2005). 
                                                               
 
      Petrosifungin A: R = H                                              Clonostachysin: A R = H 
      Petrosifungin B: R = OH                                          Clonostachysin: B R = Me 
 
Cyclic peptides with diverse biological activities have been isolated from the marine bacteria 
such as cyanobacteria and members of the genus Bacillus (Luesch et al. 2001; Zhang et al. 
2004; Plaza and Bewley 2006; Seto et al. 2007; Sivonen et al. 2010). Few representatives 
have been isolated from marine actinomycetes (Schultz et al. 2008). Cyclomarins are cyclic 
heptapeptides that have been isolated from the marine Streptomyces strain CNB-982 and 
exhibited antiviral and anti-inflammatory activities (Renner et al. 1999). Nocardamine is a 
dimeric cyclic peptide that was purified from a Streptomyces isolate which was recovered 
from an unidentified sponge (Lee et al. 2005). Nocardamine is related to the ferrichrome 
antibiotics and exhibited significant binding affinity to ferric ion displaying antibacterial activity 
against mycobacteria. The cyclic depsipeptide, valinomycin, was purified from Streptomyces 
sp. recovered from sponge Aplysina aerophoba and is known as potent antibiotic, exhibiting 
also good antiparasitic activities against Leishmania major and Trypanosoma brucei 
(Pimentel-Elardo et al. 2010). 
 
100 
 
                                                              
                         Nocardamine                                                 Cyclomarin 
 
In addition to the anti-infective activity of cyclic peptides from marine actinomycetes, 
mechercharmycin A is an example of anticancer cyclic peptide which has been isolated from 
a marine-derived Thermoactinomyces sp. strain YM3-251 collected at Mecherchar in the 
Republic of Palau (North Pacific Ocean). Mechercharmycin A showed cytotoxic activities 
against human lung adenocarcinoma A549 and Jurkat leukemia cells with IC50 values of 
0.04 μM (Kanoh et al. 2005). 
 
Mechercharmycin A 
Another example is the cyclic hexadepsipeptide, piperazimycin A which has been isolated 
from the fermentation broth of a Streptomyces sp. strain cultivated from marine sediments. 
Piperazimycin A exhibited potent in vitro cytotoxicity toward multiple tumor cell lines with a 
mean GI50 of 100 nM (Miller et al. 2007).  
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                                              Piperazimycin A: R1 = OH, R2 = CH3                                           
                                              Piperazimycin B: R1 = H, R2 = CH3 
                                              Piperazimycin C: R1 = OH, R2 = CH2CH3 
 
Moreover, cyclic peptides could be modified in a different ways such as sulfation, 
glycosylation or lipidation. Among these combinations, cyclic lipopeptides (CLPs) have 
received considerable attention due to their interesting activities which vary from 
antimicrobial, cytotoxic, to surfactant activities (Nielsen et al. 2002; de Bruijn et al. 2007). 
CLPs consist of an acyl side chain linked to a short oligopeptide, which is cyclized to form a 
lactone ring between two amino acids in the peptide chain. CLPs are diverse both structurally 
and in terms of their biological activity. The structural diversity is due to differences in the 
length and composition of the fatty acid tail as well as the variations in the number, type and 
configuration of the amino acids in the peptide part. Streptomyces roseosporus for example, 
produces daptomycin which is a cyclic lipopeptide consisting of 13 amino acids which 
includes three D-amino acid residues (D-asparagine, D-alanine, and D-serine) linked to 
decanoic acid (Huber et al. 1988). The high ratio of D- amino acids than the normal L-form 
confirm that these compounds have been biosynthesized to be more resistant to 
environmental conditions and also to perform special biological functions. Daptomycin was 
licensed by the FDA in the United States for use against skin and soft tissue infections in 
2003 and for methicillin-resistant S. aureus (MRSA) infections of the bloodstream in 2006 
(Diederen et al. 2006). Friulimicin B is a naturally occurring cyclic lipopeptide which was 
purified from the fermentation broth of actinomycete Actinoplanes friuliensis. Friulimicin B is 
highly active against a broad range of gram-positive bacteria including antibiotic-resistant 
pathogens such as methicillin-resistant Staphylococcus aureus, enterococci and obligate 
anaerobes. 
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Daptomycin    R = decanoyl 
 
 
                   
      Friulimicin B 
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4.1.2 Aim of the work 
 
The main goal of the present study was the isolation, identification, and structural elucidation 
of new and preferably biologically active secondary metabolites from marine sponge-
associated actinomycetes. After our biological screening of 14 putatively novel actinomycete 
strains cultivated from marine sponges, six actinomycetes were found to produce metabolites 
capable of inhibiting growth of at least one pathogen. Bioactive and taxonomically novel 
strains were fermented at optimized conditions and the crude extracts were subjected to 
various chromatographic methods in order to obtain pure compounds. The compounds were 
then identified using different spectroscopic tools and the biological activity was evaluated for 
the pure compounds.  
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4.2 Materials and Methods 
 
4.2.1 General procedure 
 
Melting points were determined on a Reichert-Jung Thermovar hot-plate. IR spectra were 
measured on a Jasco FT/IR-410 spectrometer. UV spectra were recorded on Varian CARY-
50-Conc-UV-visible spectrophotometer. Optical rotations were carried out on Perkin-Elmer 
241MC polarimeter (25 °C, 10 cm cell). Accurate electrospray ionization mass spectra (ESI) 
were obtained by a Bruker Daltonics micrOTOF focus. Column chromatography was 
performed using silica gel 60 (0.032-0.064 mm, Merck), while pre-coated silica gel 60 F
254 
plates (Merck) were used for TLC analyses. 1H NMR (400 MHz, 600 MHz) and 13C NMR 
(151 MHz) spectra were recorded on Bruker Avance 400 and DMX 600 instruments. Proton-
detected, heteronuclear correlations were measured using HSQC (optimized for 1JHC = 145 
Hz) and HMBC (optimized for nJHC = 8.3 Hz or nJHC = 4.0 Hz) pulse sequences. ROE 
effects were measured using a standard pulse sequence from the standard Bruker pulse 
program library. The samples were dissolved in deuterated solvents (CDCl3, CD3OD). 
Residual solvent signals of (CD3OD at 3.305 ppm,1H, and 49.0 ppm,13C), (CDCl3 at 7.26 
ppm and 77.0 ppm) were considered as internal reference signal for calibration. The 
observed chemical shift values (δ) were recorded in ppm and the coupling constants (J) in 
Hz. Preparative HPLC separation was performed on Jasco system (pump PU1580, gradient 
unit LG-980-025, degasser DG-2080-53, UV detector MD-2010Plus) on a Chromolith 
SemiPrep RP18e 10 x 100 mm (Merck) column, while the analytical detection was done on 
HPLC Jasco system (pump PU1580, gradient unit LG-980-025, degasser DG-2080-53 and 
UV detector MD-2010Plus) on a Chromolith RP-18e column (4.6 x 100 mm, Merck). ESI 
MS/MS spectra were performed using Orbitrap LTQ XL (Thermo Scientific). Five microliters 
of sample was loaded into a nanospray needle, voltage 5 kV, source temperature 275 °C, 
using MeOH supplemented with 0.1% HCOOH as solvent. For the recording of ESI MS/MS 
spectra the quadrupole was operated as a mass filter and used to select the desired 
precursor ion isotope cluster. During product ion analysis the resolving quadrupole was set to 
transmit a ± 2 m/z window around the precursor ion. Precursor ions were directed into a 
hexapole collision cell. The collision gas was helium and the collision energy was optimized 
for each analysis. 
4.2.2 Fermentation of Streptomyces strain RV15 
 
Sixteen 2 L Erlenmeyer flasks, each containing 1 L of ISP2 medium were inoculated with 0.5 
ml of 7 days culture of Streptomyces RV15 and shaking at 150 rpm at 30 °C for ten days.  
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4.2.3 Purification and characterization of the cyclic peptides 
 
After ten days of cultivation, sterilized XAD-16 resin (30 g L–1) was added. Resin was 
collected 6 h later by filtration and eluted with acetone. The acetone was removed under 
reduced pressure, and the aqueous layer was extracted with ethyl acetate (3 x 500 ml). The 
combined extracts were concentrated under vacuum and stored at 4 °C for chromatographic 
fractionation. After fractionation of crude extract (10 g) via silica gel chromatography, the 
fraction (935 mg) eluted with 40% chloroform in methanol was further chromatographed on 
sephadex LH 20. The fraction (56 mg) eluted with 70% methanol in water, was enriched in 
cyclic peptides. Further purification was carried out on HPLC using an acetonitrile (ACN) and 
water solvent mixture complemented by 0.05% trifluoroacetic acid: (10% ACN:H2O to 100% 
ACN over 20 min at flow rate of 10 ml/min), giving four pure compounds.  
Cyclodysidin A: 2 mg of white amorphous powder (Rt 7.3 min); [α]20 D -19 (c 0.55, MeOH); 
UV (MeOH): λmax (log ε) = 220 (5.75), 235 (12.0) nm; IR: 3445, 2924, 1730, 1638, 1553, 
1463, 1238, 1160, 1095, 730, 667 cm-1; 1H and 13C NMR data, see Table 4.1; ESI-MS m/z 
[M + H]+ 1006.5207 (calcd for C45H71N11O15, 1006.5209). 
Cyclodysidin B: 1.5 mg of white amorphous powder (Rt 7.7 min); [α]20 D -15.3 (c 0.55, 
MeOH): UV (MeOH): λmax (log ε) = 223 (3.82), 238 (13.13) nm; IR: 3451, 2935, 1740, 1633, 
1549, 1455, 1243, 1165, 1089, 738, 661 cm-1; 1H and 13C NMR data, see Table 4.2; ESI-MS 
m/z [M + H]+ 1020.5364 (calcd for C46H73N11O15, 1020.5366). 
Cyclodysidin C: 2 mg of white amorphous powder (Rt 8.2 min); [α]20 D -22.5 (c 0.55, 
MeOH); UV (MeOH): λmax (log ε) = 222 (4.3), 237 (14.2) nm; IR: 3440, 2920, 1735, 1629, 
1560, 1450, 1235, 1158, 1090, 729, 665 cm-1; 1H and 13C NMR data, see Table 4.3; ESI-MS 
m/z [M + H]+ 1034.5536 (calcd for C47H75N11O15, 1034.5522). 
Cyclodysidin D: 1.7 mg of white amorphous powder (Rt 8.5 min); [α]20 D -27.7 (c 0.55, 
MeOH); UV (MeOH): λmax (log ε) = 224 (6.55), 238 (13.63) nm; IR: 3442, 2928, 1735, 1632, 
1557, 1460, 1238, 1163, 1088, 733, 662 cm-1; 1H and 13C NMR data, see Table 4.4; ESI-MS 
m/z [M + H]+ 1062.5832 (calcd for C49H79N11O15, 1062.5835).  
 
4.2.4 Marfey's derivatization 
 
Since this method is important to identify the stereochemistry of our compounds, we will 
introduce it her. Marfey's reagent (MR) or 1-fluoro-2,4-dinitrophenyl-5-L-alanine amid (FDAA) 
was used to separate and determine enantiomeric amino acids in mixtures (Marfey 1984). It 
reacts in a stochiometric way with the amino group of the enantiomeric amino acid producing 
diastereoisomers that can be resolved via HPLC analysis (Kochhar and Christen 1989) in a 
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non chiral environment. The diastereoisomers derivatives are relatively stable if kept at 4 °C 
and protected from light. The detection of Marfey's derivatives is easy due to the new 
chromophore which strongly absorbs at 340 nm, allowing detection in the nanomolar range. 
D-diastereomer exhibited stronger intramolecular hydrogen bonding producing a more 
hydrophobic molecule which interact more strongly with the reversed phase of the column 
and thus have a stronger retention time and eluted later than an L-diastereomer (Bhushan 
and Bruckner 2004).  
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Marfey's reagent       DL-amino acid                        DL- Marfey's derivative         LL- Marfey's derivative     
 
One milligram of each peptide was hydrolyzed by heating in a sealed vial with 6 M HCl (2 ml) 
at 110 °C for 24 h. The hydrolysate was cooled to RT, dried under vacuum and dissolved in 
250 µl of water. Marfey's derivatization (Marfey 1984) was done by adding 100 µl of 1% of 
Marfey's reagent (1-fluoro-2,4-dinitrophenyl-5-L-alanine amid) in acetone to 50 µl of acid 
hydrolysate followed by 20 μmol of NaHCO3, the contents were mixed and incubated at 40 
°C for 1 h with frequent mixing. After cooling, the reaction was stopped by adding 20 μmol 
HCl, followed by drying under vacuum and finally dissolving in 1 ml of MeOH-H2O (1:1). 
Amino acid standards were individually derivatized in the same manner using 2.5 μmol of 
amino acid standard to react with 3.6 μmol FDAA to obtain the Marfey's derivative of amino 
acid. The obtained derivatives were filtered and analyzed by reversed phase HPLC using a 
linear gradient of CH3CN in 0.1% (v/v) aqueous TFA (20- 70% CH3CN over 50 min), flow 
rate 1 ml min-1 and detection at 340 nm. After comparison of Retention time (Rt) of the 
hydrolysate derivatives with that of derivatized standards, absolute configuration of 
diastereoisomers was detected in each peptide hydrolysate. Retention times (min) of 
authentic amino acids were as follows: L-Thr (29.7), D-Thr (31.3), L-allo-Thr (29.8), L-Asp 
(27.6), D-Asp (32.8), L-Glu (28.9), D-Glu (30.3), L-Ser (23.5), D-Ser (28.3), L-Tyr (31.9), D-
Tyr (33.7). A better resolution of the L-Thr and the L-allo-Thr derivatives was achieved using 
a linear gradient of CH3CN in 0.1% (v/v) aqueous TFA (23- 35% CH3CN over 50 min): L-Thr 
(33.5), L-allo- Thr (37.8). 
 
 
 
107 
 
4.2.5 Bioactivity testing  
 
The antibacterial, antifungal, cytotoxicity and protease inhibition assays were performed by 
the SFB 630 collaboration partners: TP Z1 (T. Öschläger, U. Würzburg) and TP A4 (T. 
Schirmeister, U. Würzburg), respectively. The anticancer activity against melanoma and 
ovarian tumor cell lines were carried out in the lab. of S. Mejerjohann (SFB 487, TP B3, U. 
Würzburg) and J. Wischhusen (Department of Gynaecology, School of Medicine U. 
Würzburg), respectively. 
 
Antibacterial activity 
 
Antibacterial activity was tested against a panel including Enterococcus faecalis JH212, 
Enterococcus faecium 6413, Staphylococcus aureus NCTC 8325, Staphylococcus 
epidermidis RP62A. After 24 h incubation at 37 °C, broth cultures were diluted in Müller-
Hinton broth (1:100) and cultivated again until the cells reached the exponential growth 
phase. 1 x 105 cells/ml were incubated in the presence of various concentrations of the tested 
compounds in DMSO to a final volume of 200 µl in a 96-well plate at 37 °C. The final 
concentration of DMSO was 0.8% in each well. After 18 h of incubation, the optical density of 
the cultures was determined at 550 nm using an ELISA microplate reader with respect to the 
control without bacteria. The lowest concentration of the compound that inhibits bacterial or 
fungal growth was defined as the minimal inhibitory concentration (MIC). 
 
Antifungal activity 
 
Antifungal activity testing was done by resuspending a colony of Candida albicans 5314 
(ATCC 90028) in 2 ml of 0.9% NaCl. Four microliters of this suspension was transferred to 2 
ml of HR medium. Various concentrations of the test compounds were diluted in 100 l of 
medium in a 96-well microplate with final DMSO concentration of 0.4%. One hundred 
microliters of the Candida suspension was added to each well then incubated at 37 °C for 48 
h. Optical density was measured at 530 nm with respect to a control well without Candida 
cells. The lowest concentration of the compound where no growth is detectable was used as 
the MIC. 
 
Antiprotease activity 
 
SARS M and Pl protease inhibition assay 
 
The fluorometric enzyme assays were carried out on a Cary Eclipse fluorescence 
spectrophotometer (Varian, Darmstadt, Germany) with a microplate reader (excitation 325 
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nm, emission 425 nm) and using 96-well microplates (Nunc GmbH, Wiesbaden, Germany) 
were used. Assays were done at 25 °C in a 20 mM Tris-HCl buffer (pH 7.5) containing 0.1 
mM EDTA, 1 mM DTT, 200 mM NaCl, and 12.5% DMSO (final concentration) in a total 
volume of 200 l. The substrate [H2N-Abz-Ser-Val-Thr-Leu-Gln-Ser-Gly-(NO2)Tyr-Arg-(MTS)-
TFA-salt for M-pro and Z-Arg-Leu-Arg-Gly-Gly-AMC-acetate salt for Pl-pro] was used at final 
concentration of 50 M, and the final enzyme concentration was 4.25 g ml-1. Inhibitors were 
used at 100 M final concentration for preliminary screening. For determination of Km 
values, the substrate was used in concentrations between 50 and 300 M. Values were 
corrected for the inner filter effect. Increase in fluorescence was determined over a period of 
10 min for Km determination and 20 min for inhibition assays. Substrate and inhibitor stock 
solutions were prepared in DMSO after dilution in assay buffer. The Km value was calculated 
by nonlinear regression analyses using the program GraFit. All values are mean values from 
at least three independent assays (Kaeppler et al. 2005).  
 
Cathepsin L and B protease inhibition assay 
 
The fluorometric enzyme assays were performed on a Cary Eclipse fluorescence 
spectrophotometer (Varian, Darmstadt, Germany) using a microplate reader (excitation 365 
nm, emission 460 nm) and 96-well microplates. Assays were performed at 25 °C in a 20 mM 
Tris-HCl buffer (pH 6.0) containing 5 mM EDTA, 2.5 mM DTT, 200 mM NaCl and 0.005% Brij 
35 in a total volume of 285 ml. Substrate (Cbz-Phe-Arg-AMC for both enzymes) and inhibitor 
stock solutions were prepared in DMSO (10% final concentration) after dilution with assay 
buffer; enzymes were held in buffer. The final substrate concentration for inhibition assays 
was between 10.0 and 81.0 mm; the final enzyme concentration was 53 ng ml-1 for CL (P. 
tetraurelia) and 58 pg ml-1 for CB (recombinant, human liver) (Vicik et al. 2006a). Inhibitors 
were tested at final concentration of 100 µM. 
 
Rhodesain protease inhibition assay 
 
The fluorometric enzyme assays were performed as described in Cathepsin assays using 50 
mM acetate (pH 5.5) containing 5 mM EDTA, 5 mM DTT, 200 mM NaCl, and 0.005% Brij 35 
in a total volume of 285 µl. Substrate (Cbz-Phe-Arg-AMC) and inhibitor stock solutions were 
prepared in DMSO (10% final concentration) and diluted with the assay buffer. The final 
substrate concentrations used in the inhibition assays ranged from 12.4 to 81.0 µM and the 
final enzyme concentration was 41 nM. Inhibitors were used at final concentration of 100 µM 
(Vicik et al. 2006b).  
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Cytotoxicity 
 
J774.1 macrophages and kidney epithelial 293T cells were cultured in complete medium 
(DMEM medium for kidney epithelial cells) without phenol red in the absence or presence of 
increasing concentrations of the test compounds at a cell density of 1 x 105 cells/ml (2 x 104 
cells/ml for kidney epithelial cells) for 24 h at 37 °C, 5% CO2, and 95% humidity. Following 
the addition of 20 l of Alamar Blue, the plates were incubated and the optical densities were 
measured at 24, 48 and 72 h later with a Multiskan Ascent enzyme-linked immunosorbent 
assay (ELISA) reader (Thermo Electron Corporation, Dreieich, Germany) using a test 
wavelength of 540 nm and a reference wavelength of 630 nm.  
 
Anticancer activity 
 
Melanoma testing 
 
Human melanoma cell lines A375 and Mel Juso were seeded at a density of 1x104 cells per 
well of a 12-well plate and were cultivated in DMEM containing 10% FCS, either in the 
presence or absence of the test compounds. Cells were harvested by trypsinization after 3, 
5, and 8 days, pelleted, resolved in PBS and counted under the microscope. 
 
Ovarian cell carcinoma testing 
 
SKOV3 ovarian carcinoma cells were cultured in RPMI 1640 medium supplemented with 
10% fetal bovine serum. Cells were seeded in microtiter plates 10000/well and 24 h later, 
different concentrations of test substances were added and serially diluted. The cells were 
incubated at 37 °C for 24 h. The medium was removed from the cells and cells were rinsed 
with PBS 100 µl/well. Fifty microliters of crystal violet was added with shaking for 20 min at 
room temperature. Stain was discarded and the excess of the crystal violet was washed with 
water till clearance. The plates were dried overnight and 200 µl methanol/well was added 
with for 20 min at room temperature. Absorbance was then measured by ELISA reader at 
540 nm.  
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4.3 Results and Discussion 
 
4.3.1 Isolation and structure elucidation of cyclodysidins  
 
Among all actinomycete strains tested in our study against different bacteria, Candida and 
parasites, Streptomyces sp. RV15 gave the greatest inhibition against Staphylococcus 
aureus as well as against Candida albicans. This strain was isolated from sponge Dysidea 
tupha, collected from Rovinj (Croatia) in 2008. The strain was fermented in ISP2 medium and 
the secondary metabolites were adsorbed on XAD-16 resin. The resin was then eluted with 
acetone and the crude extract was fractionated via normal phase silica gel chromatography 
followed by gel filtration on Sephadex LH-20 to give the fraction enriched in peptides (Figure 
4.1). 
 
 
 
Figure 4.1 HPLC chromatogram of Streptomyces strain RV15 peptidic fraction at 220 nm. 
 
Final purification was performed on reversed phase HPLC (Chromolith SemiPrep RP18e 10 
x 100 mm (Merck) column, with the solvents (A) Water (0.05% trifluoroacetic acid) and (B) 
MeCN (0.05% trifluoroacetic acid) as the eluents, linear gradient, 0 min 10% B, 20 min 100% 
B, flow rate 10 ml min-1) to afford four pure compounds, designated, cyclodysidins A-D. 
cyclodysidin A, showed molecular formula C45H71N11O15 through ESIMS analysis (measured, 
m/z 1006.5207, [M+H]+) with 16 degrees of unsaturation. The presence of several doublets, 
and doublets of doublets at 4-5 ppm (Figure 4.2), attributed to α-protons of amino acids as 
well as the characteristic chemical shifts for the amide carbonyls at 170-180 ppm, suggesting 
a peptidic nature of the molecules. Moreover, the IR spectrum showed bands at 3381, 3260, 
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and 1668 cm-1, confirming the presence of amide functionality. The compounds gave no 
colour with ninhydrin reagent but they gave purple colour upon hydrolysis with 6 M HCl, 
indicating a cyclic nature.  
 
 
Figure 4.2 Characteristic regions of 1H NMR spectrum of compound cyclodysidin A. 
 
The 13C NMR spectrum displayed eleven ester/amide-type carbonyls (δ 172.4, 172.9, 173.0, 
173.7, 174.1, 174.3, 174.4, 174.5, 174.9, 175.1, 176.6), seven α-methine carbons (δ 52.3, 
52.4, 55.6, 56.9, 57.2, 57.4, 60.0), two primary carbinols (δ 62.3, 62.4), a secondary carbinol 
(δ 67.3), tertiary carbinol (δ 157.3), aromatic signals for a di-substituted phenyl ring (131.3, 
129.0, 157.3, and 116.4) and distinct signals at δ 23.6, 30.1-30.4, 35.7 and 14.4 consistent 
with a terminal hydrocarbon side chain supporting the presence of a lipopeptide metabolite. 
Analysis of COSY, HSQC, ROESY and HMBC data assigned 7 partial structures (Table 4.1): 
(2) asparagine (Asn), (1) glutamine (Gln), (2) serine (Ser), (1) tyrosine (Tyr) and (1) threonine 
(Thr). The COSY, HSQC and HMBC experiments also correlated deshielded methylene (H-
2, δ 2.43), a deshielded methine (H-3, δ 4.13), contiguous methylene resonances (H4-5 to 
H11-12, δ 1.25-1.31, brs) and a terminal methyl proton (H-13, δ 0.88), delineating an amino 
fatty acid residue (β-AFA) accounted for β-aminotridecanoic acid. HMBC correlations from 
each α-proton (β-proton of β-aminotridecanoic acid) to the carbonyl carbon of the 
neighboring amino acid and to its own carbonyl carbon were detected. Lipidation of cyclic 
peptides via ester or amide bonds has been reported from a variety of bacterial genera 
including Mycobacterium, Streptomyces, Pseudomonas and Bacillus (Debono et al. 1988; 
Nielsen and Sorensen 2003; Zhang et al. 2004; Seto et al. 2007). Because only 10 of the 
calculated 11 degrees of unsaturation could be accounted for by the functionalities in the 
eight individual fragments, it became obvious that cyclodysidin A had a cyclic nature.  
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Table 4.1 CD3OD NMR data of cyclodysidin A. 
 
Position 13C (ppm) 1H (ppm) COSY HMBC ROESY 
Asn1      
CO 173.7     
α 52.4 4.65, dd (7.5,6.4) β CO, β, γ, Tyr-CO Tyr- β 
β 37.1 2.76/2.72, m α CO, α, γ  
γ 174.9     
Asn2      
CO 174.3     
α 52.3 4.51, dd (7.9,5.7) β CO, β, γ, Gln-CO  
β 37.4 2.52/2.44, m α CO, α, γ Gln-α 
γ 175.1     
Gln      
CO 174.1     
α 55.6 4.19, dd (8.3,5.8) β CO, β, γ, Ser2-CO Asn2- β 
β 27.1 2.17/2.10, m α, γ  CO, α, γ, δ   
γ 32.9 2.47, m β α, β, δ  
δ 176.6     
Ser1      
CO 172.9     
α 57.4 4.37, t (5.6) β CO, β, Asn1-CO Asn1-β 
β 62.4 3.84, m α CO, α Thr-β 
Ser2      
CO 173.0     
α 57.2 4.31, t (5.3) β CO, β, β-AFA-CO β-AFA-2 
β 62.3 3.92, m α CO, α  
Thr      
CO 172.4     
α 60.0 4.28, d (2.6) β CO, β, γ, Ser1-CO  
β 67.3 4.40, m α, γ CO, α, γ Ser1- β 
γ 20.4 1.16, d (6.5) β α, β  
Tyr      
CO 174.4     
α 56.9 4.46, dd (9.2,4.8) β CO, β, Asn2-CO, 1  
β 36.4 3.14/2.85, dd 
(14.2,4.7) 
α CO, α, 1, 2, 6 Asn1-α 
           Bz-I 129.0     
            Bz-o 131.3 7.06, d (8.5) Bz-m Bz-I, Bz-m, Bz-p  
             Bz-m 116.4 6.71, d (8.4) Bz-o Bz-I, Bz-o, Bz-p  
            Bz-p 157.3     
β-AFA      
CO 174.5     
2 42.1 2.43, m 3 CO, 3, 4 Ser2-α 
3 48.8 4.14, m 2, 4 CO, 2, 4, Thr-CO  
4 35.7 1.5, m 3, 5-12 2, 3  
5-12 23.6, 30.1-
30.4, 33.1 1.25-1.31, m 
4, 13 4, 13  
13 14.4 0.88, t (7.1) 5-12 5-12  
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The sequential arrangement of amino acids was accomplished by interpretation of HMBC 
and ROESY data as well as fragmentation by CID MS/MS (Figure 4.3).  
 
 
Figure 4.3 CID MS/MS mass spectrum of cyclodysidin A. 
 
The complete sequence was confirmed on the basis of the results of CID MS/MS 
experiment. This technique employs collision-induced dissociation (CID) to fragment a 
precursor ion. After generation of a spectrum of ions by ESI, The ion of interest is then 
selectively allowed to progress into the collision cell, containing an inert gas typically argon or 
helium, which is allowed to collide with the selected ion. This induces fragmentation and the 
resulting ions are then analyzed as product ions. Sequence information derived from the 
mass differences between the b series ions and between the y series ions (Table 4.2). The 
structure of cyclodysidin A was thus confirmed as cyclo-(-AFA-Ser-Gln-Asn-Tyr-Asn-Ser-
Thr). 
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Table 4.2 Annotated MS-fragments for cyclodysidin A. 
 
Experimental 
[Da] 
Predicted 
[Da] 
Fragmentation 
Sequence 
after first cleavage 
Fragment 
after second cleavage 
478.18 478.18 b/b4-1 NYNSTxSQ NYNS 
505.32 505.32 b/y4 QNYNSTxS QNYN 
583.23 583.24 b/z5+1 xSQNYNST NYNST 
642.39 642.38 b/y5-H2O YNSTxSQN TxSQN 
787.42 787.43 b/b6-H2O TxSQNYNS TxSQNY 
833.49 833.48 b6 TxSQNYNS TxSQNY 
849.53 849.46 b/a7-1 NYNSTxSQ NYNSTxS 
878.47 878.46 b/y7- H2O QNYNSTxS NYNSTxS 
897.52 897.49 b/c7+2 NYNSTxSQ NYNSTxS 
919.52 919.49 b/y7- H2O STxSQNYN TxSQNYN 
989.54 989.52 M- H2O+1   
1006.46 1006.52 M   
 
Cyclodysidin B, exhibited molecular formula C46H73N11O15 by ESIMS analysis (measured, 
m/z 1020.5365, [M+H]+) with 16 degrees of unsaturation. Cyclodysidin C, showed molecular 
formula C47H75N11O15 by ESIMS analysis (measured, m/z 1034.5517, [M+H]+) with 16 
degrees of unsaturation. Cyclodysidin D, had a molecular formula of C49H79N11O15 by ESIMS 
analysis (measured, m/z 1062.5834, [M+H]+) with 16 degrees of unsaturation. The difference 
in molecular weight between all four compounds was only 14 or 28 mass units indicating a 
difference of CH2 group. The compounds showed similar NMR spectra and the only 
difference was in the aliphatic part (δ 1.25-1.28 ppm) in the 1H NMR spectrum corresponding 
to the difference in hydrocarbon of fatty acid part, indicating the same amino acid building 
blocks but different fatty acid. The UV spectrum of all compounds showed absorption λmax 
(MeOH) at 220 and 235 nm indicating the same chromophoric functionalities. Thus, the 
structures of all cyclic peptides were confirmed to be cyclo-(-AFA-Ser-Gln-Asn-Tyr-Asn-Ser-
Thr-) by NMR data (Figure 4.5) and CID MS/MS experiment (Figure 4.4, Table 4.6). 
Comparison of the spectral data of the compounds with that in the database using the 
SciFinder Scholar tool and AntiMarin database revealed that these compounds are new and 
have never been isolated from other sources. 
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Table 4.3 CD3OD NMR data cyclodysidin B. 
 
Position 13C (ppm) 1H (ppm) COSY HMBC ROESY 
Asn1      
CO 173.9     
α 52.5 4.66, m β CO, β, γ, Tyr-CO Tyr- β 
β 37.2 2.77/2.73, m α CO, α, γ  
γ 175.0     
Asn2      
CO 174.3     
α 52.4 4.53, m β CO, β, γ, Gln-CO  
β 37.5 2.53/2.45, m α CO, α, γ Gln-α 
γ 175.2     
Gln      
CO 174.2     
α 55.9 4.21, m β CO, β, γ, Ser2-CO Asn2-β 
β 27.2 2.16/2.10, m α, γ  CO, α, γ, δ   
γ 33.2 2.46, m β α, β, δ  
δ 176.7     
Ser1      
CO 173.0     
α 57.5 4.38, t (5.6) β CO, β, Asn1-CO Asn1-β 
β 62.7 3.86, m α CO, α Thr-β 
Ser2      
CO 173.1     
α 57.4 4.33, t (5.4) β CO, β, β-AFA-CO β-AFA-2 
β 62.6 3.93, m α CO, α  
Thr      
CO 172.4     
α 60.3 4.29, d (2.5) β CO, β, γ, Ser1-CO  
β 67.7 4.42, m α, γ CO, α, γ Ser1- β 
γ 20.6 1.17, d (6.5) β α, β  
Tyr      
CO 174.4     
α 57.1 4.48, dd (9.3, 4.9) β CO, β, Asn2-CO, 1  
β 36.7 3.15/2.86, dd 
(14.3,4.8) 
α CO, α, 1, 2, 6 Asn1-α 
           Bz-I 129.2     
            Bz-o 131.5 7.08, d (8.5) Bz-m Bz-I, Bz-m, Bz-p  
             Bz-m 116.5 6.73, d (8.4) Bz-o Bz-I, Bz-o, Bz-p  
            Bz-p 157.5     
β-AFA      
CO 174.5     
2 42.4 2.44, m 3 CO, 3, 4 Ser2-α 
3 48.6 4.14, m 2, 4 CO, 2, 4, Thr-CO  
4 35.9 1.5, m 3, 5-13 2, 3  
5-13 23.9, 30.3-30.8, 
33.3 1.26-1.32, m 
4, 14 4, 14  
14 14.6 0.89, t (7.2) 5-13 5-13  
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Table 4.4 CD3OD NMR data cyclodysidin C. 
 
Position 13C (ppm) 1H (ppm) COSY HMBC ROESY 
Asn1      
CO 173.9     
α 52.5 4.67, dd (7.6,6.5) β CO, β, γ, Tyr-CO Tyr- β 
β 37.3 2.77/2.73, m α CO, α, γ  
γ 174.8     
Asn2      
CO 174.3     
α 52.4 4.54, dd (7.9,5.8) β CO, β, γ, Gln-CO  
β 37.6 2.53/2.44, m α CO, α, γ Gln-α 
γ 174.9     
Gln      
CO 174.2     
α 55.8 4.21, m β CO, β, γ, Ser2-CO Asn2- β 
β 27.0 2.16/2.10, m α, γ  CO, α, γ, δ   
γ 32.9 2.46, m β α, β, δ  
δ 176.7     
Ser1      
CO 172.9     
α 57.0 4.38, m β CO, β, Asn1-CO Asn1-β 
β 62.7 3.85, m α CO, α Thr-β 
Ser2      
CO 173.0     
α 57.6 4.34, t (5.4) β CO, β, β-AFA-CO β-AFA-2 
β 62.6 3.93, m α CO, α  
Thr      
CO 172.3     
α 60.3 4.28, d (2.5) β CO, β, γ, Ser1-CO  
β 67.7 4.40, m α, γ CO, α, γ Ser1- β 
γ 20.6 1.17, d (6.6) β α, β  
Tyr      
CO 174.5     
α 57.0 4.48, dd (9.4,4.9) β CO, β, Asn2-CO, 1  
β 36.7 3.14/2.85, dd 
(14.3,4.8) 
α CO, α, 1, 2, 6 Asn1-α 
           Bz-I 129.2     
            Bz-o 131.5 7.06, d (8.6) Bz-m Bz-I, Bz-m, Bz-p  
             Bz-m 116.5 6.72, d (8.5) Bz-o Bz-I, Bz-o, Bz-p  
            Bz-p 157.5     
β-AFA      
CO 174.6     
2 42.3 2.43, m 3 CO, 3, 4 Ser2-α 
3 48.9 4.13, m 2, 4 CO, 2, 4, Thr-CO  
4 35.8 1.5, m 3, 5-11 2, 3  
5-14 23.9, 30.4-30.9, 
33.2 1.25-1.31, m 
4, 15 4, 15  
15 14.6 0.88, t (6.5) 5-14 5-14  
 
117 
 
Table 4.5 CD3OD NMR data cyclodysidin D. 
 
Position 13C (ppm) 1H (ppm) COSY HMBC ROESY 
Asn1      
CO 173.7     
α 52.4 4.65, dd (7.5,6.5) β CO, β, γ, Tyr-CO Tyr- β 
β 37.2 2.77/2.71, m α CO, α, γ  
γ 175.0     
Asn2      
CO 174.3     
α 52.3 4.53, m β CO, β, γ, Gln-CO  
β 37.3 2.52/2.44, m α CO, α, γ Gln-α 
γ 175.2     
Gln      
CO 174.1     
α 55.9 4.21, dd (8.4,5.9) β CO, β, γ, Ser2-CO Asn2- β 
β 27.4 2.18/2.10, m α, γ  CO, α, γ, δ   
γ 32.8 2.48, m β α, β, δ  
δ 176.7     
Ser1      
CO 172.9     
α 57.4 4.37, m β CO, β, Asn1-CO Asn1-β 
β 62.5 3.84, m α CO, α Thr-β 
Ser2      
CO 173.1     
α 57.3 4.33, m β CO, β, β-AFA-CO β-AFA-2 
β 62.3 3.92, m α CO, α  
Thr      
CO 172.3     
α 60.1 4.28, d (2.5) β CO, β, γ, Ser1-CO  
β 67.4 4.40, m α, γ CO, α, γ Ser1- β 
γ 20.5 1.16, d (6.4) β α, β  
Tyr      
CO 174.5     
α 57.0 4.47, dd (9.3,4.9) β CO, β, Asn2-CO, 1  
β 36.6 3.14/2.85, dd 
(14.3,4.8) 
α CO, α, 1, 2, 6 Asn1-α 
1 129.2     
2,6 131.1 7.06, d (8.5) Bz-m Bz-I, Bz-m, Bz-p  
3,5 116.4 6.72, d (8.4) Bz-o Bz-I, Bz-o, Bz-p  
4 157.5     
β-AFA      
CO 174.6     
2 42.2 2.43, m 3 CO, 3, 4 Ser2-α 
3 48.6 4.14, m 2, 4 CO, 2, 4, Thr-CO  
4 35.6 1.5, m 3, 5-11 2, 3  
5-16 23.6, 30.4-30.8, 
33.3 1.26-1.32, m 
4, 17 4, 17  
17 14.4 0.88, t (7.2) 5-16 5-16  
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Figure 4.4 CID MS/MS mass spectrum of cyclodysidin C. 
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Table 4.6 Annotated MS-fragments for cyclodysidin C.  
Experimental 
[Da] 
Predicted 
[Da] 
Fragmentation 
Sequence 
after first cleavage 
Fragment 
after second cleavage 
494.18 494.21 y4 NSTxSQNY SQNY 
556.36 556.37 b4 TxSQNYNS TxSQ 
629.41 629.39 b5 NSTxSQNY NSTxS 
732.44 732.43 b5 xSQNYNST xSQNY 
819.46 819.46 b6 NYNSTxSQ NYNSTx 
833.49 833.48 b6 TxSQNYNS TxSQNY 
846.42 846.47 b6 xSQNYNST xSQNYN 
915.49 915.49 b7-H2O xSQNYNST xSQNYNS 
1034.54 1034.54 M   
 
 
 
  
 
Figure 4.5 Selected NMR correlations of cyclodysidin A 
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Synthesis of (R) and (S) 3-amino tridecanoic acid  
 
This work was done by A. Phillipe (AG Bringmann, Institute of Organic Chemistry, U. 
Würzburg). 3-amino fatty acid is a component of the new cyclic peptides, cyclodysidins. To 
determine the stereochemistry of this residue in all cyclic peptides, (S)- and (R)-3-amino fatty 
acids (1-4) were synthesized as authentic standards (Figure 4.6). A synthesis giving an easy 
access to the both eantiomers is required. The aliphatic -amino acids were obtained 
starting with the corresponding aliphatic aldehydes. The aldehydes were then condensed 
with maleic acid and ammonium acetat in refluxing ethanol (Rodionov reaction) to give the 
corresponding amino acids as insoluble crystals. The two enantiomers were afterwards 
separated on chiral HPLC.  
 
 
 
Figure 4.6 Synthesis plan of 3-amino fatty acid residue. 
 
The absolute configuration of (S) and (R)-3-amino fatty acids was determined by comparison 
of the optical rotation of those compounds with the values of similar examples reported in the 
literature. Analysis of CD-spectra of the secondary amines with the help of computational 
method was helpful to confirm the absolute configuration of those compounds.  
 
Chiral derivatization 
 
Absolute configuration was determined by acid hydrolysis followed by chiral derivatization 
with Marfey's reagent. HPLC analysis of Marfey's derivatives in comparison to their 
analogues of authentic amino acids (Table 4.7) revealed that all of our cyclic peptides 
consist of L-asparagine, D-serine, L-glutamine, L-threonine, and D-tyrosine. Moreover, 
Marfey's analysis revealed that the second stereogenic center in threonine is R which is the 
normal form produced by microorganisms. The absolute configuration of β-AFA is currently in 
progress.  
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                  Table 4.7 Retention times of Marfey's derivatives of amino acids. 
 
Rt [min] Amino acid 
28.3 D-Ser 
23.5 L-Ser 
32.8 D-Asp 
27.6 L-Asp 
33.7 D-Tyr 
31.9 L-Tyr 
31.3 D-Thr 
29.7 L-Thr 
29.9 L-allo Thr 
30.3 D-Glu 
28.9 L-Glu 
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Figure 4.7 Structures of cyclodysidins A-D. 
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4.3.2 Bioactivity of cyclodysidins  
 
In spite the fact that the crude methanolic extract of the Streptomyces strain RV15 showed 
antibacterial activity against Gram positive bacteria and antifungal activities against C. 
alibicans, the four cyclic peptides did not exhibit any antimicrobial activities. The activity of 
cyclic peptides were tested against different proteases but no activity was detected (Table 
4.8). They also did not show any cytotoxic against kidney epithelial cells and macrophages 
indicating that they are not cytotoxic to human cells. Diverse activities have been reported for 
the cyclic peptides such as antibacterial, antifungal, antiviral, antiparasitic, anti-inflammatory, 
antioxidant and anticancer activities (Dalsgaard et al. 2005; Steenbergen et al. 2005; Li et al. 
2008; Yang et al. 2008; Barbosa et al. 2010; Hashizume et al. 2010; Ibrahim et al. 2010; 
Pimentel-Elardo et al. 2010; Tabbene et al. 2010).   
 
Table 4.8 Antiprotease activity of cyclic peptides. 
 
                % Protease inhibition  
Sample 
 
Cath 
B 
Cath 
L Falcipain Rhodesain SARS M
pro SARS plpro 
Cyclodysidin A 6.4 7.4 ND 6.2 5.0 11.7 
Cyclodysidin B 3.7 9.2 6.2 7.7 7.4 23.1 
Cyclodysidin C ND 11.1 11.3 13.4 6.3 13.4 
Cyclodysidin D 8.9 20.6 18.4 19.5 14.8 15.8 
 
ND: Not detected 
 
Several cyclic peptides from different sources exhibited anticancer activities. Over the past 
decade, a great number of cyclic peptides with potent antitumor activity have been 
discovered from plants, animals, marine organisms and microorganisms (da Rocha et al. 
2001; Schmidt et al. 2004; Simmons et al. 2005; Kinghorn et al. 2009; Olano et al. 2009; 
Skinner 2010). Our aim was not to test the anticancer activity of our compounds but because 
the anticancer activity from cyclic peptides is well known, cyclodysidins were tested against 
ovarian and melanoma cell lines but no activity was reported. There are still a lot of tumor 
cell lines to be tested but this will require the availability of more material from the cyclic 
peptides. Bioassay-guided fractionation was successfully used to isolate compounds with 
particular activity from crude extracts of several organisms (Han et al. 2007; Awad et al. 
2009; Ene et al. 2009; Asolkar et al. 2010; Ibrahim et al. 2010; Peters et al. 2010; Sheeja et 
al. 2010). It is based on the chromatographic fractionation of the whole extract and 
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refractionation until pure biologically active compounds are isolated. Activity-directed 
fractionation of the methanolic extract of Streptomyces strain RV15 yielded four inactive 
compounds. The absence of activity might be explained in many ways. The change in 
chemical nature of the compounds due to harsh extraction conditions, bad storage conditions 
or compounds instability can lead to degradation or loss of essential parts of the molecule 
such as alcoholic or carboxylic functions, sugar or hydrocarbon part. It might be also due to 
the presence of other compounds in the extract which could be responsible for the 
antimicrobial activity and this consistent with our results due to the presence of other peaks 
to be identified. Another possibility might be the presence of other compounds in the extract 
which work synergistically with the cyclic peptides.  
 
4.3.3 Conclusion and Outlook 
 
Four new cyclic lipopeptides were isolated from marine Streptomyces RV15 strain which was 
recovered from sponge Dysidea tupha that was collected from Rovinj (Croatia, 2008). Their 
structures were elucidated using NMR, MS, and chiral derivatization with Marfey's Reagent. 
The new cyclic peptides have the sequence cyclo-(AFA-Ser-Gln-Asn-Tyr-Asn-Ser-Thr) 
based on NMR data and CID MS/MS. The difference between the four compounds was in 
the hydrocarbon side chain of the amino fatty acid part. The absolute configuration of amino 
acid building blocks was found to be L for all except tyrosine and serine had D-configuration. 
Moreover, Marfey's analysis revealed that the second stereogenic center in threonine is R 
which is the normal form produced by microorganisms. The absolute configuration of β-AFA 
is currently in progress. The cyclic peptides were tested against different proteases, bacteria, 
fungi and tumor cell lines but no activity was reported. 
 
Our future directions will include synthesis of the cyclic peptides and test them against NCI 
60 panel as well as further chemical investigation of Streptomyces RV15 strain to get the 
bioactive compounds. 
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Chapter 5 
General discussion and outlook 
 
 
5.1 Plant cell cultures as sources of antimicrobial proteins  
 
Antimicrobial resistances together with emerging and re-emerging infections are thought to 
be driven largely by socio-economic, environmental and ecological factors (Morens et al. 
2004; Jones et al. 2008; Woolhouse 2008). This is happening at the time when the arsenal of 
antibiotics available to treat infectious diseases, is decreasing due to progressive increasing 
resistance of microbes to antimicrobial drugs, necessitating the looking for new sources of 
novel antibiotics. Nature was the main supply for most of discovered antibiotics and still 
many sources are unexplored. About 100,000 compounds of molecular weight less than 
2500 have been characterized, half from microbes and the other half from plants (Zhang 
2005). Natural product-derived drugs are still a major portion among the total number of anti-
infective approved drugs (Table 5.1).  
 
Table 5.1 Number of approved antibacterial drugs in the period from 1990 to 2002 (Newman 
et al. 2003). 
 
Year Number of antibacterial drugs Natural product-derived Synthetic 
1990–1995 24 17 7 
1996–2000 11 6 5 
2001–2002 2 2 0 
 
Plant suspension cultures have proven to be valuable experimental systems applicable in 
various aspects of defense response, secondary metabolite production and signal 
transduction (Baldi et al. 2008; Caretto et al. 2010). They have been used to produce 
pharmacologically and commercially interesting compounds (Vanisree et al. 2004; 
Hernandez-Vazquez et al. 2010). Treatments such as the use of biotic and abiotic elicitors 
were reported by several studies to enhance the production of secondary metabolites from 
plant cell cultures (Namdeo et al. 2002; Baldi et al. 2009; Ramos-Solano et al. 2010; Zhao et 
al. 2010). Bioactivity testing of different fractions from seven heterotrophic and 
photomixotrophic plant cell cultures elicited with nine elicitors revealed that the intracellular 
fraction of L. angustifolia elicited with DC3000 was the most active fraction against Candida 
maltosa. Furthermore, the bacterial and fungal elicitors were more effective than other 
elicitors of non microbial origin with respect to antimicrobial activity induction which was 
consistent with the previous studies (Broeckling et al. 2005; Naoumkina et al. 2008). The 
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antimicrobial activities from plant cell cultures were attributed to proteins rather than small 
molecular weight organic compounds. Antimicrobial proteins (AMPs) have been isolated from 
various multicellular plant and animal species as well as by some single-celled organisms 
(Zasloff 2002; Harvey 2008). AMPs help plants and animals to resist the infection by 
environmental microbes and represent evolutionarily conserved component of the innate 
immune response of animals (Boman 1995). Several antimicrobial proteins were purified 
from plants with the majority have been isolated from seeds (Hammami et al. 2009b; 
Pelegrini et al. 2009; Park et al. 2010). The majority of them are broad spectrum antibiotics 
with potent activities which demonstrate their potential as novel therapeutic agents (Brogden 
2005; Hancock and Sahl 2006). Here, we reported plant cell suspension cultures as new 
sources for isolating AMPs after elicitation with different elicitors. One putatively 19 kDa 
antimicrobially active protein, named AtAMP, was purified from A. thaliana cell culture elicited 
with salicylic acid. Some antimicrobial proteins have been applied in the agriculture such as 
the expression of α-hordothionin gene under control of CaMV35S promoter to increase the 
resistance against Pseudomonas syringae (Carmona et al. 1993). The constitutive 
expression of a novel alfalfa defensin gene in potato to provide resistance against Dahliae 
(Gao et al. 2000). AMPs exhibited several advantages such as the potent activity against a 
broad range of microbes (Andra et al. 2001; Cole 2003; Toke 2005; Rivas et al. 2009), the 
lower probability of developing microbial resistance than observed with other anti-infective 
agents as well as the synergistic compatibility with other classes of antibiotics (Biragyn et al. 
2002). These advantages make AMPs as attractive candidates for biopharmaceutical 
development. However, the development of AMPs as real antibiotics has been hindered, in 
large part, by the lack of a cost-effective means of commercial-scale production (Zasloff 
2002). This study highlights plant cell cultures as alternative new sources for AMPs that 
could be possible candidates for future antibiotics taking the advantages of simpler 
procedure for isolation and purification of compounds from plant cell cultures as well as the 
possibility to scale up to commercial level. Future work will include further characterization of 
the purified protein, bioactivity testing and heterologously expressing it in transgenic plants. 
 
5.2 Marine actinomycetes as sources of new anti-infectives 
 
Marine sponges (Porifera) have attracted significant attention from various scientific 
disciplines, remarkably due to their potential to produce arsenal of diverse compounds with 
various biological activities (Dalisay et al. 2009; Laville et al. 2009; Andavan and Lemmens-
Gruber 2010; Ebada et al. 2010; Fusetani 2010). Sponges are reservoirs of abundant, dense 
and morphologically diverse microbial communities (Hentschel et al. 2006). Recent studies 
have shown that some secondary metabolites with promising activities isolated from marine 
sponges were speculated to be biosynthesized by sponge-associated microbes rather than 
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the host itself (Kobayashi et al. 1993; Piel 2004; Kim and Fuerst 2006). In the case of 
production of compounds by a microbe, isolation and culture of the producing bacteria can 
provide with a reliable source for the bioactive compound of interest and open a wide range 
of possible testing and analyses. By the use of molecular approaches to investigate the 
diversity of sponge microbial communities, actinomycetes have been shown to be a major 
component of these communities (Webster et al. 2001; Hentschel et al. 2002; Schneemann 
et al. 2010). The cultivation efforts have recently revealed considerable actinomycete 
diversity from various marine samples (Mincer et al. 2002; Jensen et al. 2005; Maldonado et 
al. 2005b; Bredholdt et al. 2007b; Lampert et al. 2008; Hardoim et al. 2009; Sun et al. 2010). 
Both culture-independent studies and culture-based methods revealed the existence of high 
actinobacterial diversity in sponges (Table 5.2). In this Ph.D. study, 90 actinomycete isolates 
belong to 18 diverse genera were recovered from 11 taxonomically and geographically 
different marine sponges which represents high diversity in comparison to other studies 
(Table 5.2).  
 
Table 5.2 Actinomycetes diversity in terrestrial and marine environments. 
 
No of actinomycete 
isolates 
No of genera 
recovered Source Reference 
47 4 Soil (Moncheva et al. 2002) 
60 3 Soil (Abbas 2006) 
330 4 Plant (Taechowisan et al. 2003) 
10 5 Plant (Nimnoi et al. 2010) 
55 6 Plant (Verma et al. 2009) 
242 5 Plant (Cao et al. 2004) 
289 11 Marine sediment (Jensen et al. 1991) 
192 9 Marine sediment (Vijayakumar et al. 2007) 
600 4 Marine sediment (Fiedler et al. 2005) 
90 18 Sponge (Abdelmohsen et al. 2010a) 
79 20 sponge (Tabares et al. 2010) 
35 4 Sponge (Radwan et al. 2009) 
184 6 Sponge (Sun et al. 2010) 
106 7 Sponge (Zhang et al. 2006b) 
181 3 Sponge (Zhang et al. 2008) 
59 10 Sponge (Xin et al. 2009) 
19  6 Sponge (Pimentel-Elardo 2009) 
46 5 Sponge (Schneemann et al. 2010) 
 
Fourteen putatively novel species belong to 11 genera recovered from Mediterranean Sea 
and Red Sea sponges were identified by 16S rRNA gene analysis. Strains belonging to 
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Actinoalloteichus, Brachybacterium, Brevibacterium, Curtobacterium, Gordonia, Kocuria, 
Micrococcus, Micromonospora, Nocardiopsis, Rhodococcus, Salinispora and Streptomyces 
have been previously isolated from marine sponges (Montalvo et al. 2005; Taylor et al. 2007; 
Zhang et al. 2008; Radwan et al. 2009). However, none of the strains recovered in our study 
showed sequence similarities with those previously reported from sponges, thus raising the 
question if these strains are true sponge symbionts or they might be transient bacteria and/or 
just came from surrounding seawater.  
 
Given that less than 1% of bacteria associated with sponges can be cultured hindering the 
access to this enormous reservoir of secondary metabolites producers. It could be argued 
that the traditional culturing strategies use conditions that are completely different from the 
normal growth habit of many microbes and are a major contributing factor to the failure to 
cultivate most microorganisms in pure culture. Thus, the use of appropriate isolation 
protocols could be efficient for improving the isolation of rare and new actinomycete species. 
It has been reported that the structure of actinobacterial community could be influenced by 
DNA extraction methods and the use of different media (Seong et al. 2001; Hardoim et al. 
2009; Schneemann et al. 2010). In this study, DNA was extracted from actinomycetes using 
two different methods. The first method was done by heating the colonies with water and the 
second using FastDNA spin kit and both methods were successful in most of cases except in 
some cases where the colonies are hard, only the kit was able to extract DNA. Among the 
eight different media used in the study, M1 agar exhibited the highest recovery. Several 
studies have shown that M1 was effective medium for cultivating different genera of marine 
actinomycetes (Mincer et al. 2002; Pimentel-Elardo et al. 2008b; Solano et al. 2009). The 
selectivity of the isolation procedure may be influenced by pretreatment of the sample before 
plating and by the conditions under which the bacterial communities in suspensions of the 
sample are cultivated. Different pretreatments have been used in previous studies to 
enhance growing of actinomycetes or specific group of actinomycetes. Heat shock was used 
to reduce the numbers of Gram negative bacteria that growing and overrunning the plates 
(Takizawa et al. 1993). Pretreatment with UV irradiation and high frequency radiations have 
been shown to effectively stimulate the germination of spores of rare actinomycete genera 
(Bredholdt et al. 2007a). The centrifugation has been used to concentrate spores in seawater 
samples (Goodfellow and Williams 1983). In this study, cultivation media were supplemented 
with antibiotics cycloheximide and nystatin to inhibit fungal growth while, nalidixic acid was 
added to inhibit many fast-growing Gram-negative bacteria (Webster et al. 2001). Additives 
such as sodium carbonate has been utilized in the previous studies to enhance the growth of 
alkalophilic actinomycetes (Selianin et al. 2005). Media with low-nutrient composition 
(Santavy and Colwell 1990; Olson et al. 2000) have been used to enhance growth of 
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oligotrophic bacteria which are capable of producing trace concentrations of organic 
substances in the medium (Kuznetsov et al. 1979). The cellulose-based media have been 
used in order to isolate cellulose-decomposing bacteria (Magarvey et al. 2004). Furthermore, 
macromolecules such as casein, chitin, and humic acid have been used as carbon and 
nitrogen sources to enhance growth of rare actinomycetes (Cho et al. 1994). In this study, 
the addition of aqueous sponge extract to M1 medium resulted in the isolation of a putatively 
new genus with Rubrobacter as its closest relative. This shows that variation from standard 
protocols is a worthwhile procedure which is consistent with previous observations (Webster 
et al. 2001; Bredholt et al. 2008; Zhang et al. 2008).  
 
Extracts of cultures of 20 selected actinomycetes out of 90 strains, isolated from different 
sponges, were first screened to detect their ability to produce bioactive substances. 
Screening tests were performed to detect antibacterial, antifungal activities as well as 
antiparasitic activities. Of these extracts, 10 (11%) obtained from different species belonging 
to ten genera showed interesting biological activities, confirming marine actinobacteria as a 
prolific source for active compounds. Out of the 10 actinomycete strains that were selected 
as producers of active secondary metabolites, 50% exhibited significant antibacterial and 
antifungal activities and 20% were active against parasites. Furthermore, one putatively 
novel strain related to the genus Actinokineospora showed both antifungal as well as 
antiparasitic potential. This great taxonomical variety of the producer microorganisms 
demonstrates that the production of active secondary metabolites is not restricted to 
particular genera or species. 
 
The rate of discovery of new compounds from existing genera has decreased with increasing 
the rate of re-isolation of known compounds. It has been reported that new actinomycete 
taxa produce new bioactive compounds, making this targeted approach a more productive 
way to new discoveries (Feling et al. 2003; Kwon et al. 2006; Pimentel-Elardo et al. 2008a). 
This could be best exemplified by isolation of salinisporamide A and arenimycin from the new 
genus Salinispora (Feling et al. 2003; Asolkar et al. 2010) as well as the isolation of 
marinomycins A–D from the new genus Marinispora (Kwon et al. 2006). Thus, it is critical to 
pursue with new groups of microbes from unexplored habitats as sources of novel 
compounds. In order to avoid rediscovery of known secondary metabolites, new approach 
was used in this study to target new bioactive compounds (Figure 5.1). 
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Figure 5.1 Protocol targeting new bioactive compounds. 
 
In spite of the fact that strains belonging to unusual genera may provide a higher probability 
of finding novel bioactive molecules, the little knowledge about their physiology and 
appropriate cultivation might hinder the processing with those strains. Among the thousands 
of compounds that have been isolated from microbes, around 80% were produced by 
members of the order Actinomycetales (phylum Actinobacteria) with the genus Streptomyces 
accounting for approx 50% (Strohl 1997; Lazzarini et al. 2001). Numerous, useful 
compounds have been isolated from the genus Streptomyces, including anti-inflammatory, 
antiviral, antitumor, antifungal and antibacterial compounds (Pfefferle et al. 2000; Kelecom 
2002; Berdy 2005; Hughes et al. 2008; Dharmaraj 2010). Despite their broad range of 
activities, the most studied secondary metabolites through the history were the antibiotics. It 
was reported that some microorganisms are capable of producing a variety of compounds 
belong to different chemical classes and are termed metabolically talented (Bode et al. 2002; 
Zhang 2005). One metabolically talented microorganism, Streptomyces sp. strain Go.40/10, 
Dysidea tupha  Streptomyces sp. 
Cloning and sequencing of 
16S rDNA  
Bioactivity      
screening 
Microbial fermentation LC/MS analysis  Purification of bioactive  compounds  
Structure elucidation  
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synthesized at least 30 different compounds, many of which are new compounds (Schiewe 
and Zeeck 1999).  
 
The secondary metabolites produced by marine invertebrates as well as marine bacteria 
have been shown to be structurally biosynthesized by polyketide synthases (PKS) and/or 
nonribosomal peptide synthetases (NRPS). Many microbial strains have been found to have 
several gene clusters based on PCR screening but they do not readily express them when 
grown under standard growth conditions (Bentley et al. 2002). It is possible that these gene 
clusters are not expressed under standard growth conditions and require specific media or 
conditions or their constitutive expression require external signaling. Thus by using different 
fermentation conditions, the probability that each of its gene clusters will be expressed will be 
increased. Carbon source is important factor that could affect the secondary metabolites 
production and usually there are differences between the optimal carbon sources for growth 
and those that are appropriate for secondary metabolism. Glucose was the excellent carbon 
source for growth in most cases, but suppresses the production of a series of secondary 
metabolites such as actinomycin and cephalosporin (Aharonowitz and Demain 1978; 
Praveen et al. 2008). Glucose has also been reported to transiently repress erythromycin 
production in Saccharopolyspora ervthraea, although, it does not interfere with the 
production of aminoglycosides or chloramphenicol (Doull and Vining 1990). An excess 
supply of a readily assimilated nitrogen source might negatively stimulate secondary 
metabolites biosynthetic pathways, especially those that are biosynthetically related to lipid 
metabolism, notably the polyketide-derived metabolites. The addition of ammonium salts was 
capable of inhibiting the production of cephamycin and rifamycin (Aharonowitz 1980). 
Inorganic phosphate could suppress the biosynthesis of many secondary metabolites. Thus, 
the optimal phosphate concentration needed for production of secondary metabolites is 
generally lower than that required for growth (Gonzalez et al. 1990). However, the optimal 
concentration can vary drastically between strains as in case of avermectin biosynthesis in 
Streptomyces avermitilis which tolerates high concentrations of phosphate in the medium. 
The influence of amino acids on secondary metabolite production is very variable and can 
depend on the precursor or the natural inducer. The addition of L-valine increased the 
specific production of cyclosporin A by 62% in comparison to an unsupplemented control 
culture (Lee and Agathos 1989). Optimal temperatures for the production of secondary 
metabolites are in general lower than for growth but can vary considerably. For example, the 
optimal temperature for biosynthesis of cyclosporin by Tolypocladium inflatum 21 °C is 
optimal (Ly and Margaritis 2007), while 28 °C is best for nebramycin production by 
Streptomyces tenebrarius (Stark et al. 1971). Incubation time is also critical factor and is 
totally dependent on the growth characteristics of the microorganism and the culture 
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conditions. The addition of adsorbents such as XAD-16 resin to liquid cultures can enhance 
the concentration of secondary metabolites produced (Buchanan et al. 2005). The solid-
phase fermentation might be a good approach to get novel compounds which allows the 
biosynthesis of new compounds that are mainly related to the sporulation process. Cell 
immobilization technology is one of the main trends in modern biotechnology and is 
employed mostly in secondary metabolites production. It provides many operational and 
economic advantages such as prolonged metabolic activity, reuse of the biocatalyst and the 
possibility to increase the cell concentration. In last few years, the production of antibiotics by 
immobilized microbial cells was successfully reported. Erythromycin and neomycin were 
produced by Saccharopolyspora and Sterptomyces cells, respectively, entrapped in calcium 
alginate beads (Srinivasulu et al. 2002; Hamedi et al. 2005). The antibiotic producing 
microorganisms Streptomyces rimosus PFIZER 18234-2 and Amycolutopsis mediterranei 
CBS 42575 were immobilized in glass wool for the production of oxytetracycline and 
rifamycins B, respectively (Farid et al. 1994). The identification of appropriate culture 
conditions for optimal production of bioactive metabolites was critical for facilitating the 
isolation and characterization of the bioactive molecules from the isolated actinomycete 
strains. In this Ph.D. study, five different media with different carbon and nitrogen sources 
were used to optimize the production of antibiotics based on activity testing by disc diffusion 
assay. ISP2 medium produced the maximal activity which was consistent with previous 
reports (Yang et al. 2010).  
 
Bioassay-guided fractionation was used in several studies to monitor and direct the isolation 
of the compounds with corresponding activity from the crude extract (Ene et al. 2009; Asolkar 
et al. 2010; Peters et al. 2010). The putatively new bioactive Streptomyces RV15 strain 
cultivated from the sponge Dysidea tupha yielded four new cyclic peptides, namely, 
cyclodysidins after chromatographic and spectroscopic analysis. Although the methanolic 
crude extract of the strain showed potent antibacterial (against Gram positive bacteria) and 
antifungal (against C. albicans) activities, the bioassay-guided fractionation yielded pure 
compounds which did not exhibit such activities. They were also additionally tested against 
various proteases and two different tumor cell lines but no activities were detected. The lack 
of activity could be explained by the presence of other compounds which could be 
responsible for these activities and this is consistent with the presence of other peaks which 
to be identified. The other possibility is the synergism between the cyclic peptides and other 
compounds in the extract. Our future work will include further identification of other 
compounds in the crude extract since some peaks still unidentified. Intelligent screening 
approaches towards natural products discovery are required. One of the approaches is the 
screening of synergism between natural products and commercially used pharmaceuticals. 
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Some marketed drugs might be more effective at a reduced dosage if they taken with low 
dosages of other synergistic natural products which might fail to show potent activity alone. 
In addition to the high efficacy of the synergistic action, there is also decrease in the toxic 
effects of the synthetic drugs. Many marketed traditional medicines have demonstrated great 
efficacy and safety profiles during their long history. However, the activity was lost when 
attempts were done to purify a single molecule. Synergistic co-drugs from natural products 
will help existing drugs to be more effective to cure disease. Because it was reported by 
many studies that cyclic peptides exhibited anticancer activities against various tumor cell 
lines (Fenical et al. 2003; Simmons et al. 2005; Olano et al. 2009; Sivonen et al. 2010), we 
will pursue synthesizing the cyclic peptides to generate enough amounts for testing against 
National cancer Institute (NCI) 60 tumor cell line panel. 
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I. Screening of intracellular fractions for antimicrobial activities (Chapter 2) 
                         Elicitor 
Pathogen 
Alt ASA Chitosan DC3000 Fol MeJ PGA RPM1 SA 
A
gr
os
tis
 te
nu
is
 B. subtilis 0 0 0 0 0 0 0 0 0 
C. maltosa 11 7 9 12 11 0 7 9 9 
E. coli 9 7 11 11 9 0 7 12 11 
P. aeruginosa 12 8 9 12 10 0 8 11 12 
S. aureus 0 0 0 0 0 0 0 0 0 
A
ra
bi
do
ps
is
 
th
al
ia
na
 
B. subtilis 13 12 9 11 12 13 9 11 15 
C. maltosa 10 13 10 12 11 12 11 13 17 
E. coli 11 12 9 11 13 10 9 11 16 
P. aeruginosa 11 13 9 12 11 8 11 12 15 
S. aureus 9 11 10 9 13 9 12 11 14 
B
ap
hi
ca
nt
hu
s 
 
cu
si
a 
B. subtilis 10 11 7 14 9 9 12 10 12 
C. maltosa 0 7 0 7 0 7 0 0 7 
E. coli 0 0 0 0 0 0 0 0 0 
P. aeruginosa 7 7 0 0 0 0 0 0 0 
S. aureus 9 9 7 11 12 9 11 10 13 
D
au
cu
s 
ca
ro
ta
 B. subtilis 0 0 0 0 0 0 0 0 0 
C. maltosa 0 0 0 7 0 0 0 7 7 
E. coli 11 11 8 12 9 10 7 10 12 
P. aeruginosa 9 10 7 10 11 9 8 9 10 
S. aureus 0 0 0 0 0 0 0 0 0 
La
ve
nd
ul
a 
an
gu
st
ifo
lia
 B. subtilis 0 7 0 7 0 0 0 7 0 
C. maltosa 12 13 11 16 10 10 9 12 14 
E. coli 7 0 7 7 0 0 0 0 0 
P. aeruginosa 7 0 7 0 0 0 0 0 0 
S. aureus 0 0 0 0 0 0 0 0 0 
N
ic
ot
ia
na
 
ta
ba
cu
m
 p
et
it 
ha
va
nn
a 
B. subtilis 8 8 8 11 8 7 7 9 11 
C. maltosa 9 9 7 9 9 8 7 10 9 
E. coli 9 9 7 10 7 7 8 8 10 
P. aeruginosa 10 10 8 8 8 8 7 8 8 
S. aureus 9 9 9 8 8 7 7 7 9 
ve
rt
ic
ill
at
a 
 
B. subtilis 7 0 0 7 0 0 0 7 7 
C. maltosa 11 10 11 12 12 11 9 11 13 
E. coli 0 0 0 0 0 0 0 0 0 
P. aeruginosa 0 0 0 0 0 0 0 0 0 
S. aureus 7 0 7 7 0 0 0 0 7 
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II. Screening of extracellular fractions for antimicrobial activities (Chapter 2) 
 
                     Elicitor 
pathogen  Alt ASA Chitosan DC3000 Fol MeJ PGA RPM1 SA 
A
gr
os
tis
 te
nu
is
 B. subtilis 0 0 0 0 0 0 0 0 0 
C. maltosa 10 0 9 9 10 0 0 8 8 
E. coli 9 0 10 11 9 0 0 12 10 
P. aeruginosa 11 0 9 10 9 0 0 9 12 
S. aureus 0 0 0 0 0 0 0 0 0 
A
ra
bi
do
ps
is
 
th
al
ia
na
 
B. subtilis 12 11 8 10 12 11 9 11 13 
C. maltosa 9 12 9 10 11 12 9 9 15 
E. coli 9 12 8 11 13 9 7 10 13 
P. aeruginosa 11 13 9 12 10 0 11 9 12 
S. aureus 7 10 9 9 13 9 8 11 12 
B
ap
hi
ca
nt
hu
s 
 
cu
si
a 
B. subtilis 9 11 0 13 8 9 11 10 11 
C. maltosa 0 7 0 7 0 7 0 0 7 
E. coli 0 0 0 0 0 0 0 0 0 
P. aeruginosa 7 8 0 0 0 0 8 0 8 
S. aureus 9 9 0 11 12 0 10 9 9 
D
au
cu
s 
ca
ro
ta
 B. subtilis 0 0 0 0 0 0 0 0 0 
C. maltosa 0 0 0 0 0 0 0 0 0 
E. coli 10 11 0 11 8 9 0 10 11 
P. aeruginosa 8 10 0 9 10 9 0 7 8 
S. aureus 0 0 0 0 0 0 0 0 0 
La
ve
nd
ul
a 
an
gu
st
ifo
lia
 B. subtilis 0 7 0 7 0 0 0 7 0 
C. maltosa 11 12 9 14 10 7 8 11 13 
E. coli 7 0 7 7 0 0 0 0 0 
P. aeruginosa 7 0 7 0 0 0 0 0 0 
S. aureus 0 0 0 0 0 0 0 0 0 
N
ic
ot
ia
na
 
ta
ba
cu
m
 p
et
it 
ha
va
nn
a
B. subtilis 7 8 0 10 8 8 0 8 10 
C. maltosa 8 8 0 9 9 8 0 9 9 
E. coli 9 9 0 9 7 7 0 8 9 
P. aeruginosa 8 7 0 8 8 8 0 8 8 
S. aureus 7 9 0 7 8 7 0 7 8 
R
au
vo
lfi
a 
ve
rt
ic
ill
at
a 
B. subtilis 0 0 0 7 0 0 0 0 0 
C. maltosa 10 9 8 11 10 8 7 9 12 
E. coli 0 0 0 0 0 0 0 0 0 
P. aeruginosa 0 0 0 0 0 0 0 0 0 
S. aureus 0 0 0 0 0 0 0 0 0 
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III. Screening of cell wall bound fractions for antimicrobial activities (Chapter 2) 
 
                       Elicitor 
Pathogen 
Alt ASA Chitosan DC3000 Fol MeJ PGA RPM1 SA 
A
gr
os
tis
 te
nu
is
 B. subtilis 0 0 0 7 0 0 0 0 7 
C. maltosa 0 0 7 0 0 0 7 0 0 
E. coli 0 0 0 0 0 7 0 0 0 
P. aeruginosa 0 7 0 0 0 0 7 0 0 
S. aureus 0 0 7 0 0 7 0 0 0 
A
ra
bi
do
ps
is
 
th
al
ia
na
 
B. subtilis 7 7 0 0 0 7 0 0 8 
C. maltosa 0 7 7 0 0 0 0 7 8 
E. coli 0 0 0 7 0 0 0 8 7 
P. aeruginosa 7 0 0 8 7 0 0 0 8 
S. aureus 0 0 0 0 7 0 0 0 0 
B
ap
hi
ca
nt
hu
s 
 
cu
si
a 
B. subtilis 0 0 7 0 0 0 0 0 0 
C. maltosa 0 7 0 7 0 0 0 0 7 
E. coli 0 0 0 0 0 0 0 0 0 
P. aeruginosa 7 7 0 0 0 0 0 0 0 
S. aureus 0 0 7 8 7 0 0 0 7 
D
au
cu
s 
ca
ro
ta
 B. subtilis 0 0 0 0 0 0 0 0 0 
C. maltosa 0 0 0 7 0 0 0 7 7 
E. coli 0 7 0 8 0 0 7 0 0 
P. aeruginosa 7 8 7 7 0 0 0 0 7 
S. aureus 7 0 0 0 0 0 0 0 0 
La
ve
nd
ul
a 
an
gu
st
ifo
lia
 B. subtilis 0 0 0 0 0 0 0 0 0 
C. maltosa 0 8 0 8 0 0 0 7 8 
E. coli 0 0 0 0 0 0 0 0 0 
P. aeruginosa 7 0 0 0 0 0 0 0 0 
S. aureus 0 0 0 0 0 0 0 0 0 
N
ic
ot
ia
na
 
ta
ba
cu
m
 p
et
it 
ha
va
nn
a
B. subtilis 8 0 0 7 0 7 0 0 7 
C. maltosa 0 0 0 0 0 0 0 0 0 
E. coli 0 0 0 7 0 0 0 0 7 
P. aeruginosa 7 0 7 7 0 0 0 0 7 
S. aureus 0 0 0 0 0 0 0 0 0 
R
au
vo
lfi
a 
ve
rt
ic
ill
at
a 
B. subtilis 7 0 0 7 0 0 0 7 7 
C. maltosa 0 0 0 0 0 0 0 0 0 
E. coli 0 0 0 0 0 0 0 0 7 
P. aeruginosa 0 0 0 0 0 0 0 0 0 
S. aureus 7 0 0 7 0 0 0 0 7 
 
0: no activity was detected 
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            IV. 16S rRNA gene phylogenetic affiliation of cultivated strains (Chapter 3) 
 
Isolate 
Code 
Sequence 
Length (bp) Closest relative by BLAST (Accession number)-Source 
% Sequence 
Similarity 
EG2 1483 Brachybacterium conglomeratum NCIB 9859 (X91030)-
environmental sample 
99.1 
EG4 1482 Microbacterium resistens 3352 (EU714361)-environmental 
sample 
98.0 
EG6 1486 Micrococcus luteus CV44 (AJ717369)-environmental sample 99.3 
EG7 1482 Brachybacterium sp. 511 (EU086801)-environmental sample 98.0 
EG8 1484 Corynebacterium ureicelerivorans strain CNM462/06 (FJ392017)-
environmental sample 
98.7 
EG10 1488 Brevibacterium iodinum DSM 2062T (X83813)- environmental 
sample 
98.9 
EG11 1486 Microbacterium resistens 3352 (EU714361)-environmental 
sample 
98.2 
EG12 1488 Micrococcus luteus CV44 (AJ717369)-environmental sample 99.5 
EG14 1495 Kocuria sp. CNJ900 PL04 (DQ448710)-marine sediments 99.7 
EG16 1483 Mycobacterium sp. CNJ823 PL04 (DQ448717)-marine sediments 99.9 
EG18 1492 Brevibacterium iodinum DSM 2062T (X83813)-environmental 
sample 
98.8 
EG22 1488 Microbacterium oxydans B5 (DQ350825)-environmental sample 97.3 
EG33 1379 Rhodococcus opacus B4(AB192962)-enviromental sample 98.0 
EG34 1489 Brevibacterium casei 3Tg (AY468375)-environmental sample 98.4 
EG36 1490 Mycobacterium houstonense ATCC 49403 (AY012579)-
environmental sample 
97.9 
EG37 1486 Brevibacterium epidermidis ZJB-07021 (EU046495)-
environmental sample 
97.1 
EG38 1498 Kocuria sp. CNJ900 PL04 (DQ448710)-marine sediments 99.9 
EG40 1486 Micrococcus sp. B5W22-1 (EF114312)-environmental sample 99.3 
EG43 1495 Brevibacterium sp. BBH7 (AM158906)-marine sediments 98.3 
EG45 1487 Micrococcus sp. CNJ719 PL04 (DQ448712)-marine sediments 97.9 
EG47 1489 Microbacterium indicum BBH9 (AM286267)-marine sediments 97.5 
EG49 1482 Actinokineospora diospyrosa NRRLB-24047T (AF114797)-marine 
sediments 
97.0 
EG50 1485 Gordonia terrae AIST-1 (AB355992)-sea water 99.3 
EG53 1501 Arthrobacter sp. VTT E-052904 (EF093123)-environmental 
sample 
99.3 
EG55 1328 Salinispora pacifica CNH732 RS00 (DQ224165)-sea water 99.6 
EG56 1488 Micrococcus sp. TPR14 (EU373424)-environmental sample 99.0 
EG62 1487 Microbacterium oxydans B5 (DQ350825)-environmental sample 97.4 
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Isolate 
Code 
Sequence 
Length (bp) Closest Relative by BLAST (Accession number)-Source 
% Sequence 
Similarity 
EG65 1497 Brevibacterium aurantiacum NCDO 739 (X76566)-environmental 
sample 
99.0 
EG67 1390 Dietzia cinnamea IMMIB RIV-399 (AJ920289)-environmental 
sample 
99.4 
EG69 1487 Microbacterium indicum BBH6 (AM158907)-marine sediments 97.3 
RV13 1495 Rothia sp. L-143 (DQ822568)-environmental sample 97.0 
RV15 1492 Streptomyces lincolnensis NRRL2936 (X79854)-marine 
sediments 
98.0 
RV28 1494 Mycobacterium septicum ATCC 700731 (AY457070)-
environmental sample 
99.1 
RV43 1478 Micromonospora sp. HBUM84229 (EU119232)-environmental 
sample 
99.8 
RV45 1477 Micromonospora sp. HBUM84229 (EU119232)-environmental 
sample 
99.9 
RV63 1481 Micromonospora sp. RtII195 (EU427443)-environmental sample 99.7 
RV71 1481 Micromonospora matsumotoense IMSNU 22003T (AF152109 )-
environmental sample 
98.3 
RV75 1491 Kocuria palustris isolate SCH0404 (AY881237)-marine sediment 99.6 
RV76 1485 Gordonia terrae strain COE-O1 (AF467984)-environmental 
sample 
99.8 
RV77 1482 Rhodococcus opacus B-4 (AB192962)-environmental sample 98.4 
RV83 1487 Mycobacterium septicum ATCC 700731 (AY457070)-
environmental sample 
99.3 
RV89 1493 Kocuria kristinae DSM 20032 (X80749)-environmental sample 96.6 
RV113 1512 Rubrobacter radiotolerans DSM 46359-T (X87134)-environmental 
sample 
92.8 
RV115 1481 Micromonospora sp. 215009 (FJ263418)-environmental sample 99.2 
RV116 1484 Micromonospora sp. 215009 (FJ263418)-environmental sample 99.3 
RV145 1481 Corynebacterium sp. 3301750 (AY581884)-enviromental sample 99.0 
RV147 1484 Corynebacterium sp. 3301750 (AY581884)-enviromental sample 99.1 
RV151 1502 Mycobacterium gordonae agha3 (AJ581472)-environmental 
sample 
99.0 
RV152 1493 Mycobacterium gordonae agha3 (AJ581472)- environmental 
sample 
99.1 
RV154 1493 Kocuria sp. Am 16 (AJ971854)-environmental sample 99.5 
RV157 1483 Rhodococcus opacus B-4 (AB192962)-environmental sample 98.6 
RV163 1345 Nocardiopsis dassonvillei HBUM174177 (FJ532466)-
environmental sample 
99.4 
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V. Abbreviations and Acronyms 
 
δ  Chemical shift (ppm) 
 
Alt Boiled spores of Alternaria brassiciola 
ASW Artificial Sea Water 
 
AtAMP   Arabidopsis thaliana Antimicrobial Protein 
AMPs Antimicrobial Peptides or Proteins 
APS   Ammonium persulfate 
ASA Acetyl Salicylic Acid 
BLAST Basic Local Alignment Search Tool 
 
BSA Bovine Serum Albumin 
B. subtilis Bacillus subtilis 
13C NMR Carbon Nuclear Magnetic Resonance 
 
COSY Correlation Spectroscopy 
 
d Doublet 
dd Doublet of doublet 
 
DC3000 Boiled bacterial suspension of virulent strain of Pseudomonas syringae 
DMSO Dimethylsulfoxide 
DNA Deoxyribonucleic acid 
 
dNTP Deoxynucleotide triphosphate 
EDTA Ethylenediamine tetraacetic acid 
E. Coli  Escherichia coli 
EtOH Ethanol 
FDAA 1-Fluoro-2,4-Dinitrophenyl-5-L-Alanine Amide 
Fol Mycelial suspension of Fusarium oxysporium lycopersici 
g  Gram 
h Hour 
HMBC Heteronuclear Multiple Bond Correlation 
1H NMR Proton Nuclear Magnetic Resonance 
HPLC High Performance Liquid Chromatography 
 
HSQC               Heteronuclear Single Quantum Coherence 
J Coupling constant 
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V. Abbreviations and Acronyms 
 
kDa Kilo Dalton 
µg  Microgram 
µl Microliters 
M Molar 
mA  Milli Ampere 
Mej Methyljasmonate 
min Minute 
ml Milliliter 
mM Millimolar 
m Multiplet 
MS Mass Spectrometry 
NMR Nuclear Magnetic Resonance 
OD Optical Density 
ppm Parts Per Million 
PAGE Polyacrylamide Gel Electrophoresis 
PGA Polygalcturonic acid 
P. aeruginosa Pseudomonas aeruginosa  
Rt  Retention time 
 
rpm  Revolution per minute 
RPM1 Boiled bacterial suspension of avirulent strain of Pseudomonas syringae 
RT Room Temperature 
s Singlet 
SA Salicylic Acid 
strainT Type strain 
t Triplet 
UV Ultraviolet 
V/V Volume/Volume 
W/V Weight/Volume 
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VI. Recipes for different preparations 
 
Media were sterilized by autoclaving at 121 C for 30 min. Components that are volatile, 
altered or damaged by heat or whose pH or concentration are critical were sterilized by 
filtration through a 0.22 µm filter and added to autoclaved media after cooling to hand warm 
temperature. 
 
A- Growth media 
 
AIA medium 
Asparagine 0.1 g
Ferrous sulfate 1.0 mg
Magnesium sulfate 100.0 mg
Potassium phosphate 0.5 g
Sodium propionate 4.0 g
Sodium casein    2.0 g
Agar 18.0 g
ASW                                       to                  1.0 L
 
Baltz medium 
Adenosine 10.0 mg
Bathocuproine disulfonic acid 14.0 mg
Glucose  1.0 g
Glutamine 146.0 mg
HEPES 5.95 g
Hypoxanthine 2.0 mg
MEM 500.0 ml
Sodium pyruvate 220.0 mg 
Thymidine 4.0 mg
H2Odd                     to       1.1 L    
 
After autoclaving, 10 ml sterile non-essential amino acid concentrate (100x, pH 7.5) was 
added. 
 
B5 medium 
2,4-dichlorophenoxyacetic acid 994.5 µg
Gamborg B5  3.20 g
Sucrose 20.0 g
H2Odd                                       to 1.0 L
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pH of the medium was adjusted to 5.7 before autoclaving. 
 
Complete medium 
L- glutamine    0.3 g
Foetal calf serum 16.0 ml
HEPES  5.95 g
Gentamicin (50 μg/ml) 0.8 ml
2-mercaptoethanol               3.9 mg  
Penicillin (100 U/ml) 0.8 ml
Sodium bicarbonate 0.35 g
H2Odd                    to                  1.0 L
 
Complete Baltz medium 
2-mercaptoethanol 3.9 mg  
Baltz Medium Basic Solution   0.8 ml
Foetal calf serum  16.0 ml
Penicillin (10,000 U/ml) 0.8 ml
Streptomycin (10,000 U/ml) 0.8 ml
H2Odd                   to       1.0 L   
 
FCS (pH 7.2) was inactivated for 30 min at 56 °C before autoclaving while penicillin and 
streptomycin were added after autoclaving. 
 
DMEM medium 
DMEM without glutamine   4.5 g
Foetal calf serum 20 g
L-glutamine  29.2 g
2-mercaptoethanol 3.9 mg
H2Odd                    to        1.0 L  
 
HR medium 
Disodium hydrogen phosphate 35.60 g
HR medium 14.67 g
Potassium dihydrogen 
phosphate 
27.22 g  
Sodium bicarbonate 1.00 g
H2Odd                    to      1.0 L   
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GAA medium 
Glycerol 10.0 g
L-asparagine    1.0 g
Potassium phosphate 1.0 g
Agar 18.0 g
ASW                                       to                  1.0 L
 
ISP 2 medium 
Dextrose  4.0 g
Malt extract    10.0 g
Yeast extract  4.0 g
Agar 18.0 g
ASW                                       to                  1.0 L
 
LB medium 
Peptone    10.0 g
Sodium chloride 5.0 g
Yeast extract  5.0 g
Agar 18.0 g
H2Odd                                       to                  1.0 L
 
      LB/amp 
Ampicillin  100.0 µg
LB medium    1.0 L
 
Ampicillin was sterilized by filtration and then added to LB agar after autoclaving. 
 
LB/amp/IPTG/X-gal 
Ampicillin  100 μg
IPTG   119.2 mg
X-gal  80 μg
LB agar    1.0 L
 
Ampicillin, IPTG and X-gal were sterilized by filtration and then added LB agar after 
autoclaving. 
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LS medium 
2,4-dichlorophenoxyacetic acid 221.0 µg
Linsmaier & Skoog medium  4.60 g
Naphthalene acetic acid 186.2 µg
Sucrose 30.0 g
H2Odd                   to 1.0 L
 
pH of the medium was adjusted to 6.0 before autoclaving.  
 
MA medium 
Ammonium carbonate 1.5 mg
Boric acid 22.0 mg
Calcium chloride 1.8 g
Ferric citrate 0.1 g
Magnesium chloride  5.9 g
Magnesium sulfate  3.2 g
Potassium bromide 80.0 mg
Potassium chloride 0.5 g
Sodium chloride  19.5 g
Sodium bicarbonate 0.16 g
Sodium fluoride 2.4 mg
Sodium phosphate 8.0 mg
Strontium chloride 34.0 mg
Sodium silicate 4.0 mg
Starch    0.5 g
Yeast extract 1.0 g
Agar 18.0 g
ASW                                      to                  1.0 L
 
M1 medium 
Peptone  2.0 g
Soluble starch    10.0 g
Yeast extract 4.0 g
Agar 18.0 g
ASW                                      to                  1.0 L
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M1+ medium 
Peptone  2.0 g
Soluble starch    10.0 g
Yeast extract 4.0 g
Sponge extract (1%) 1.0 ml
Agar 18.0 g
ASW                                       to                  1.0 L
 
Sponge extract was sterilized by filtration and then added to the medium after autoclaving.  
 
OLIGO medium 
Sodium glycerophosphate 100.0 mg
Tryptone    0.5 g
Yeast extract 50.0 mg
Agar 18.0 g
ASW                    to             1.0 L
 
R2A medium 
Casamino acids 0.5 g
Dextrose 0.5 g
Peptone  0.5 g
Potassium phosphate 0.3 g
Sodium pyruvate 1.0 mg
Starch    0.5 g
Yeast extract 0.5 g
Agar 18.0 g
ASW                                      to                  1.0 L
 
SOC medium 
Glucose  12.3 g
Magnesium chloride  12.8 g
Magnesium sulfate  15.4 g
Potassium chloride  4.6 g
Tryptone    20.0 g
Sodium chloride                   3.6 g
Yeast extract 5.0 g
H2Odd                  to                  1.0 L
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Glucose, magnesium chloride and magnesium sulfate were sterilized by filtration and then 
added to the medium after autoclaving.  
 
YPD medium 
Dextrose    20.0 g
Peptone  20.0 g
Yeast extract 10.0 g
Agar 18.0 g
H2Odd                   to                  1.0 L
     
 
B- Miscellaneous solutions and buffers 
 
Artificial seawater 
Boric acid 0.26 g
Calcium chloride 11.0 g
Magnesium chloride 106.4 g
Potassium chloride 6.64 g
Potassium bromide 0.96 g
Sodium chloride 234.7 g
Sodium fluoride 30.0 mg
Sodium sulfate 39.2 g
Sodium bicarbonate 1.92 g
Strontium chloride 0.24 g
H2Odd                                         to 10.0 L
                 
Bradford reagent 
Coomassie Brilliant Blue G-250  10.0 mg
Ethanol (95%) 5.0 ml
Phosphoric acid (85%) 10.0 ml
H2Odd                            to 100.0 ml
 
Coomassie staining solution 
Acetic acid 9.0 ml
Coomassie blue R 250 250.0 mg
Methanol 45.5 ml
H2Odd                            to 100.0 ml
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Coomassie destaining solution 
Acetic acid 9.0 ml
Methanol 45.5 ml
H2Odd                            to 100.0 ml
 
EDTA (0.5 M, pH 8.0) 
Na2EDTA.2H2O 93.05 g
H2Odd                            to 500.0 ml
 
EDTA was dissolved in 450 ml water and the pH of the solution was adjusted to 8.0 with 
sodium hydroxide pellets. The water was then added to a final volume of 500 ml. 
 
Extraction buffer A 
Benzamidine hydrochloride 156.0 mg
Disodium hydrogen phosphate 2.67 g
PMSF 348.0 mg
Sodium dihydrogen phosphate 2.07 g 
H2Odd                            to 1.0 L
 
Extraction buffer B 
Benzamidine hydrochloride 156.0 mg
Disodium hydrogen phoshate 2.67 g
EDTA 4.38 g
PMSF 348.0 mg
Sodium dihydrogen phosphate 2.07 g 
Sodium chloride 0.88 g
H2Odd                            to 1.0 L
 
IPTG (1 M) 
IPTG                2.38 g
H2Odd                                       to              10.0 ml
                                   
 
Plasmid mini-prep. buffers 
 
Buffer P1 
EDTA (0.5 M, pH 8.0) 
RNAse A (10 mg/ml)  
                2.0 ml
                1.0 ml
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Tris-Cl (1 M, pH 7.5) 5.0 ml
H2Odd                                      to          100.0 ml
                                             
Buffer P2 
Sodium hydroxide  0.8 g
SDS                   1.0 g
H2Odd                                       to            100.0 ml
  
Buffer P3 
Potassium acetate 29.4 g
Glacial acetic acid                11.5 ml  
H2Odd                                        to          100.0 ml
 
pH of the solution was adjusted to pH 5.5 using glacial acetic acid. 
 
PMSF 
PMSF 1.57 g
Ethanol                    to                    100.0 ml
 
Sample buffer for SDS-PAGE 
Bromophenol blue 20.0 mg
Glycerin  40.0 g
SDS 10.0 g
EDTA (4 µM) 1.6 ml
Tris-HCl (0.5, pH 6.8)   to 50.0 ml
 
SDS running buffer 
Glycine 14.4 g
SDS 1.0 g
Tris 3.0 g
H2Odd                            to 1.0 L
 
                   SDS  solution (10% w/v) 
SDS 10.0 g
H2Odd                            to 100.0 ml
 
SDS was dissolved in about 85 ml distilled water with warming at 50 C. The pH of the 
solution was then adjusted to 7.0 using concentrated HCl and the water was added to obtain 
a final volume of 100 ml. 
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            Separating gel solution (12%) 
30% Acrylamide/Bisacrylamide  4.0 ml  
Ammonium persulfate (10%)       100.0 µl
SDS (10%) 100.0 µl
Tris (1.5 M, pH 8.8) 2.5 ml
TEMED 4.0 µl
H2Odd 3.3 ml
 
Stacking gel solution (5%) 
30% Acrylamide/Bisacrylamide 330.0 µl
Ammonium persulfate (10%)       20.0 µl
SDS (10%) 20.0 µl
Tris (1 M, pH 6.8) 250.0 µl
TEMED 2.0 µl
H2Odd 1.4 ml
 
Tris-Cl (1.5 M, pH 8.8) 
Tris 18.17 g
H2Odd                            to 100.0 ml
 
Tris was dissolved in about 85 ml water. The pH of the solution was then adjusted to 8.8 by 
adding concentrated HCl. The water was then added to obtain a final volume of 100 ml.  
 
TAE buffer (5x) 
Na2EDTA.2H2O             19.0 g
Sodium acetate.3H2O             136.12 g
Tris base               242.0 g
H2Odd                            to                 1.0 L
 
The components were dissolved in about 900 ml water and the pH was adjusted to 7.2 with 
acetic acid. The water was then added to obtain a final volume of 1 L.  
 
Urea (8 M) 
Urea 48.05 g
H2Odd                            to 100.0 ml
 
X-gal (5% w/v) 
X-gal 0.5 g
Dimethylformamide           to  10.0 ml
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VII. Chemicals  
 
Chemical name Manufacturer 
Acetic acid  AppliChem 
Acetonitrile  Sigma 
Acetylsalicylic acid Sigma 
Acrylamide/Bisacrylamide 37.5:1 Roth 
Agar, granulated Difco 
Agarose, ultrapure Gibco 
Ammonium sulfate  AppliChem 
Ammoniun persulfate  Sigma 
Ampicillin  AppliChem 
Asparagine Sigma 
Bradford dye BioRad 
Benzamidine hydrochloride Roth 
Boric acid  AppliChem 
Bovine serum albumin  BioRad 
Bromphenol blue Merck 
Calcium carbonate  AppliChem 
Calcium chloride  AppliChem 
Chitosan Roth 
Chloramphenicol Sigma 
Chloroform Roth 
Coomassie R250 Pierce 
Cycloheximide Sigma 
2,4-dichlorophenoxyacetic acid Sigma-Aldrich 
Dichlormethan Sigma-Aldrich 
Deuterated methanol  Sigma-Aldrich 
Deuterated chloroform  Sigma-Aldrich 
Dipotassium hydrogen phosphate  Roth 
Disodium hydrogen phosphate  Sisma 
Dimethylformamide AppliChem 
Dimethylsulfoxide Sigma 
Ethanol absolute  Merck 
Ethanol denatured  Roth 
Ethidium bromide (1% solution)  Roth 
Ethyl acetate Roth 
Ethylenediamine tetraacetic acid dihydrate  Serva 
Ferric ammonium citrate AppliChem 
Ferrous sulfate heptahydrate  Fluka 
Formaldehyde Roth 
Gamborg B5 medium Roth 
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Chemical name Manufacturer 
Gentamicin Sigma 
Glucose  AppliChem 
Glutamine Sigma 
Glutaraldehyde Sigma 
Glycerin  Roth 
Glycin Roth 
Hydrochloric acid  AppliChem 
Isopropanol  Roth 
Isopropyl--D-1-thiogalactopyranoside (IPTG) Sigma 
LS medium Roth 
Malt extract AppliChem 
Magnesium chloride hexahydrate  AppliChem 
Magnesium sulfate heptahydrate  AppliChem 
Mannitol AppliChem 
Marfey's reagent Fluka 
Methanol Sigma, Roth 
Methyl jasmonate Sigma-Aldrich 
Naphthalene acetic acid Sigma 
Nalidixic acid Sigma 
Nystatin Sigma 
Peptone Roth 
Polygalacturonic acid Sigma 
Phenol  AppliChem 
PMSF Roth 
Potassium bromide  AppliChem 
Potassium chloride  Fluka 
Potassium pyruvate Roth 
Potassium nitrate  AppliChem 
Salicylic acid Sigma 
Serine Sigma 
Silver nitrate  Roth 
Sodium acetate trihydrate  AppliChem 
Sodium bicarbonate  Merck 
Sodium carbonate  Merck 
Sodium chloride  Roth 
Sodium dihydrogen phosphate  Sigma 
Sodium dodecyl sulfate  AppliChem 
Sodium fluoride  Fluka 
Sodium glycerophosphate Roth 
Sodium hydroxide AppliChem 
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Chemical name Manufacturer 
Sodium propionate  AppliChem 
Sodium sulfate  Merck 
Sodium thiosulfate  AppliChem 
Starch Roth 
Streptomycin Sigma 
Strontium chloride  Fluka 
Sucrose Roth 
TEMED (N,N,N',N'-Tetramethylethylendiamin) Roth 
Threonine Sigma 
Trifluoroacetic acid  Sigma 
Tris (hydroxymethyl) aminomethane hydrochloride  Sigma 
Triton X-100 AppliChem 
Tryptone Roth 
Tyrosine Sigma 
Urea Roth 
X-Gal (5-bromo-4-chloro-3-indolyl-β-D-galactoside)  Sigma 
XAD-16 resin sigma 
Yeast extract Gibco 
 
 
VIII. Software 
 
Software Application 
Align Sequence alignment and editing 
Antimarin Database Marine natural products database 
ARB Construction of phylogenetic tree  
Basic Local Alignment Search Tool (Blast) Searching within the sequences 
stored in the database 
ChemDraw Drawing of chemical structure  
ClustalX Alignment of sequences 
Multianalyist 1.1 Documentation of agarose and 
polyacrylamide gels  
Topspin 21 Visualisation of spectral data 
Treeview Visualisation of phylogenetic tree 
Vector NTI  AdvanceTM 10 Opening and editing of sequences 
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IX. Enzymes and Kits 
 
Enzyme/ Kit Manufacturer 
ABI PrismTM Big Dye TM terminator cycle sequencing ready 
reaction kit 
Applied 
Biosystems  
FastDNA® spin kit for soil Q-Biogene          
Lysozyme Sigma 
Proteinase K Sigma 
pGEM-Teasy vector system   Promega 
QIAquick PCR purification kit  Qiagen 
REDTaq® ReadyMixTM PCR reaction mix Sigma 
Restriction endonucleases and buffers New England 
Biolabs  
RNase  Roche 
Taq DNA polymerase and buffer Qiagen 
T4 DNA ligase and buffer New England 
Biolabs 
Molecular weight markers   
          GeneRulerTM 1kb DNA ladder Fermentas 
          GeneRulerTM 100bp DNA ladder Fermentas 
          FastRulerTM DNA Ladder, high range Fermentas 
Stained protein molecular weight marker                 Fermentas 
Prestained protein molecular weight marker                 Fermentas 
 
 
X. Laboratory equipments  
 
Equipment/ Supplies Manufacturer 
Autoclave (Tec 120, 9191E, FV 3.3) Fedegari 
                 (Varioklav 500, 135S) H+P Labortechnik
Benchtop centrifuge (Biofuge Frasco) Hereaus 
Instruments 
Distilling apparatus for H2Odd (Bi-Dest 2304) GFL 
Disposable cuvettes (halbmikro 1,5 ml) Plastibrand 
ELISA plate reader (Multiskan Ascent) Thermo Electron 
Gel documentation (Gel Doc 2000) BioRad 
Gel electrophoresis chamber BioRad 
Heat block (Digi-Block Jr.) Laboratory 
Devices 
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Equipment/ Supplies Manufacturer 
HPLC JASCO 
HPLC columns (Chromolith RP18) Phenomenex 
Ice maker (AF-20) Scotsman 
Incubator (Kelvitron®t) 
                (TV 40b) 
Heraeus 
Memmert 
Magnetic stirrer (L32) Labinco 
Micropipettes (MicroOne 0,5-10 l) Microlab 
Micropipettes(MicroOne 2.0-20 µl) 
                      (MicroOne 20-200 µl) 
                      (MicroOne 100-1000 µl) 
Microlab 
Microlab 
Microlab 
Microwave (Micromat) 
                   (8020) 
AEG 
Privileg 
MS (Micromass Q-TOF, MicroTOF) Bruker Daltonik 
NMR (400, 600 MHz) Bruker 
PCR cycler (T3-Thermocycler) Biometra 
pH Meter (MultiLine P4, SenTix 41) WTW 
Rotary evaporator (Laborota 4010) Heidolph 
Sequencer (ABI 377XL) ABI Prism 
Spectrophotometer (Ultraspec 3000) Pharmacia Biotech 
Speedvac concentrator (Savant) Thermo Scientific 
Shakers (Certomat U) 
              (SM-30) 
              (Rotationsmischer 3300) 
              (HT) 
Braun 
Edmund Bühler 
Eppendorf 
Infors 
 
 
XI. Microorganisms 
 
Microorganism Application 
Bacillus subtilis  ATCC 6051 Bioactivity testing 
Candida albicans 5314 Bioactivity testing 
Candida maltosa SBUG 700 Bioactivity testing 
Enterococcus faecalis JH212 Bioactivity testing 
Enterococcus faecium 6413 Bioactivity testing 
Escherichia coli ATCC 11229 Bioactivity testing 
Escherichia coli 536 Cloning 
Escherichia coli XL1-Blue Bioactivity testing 
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Microorganism Application 
Leishmania major Bioactivity testing 
Pseudomonas aeruginosa Nr. 3 Bioactivity testing 
Pseudomonas aeruginosa ATCC 22853 Bioactivity testing 
Staphylococcus aureus NCTC 8325 Bioactivity testing 
Staphylococcus aureus ATCC 6538 Bioactivity testing 
Staphylococcus epidermidis RP62A Bioactivity testing 
Trypanosoma brucei brucei 221 Bioactivity testing 
Yersinia pseudotuberculosis 252 01A Bioactivity testing 
Yersinia pestis KUMA Bioactivity testing 
 
 
XII. Oligonucleotide primers 
 
Oligonucleotide Sequence 5’ – 3’ Annealing (C) Specificity 
27f GAGTTTGATCCTGGCTCA 56 Bacterial 16S rRNA 
gene (universal) 
1492r TACGGCTACCTTGTTACGACTT 56 Bacterial 16S rRNA 
gene (universal) 
SP6 ATTTAGGTGACACTATAG 45 Sequencing of 
cloning vectors 
T7 GTAATACGACTCACTATAGGG 45 Sequencing of 
cloning vectors 
 
 
XIII. Plant cell cultures 
 
Cell culture        Source 
Agrostis tenuis Prof. M. J. Müller (Würzburg, Germany) 
Arabidopsis thaliana Prof M. H. Zenk (München, Germany) 
Baphicanthus cusi Prof. M. J. Müller (Würzburg, Germany) 
Daucus carota Prof. M. J. Müller (Würzburg, Germany) 
Lavendula angustifolia Prof. M. J. Müller (Würzburg, Germany) 
Nicotiana tabacum petit havanna Prof. M. J. Müller (Würzburg, Germany) 
Rauvolfia verticillata Prof. M. J. Müller (Würzburg, Germany)
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XIV. Special laboratory tools 
 
Tool Manufacturer 
Cryotubes (1.5 ml) Greiner Bio-One 
Eppendorf tubes Sarstedt 
Falkon tubes (50 ml) Cell star 
Filter paper discs (5 mm) Roth  
96-well plates Greiner Bio-One 
Parafilm Pechiney          
PCR tubes (0.5 ml) B. Braun 
Pipette tips  Sarstedt 
Petri Dishes (145/20 mm) Greiner Bio-One 
Petri Dishes (60/20 mm) Greiner Bio-One 
Syringe filters (0.2 µm) Schleicher & Schuell 
Serological pipettes   Sarstedt 
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1. Abdelmohsen UR, Pimentel-Elardo SM, Hanora A, Radwan M, Abou-El-Ela SH, 
Ahmed S and Hentschel U (2010). Isolation, phylogenetic analysis and anti-infective 
activity screening of marine sponge-associated actinomycetes. Marine Drugs 8: 399-
412. 
2. Abdelmohsen UR, Ali W, Eom SH, Hentschel U and Roitsch T. Screening for 
antimicrobial activities from elicited plant cell suspension cultures. Plant Cell Tissue 
and Organ Culture (submitted, August 2010).  
3. Angermeier H, Kamke J, Abdelmohsen UR, Krohne G, Pawlik JR, Lindquist NL and 
Hentschel U. The pathology of Sponge Orange Band disease affecting the Caribbean 
barrel sponge Xestospongia muta. FEMS Microbiology Ecology (submitted, June 
2010).  
4. Naseem M, Großkinsky D, Abdelmohsen UR, Plickert N, Engelke T, Griebel T, Zeier 
J, Strnad M, Pfeifhofer H, van der Graaff E, Simon U and Roitsch, T. Cytokinin-
mediated resistance against Pseudomonas syringae in tobacco is independent of 
salicylic acid signalling and accompanied by increased antimicrobial phytoalexin 
synthesis. PLOS Pathogens (submitted, September 2010). 
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Symposia  
 
 
10-13 Oct 2007, DPhG Jahrestagung, Institute of Pharmaceutical Biology, Erlangen, 
Germany. Poster presentation (Screening, purification and characterization of antimicrobial 
proteins from plant cell cultures). 
 
10 Oct 2008, 36th Natural Products Meeting: Chemistry, Biology and Ecology, Institute of 
Organic Chemistry, Würzburg, Germany. 
 
20-22 Nov 2008, 4th Joint Ph.D. Students Meeting, SFB 630, SFB 544 and SFB 766, Kloster 
Bronnbach, Germany. 
 
26-27 Mar 2009, 4th International Symposium: Research evolution, Graduate School of Life 
Sciences, Würzburg, Germany. 
 
15 May 2009, 37th Natural Products Meeting: Chemistry, Biology and Ecology, Institute of 
Organic Chemistry, Bayreuth, Germany. 
 
19-21 Nov 2009, Ph.D. Students Meeting, SFB 630, Heidelberg, Germany. Poster 
presentation (Isolation, phylogenetic analysis and antimicrobial activity screening of marine 
sponge-associated actinomycetes). 
 
Workshops 
 
28th May 2009, Poster Design and Presentation, Graduate School of Life Sciences, 
Würzburg, Germany. 
 
15th Jan 2010, Writing for Publication, Graduate School of Life Sciences, Würzburg, 
Germany. 
 
12th Mar 2010, Giving Academic Talks, Graduate School of Life Sciences, Würzburg, 
Germany. 
 
16th Apr 2010, 39 Natural Products Meeting: Chemistry, Biology and Ecology, Max-Planck 
Institute of Chemical Ecology, Jena, Germany. 
 
27th Apr 2010, Literaturverwaltung mit EndNote, Universitätsbibliothek, Würzburg, Germany. 
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